Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.142803241511937,0.00296965009822839,0.136982727319409,0.148623755704464,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLR,Low-density lipoprotein receptor,42644,0.301398722371327,0.00424419636418788,0.293080097497519,0.309717347245135,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.220780853026773,0.00260372836568934,0.215677545430022,0.225884160623524,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI,Tissue factor pathway inhibitor,42618,0.119979810978996,0.00282814955272606,0.114436637855653,0.125522984102339,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN1,CCN family member 1,42569,0.249919694294172,0.00681837262983774,0.23655568393969,0.263283704648654,2.28759574380207e-280
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.194709361140778,0.00549058669684094,-0.205470911066586,-0.183947811214969,2.75802826079787e-263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPY,Pro-neuropeptide Y,42721,0.210252874027873,0.00599753402503645,0.198497707338801,0.222008040716944,8.81255660660614e-258
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0719271575580962,0.00205548076495138,0.0678984152587915,0.0759558998574009,7.66750116566394e-255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRP,Agouti-related protein,42754,0.166723823513482,0.00482219559859306,0.157272320140239,0.176175326886724,4.15263562303113e-251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOM,Apolipoprotein M,42663,0.0884166481765725,0.00264228135705626,0.0832377767167422,0.0935955196364027,6.74882463608027e-236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROC,Vitamin K-dependent protein C,42663,0.0765852505755727,0.00235362447579371,0.0719721466030171,0.0811983545481284,1.1983787540913e-223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0758098453418971,0.00239861267970453,0.0711085644896763,0.080511126194118,1.32445834726561e-211
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APCS,Serum amyloid P-component,40419,0.100995794981556,0.00320028939771756,0.0947232277620297,0.107268362201083,1.65739049561287e-209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOC1,Apolipoprotein C-I,40516,0.10236838625433,0.00347765508377207,0.0955521822901372,0.109184590218524,1.40300375654028e-183
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F7,Coagulation factor VII,42671,0.0848724746787327,0.00292666365867011,0.0791362139077393,0.0906087354497261,2.02298014588872e-179
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.114101826641652,0.00398996077330715,0.10628150352597,0.121922149757334,1.11517589199717e-174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP1,Neuropilin-1,42705,-0.075031268338223,0.00262496592580322,-0.0801762015527973,-0.0698863351236487,1.58458035327372e-174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.199102439748262,0.00709274632653429,0.185200656948255,0.213004222548269,1.15968915125339e-167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFP,Properdin,40539,0.0580711669517264,0.0021102841020633,0.0539350101116824,0.0622073237917705,1.97807244676969e-161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHR,Growth hormone receptor,40283,0.0735120865979814,0.00267994974426068,0.0682593850992305,0.0787647880967323,2.48055268028536e-160
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA5,Plasma serine protease inhibitor,40387,0.0779342578836926,0.00298967810233627,0.0720744888031135,0.0837940269642717,1.76146638720055e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLKB1,Plasma kallikrein,40293,0.0609200351861206,0.00233779549079827,0.056337956024156,0.0655021143480852,2.3845622304909e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL23,C-C motif chemokine 23,42676,0.103088499078763,0.00398026373364352,0.095287182160822,0.110889815996705,2.20208612042514e-144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFGE8,Lactadherin,42611,0.106804705538095,0.00414182870655164,0.0986867212732539,0.114922689802936,3.71543401281506e-143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0458393722617165,0.00180002031881836,0.0423113324368326,0.0493674120866005,9.66171149221064e-140
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0894583548102798,0.00350774289653693,0.0825831787330674,0.0963335308874922,1.5528993734436e-139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42652,0.086492018058331,0.00339938948432975,0.0798292146690447,0.0931548214476173,1.61577911913262e-139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL27,C-C motif chemokine 27,42636,0.137782228385766,0.00561224406347958,0.126782230021346,0.148782226750186,3.10247668421114e-130
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0738522737610002,0.00302221145461979,0.0679287393099454,0.079775808212055,4.38163583579679e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.0755031003425535,0.00312155955065385,0.069384843623272,0.081621357061835,1.43633032471518e-126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAMR1,Inactive serine protease PAMR1,42611,0.0612263646903256,0.00254904632127478,0.056230233900627,0.0662224954800242,7.41548796760004e-125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTR,Transthyretin,40424,0.0575484962723574,0.00240774390310146,0.0528293182222786,0.0622676743224363,3.42234558470266e-123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCHE,Cholinesterase,40346,0.0620550796747433,0.00265861684723138,0.0568441906541698,0.0672659686953168,1.09355437831426e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCA,Alpha-synuclein,40283,0.255870235738757,0.0109701308504603,0.234368779271855,0.277371692205659,1.64948267146556e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.180089138659159,0.00773754290600562,0.164923554563388,0.19525472275493,1.86051297943728e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.0755796950556133,0.00328766482798388,0.0691358719927648,0.0820235181184617,9.4024336066822e-115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.188884809533382,0.0082426915439951,0.172729134107151,0.205040484959612,5.01538405499082e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYAP1,Synapse-associated protein 1,40283,0.125084777223376,0.00545948275013356,0.114384191033114,0.135785363413638,1.50863986216009e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,P4HB,Protein disulfide-isomerase,42563,0.0827271714554492,0.0036495114687515,0.0755741289766962,0.0898802139342021,1.16426957304664e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF2,Alpha-2-antiplasmin,40317,0.0293514540375177,0.0012926473285074,0.0268178652736432,0.0318850428013922,1.3016670567006e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42679,0.0531722798722129,0.00235760134229763,0.0485513812413095,0.0577931785031162,1.35983179010394e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROS1,Vitamin K-dependent protein S,40539,0.0562081822234065,0.00249897399218615,0.0513101931987216,0.0611061712480913,1.20213734033782e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FURIN,Furin,42679,0.0698760666039504,0.00311230956528054,0.0637759398560005,0.0759761933519002,1.24865443126469e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA4,Kallistatin,40342,0.0514515544072755,0.00230410368314765,0.0469355111883061,0.0559675976262449,4.30226281807989e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0847646883860748,0.00382114241015875,-0.092254127509986,-0.0772752492621637,4.13574227809412e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN3,Contactin-3,42611,0.0656306927867606,0.0029826181579964,0.0597847611970877,0.0714766243764336,1.89558922954436e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.218633150270171,0.0099731099595029,0.199085854749545,0.238180445790796,1.09317030201071e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES1,Liver carboxylesterase 1,42661,0.169570163298655,0.00773771750789423,0.154404236983182,0.184736089614128,1.25318298018824e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.237828642470293,0.0108686418211796,0.216526104500781,0.259131180439805,2.54031317750137e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.164932391841022,0.00758186077458679,0.150071944722831,0.179792838959212,3.86357386470765e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP6,Charged multivesicular body protein 6,40511,0.11533542815262,0.00534815207719754,0.104853050081313,0.125817806223928,4.04858036877453e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.040368313790103,0.00189429961988094,0.0366554865351364,0.0440811410450697,4.40275165624782e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH,Parathyroid hormone,40182,0.166799536084148,0.0078350078698315,0.151442920659278,0.182156151509017,1.38442943043984e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRN,"Attractin, Isoform 2",40539,0.0340415545878011,0.00160571360349797,0.0308943559249451,0.0371887532506571,7.4065077793367e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPL,Lipoprotein lipase,42636,-0.0936571610994866,0.00446414129752136,-0.102406878042628,-0.0849074441563448,3.46021434616391e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB2,Carboxypeptidase B2,40516,0.0442226947886407,0.00212939199111529,0.0400490864860547,0.0483963030912267,4.74157472200141e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL6,C-X-C motif chemokine 6,42754,0.151303041007,0.00732480926527533,0.136946414847061,0.16565966716694,2.33324479131326e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.22749152400869,0.0110776696989928,-0.249203756618716,-0.205779291398665,2.66069046905174e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFH,Complement factor H,39956,0.0451310012063098,0.00219481018713472,0.0408291732395257,0.0494328291730938,3.46436095831268e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.291744231616781,0.0143655803876808,0.263587694056927,0.319900769176635,2.52613755439845e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42705,0.091443270531514,0.00450597652986044,0.0826115565329875,0.10027498453004,3.21077794345371e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR5,Cadherin-related family member 5,42636,0.0747302020815137,0.00371675736085183,0.0674453576542441,0.0820150465087833,1.2988294808599e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A5,Zinc transporter ZIP5,42594,0.102626817791303,0.00516394538657877,0.0925054848336085,0.112748150748997,1.21062495156596e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.259787798427213,0.0132403442411724,0.233836723714515,0.285738873139911,2.60524782419949e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.136554559485742,0.00699128743097249,0.122851636121036,0.150257482850448,8.70275497565817e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0409672588648649,0.00209946248075363,0.0368523124025877,0.045082205327142,1.25845946203568e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN2,Ficolin-2,42597,0.0766575467612242,0.00394293183669544,0.0689294003613011,0.0843856931611472,4.74628425238974e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F10,Coagulation factor X,40532,0.0529689787942355,0.00272479006306718,0.0476283902706239,0.0583095673178472,7.89107500559355e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAPIN,SNARE-associated protein Snapin,40482,0.106675324165791,0.00551357741028471,0.0958687124416328,0.117481935889949,4.50870610898901e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.0959816721138196,0.00497075538827075,0.086238991552809,0.10572435267483,5.68207617814059e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUSB,Beta-glucuronidase,42711,0.112374049210345,0.00582189930421573,0.100963126574083,0.123784971846608,6.52168926422329e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FN1,Fibronectin,40539,0.049465891149566,0.00256186388386934,0.0444446379371821,0.0544871443619499,9.26627770727112e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,42346,0.201419609762095,0.0105208093548081,0.180798823426671,0.222040396097519,1.32840930851162e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUMB,Protein numb homolog,40199,0.150633049975606,0.0078978542589109,0.135153255628141,0.166112844323072,8.20364697576128e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBC,Inhibin beta C chain,42611,0.0747703933299364,0.00393722201464455,0.0670534381812331,0.0824873484786397,2.23350102504946e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG2,Desmoglein-2,42611,-0.0494339420856636,0.00261521452898949,-0.054559762562483,-0.0443081216088442,1.14238449711048e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0462246078200137,0.00244802578611342,0.0414264772792314,0.051022738360796,1.66556241642479e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42640,0.0723913013403738,0.00385024495484924,0.0648448212288693,0.0799377814518783,7.26370372311967e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,42476,0.0422970125697738,0.00225597431272563,0.0378753029168315,0.046718722222716,1.96897748800033e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREG1,Protein CREG1,42445,0.0693880037628511,0.00370232715592319,0.0621314425372416,0.0766445649884606,2.25683828897487e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,40199,0.152151128820861,0.00811300959029516,0.136249630023883,0.16805262761784,2.85965020200513e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORT1,Sortilin,42613,0.0663693869143605,0.00354952268989979,0.0594123224421569,0.073326451386564,4.87209955850806e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.12421037970313,0.00663753318997845,0.111200814650773,0.137219944755488,5.64239445674803e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0418749636036164,0.00226489254515898,0.0374357742151048,0.046314152992128,2.16952158859834e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42587,0.218215551290408,0.0118262484973566,0.195036104235589,0.241394998345227,4.28847140695633e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA80,N-alpha-acetyltransferase 80,40182,0.213029041600221,0.0115670716180297,0.190357581228883,0.235700501971559,1.2701169301513e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.106608088831234,0.00579812127250647,0.0952437711371208,0.117972406525346,1.38517987432148e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTD,Biotinidase,40539,0.0364696401411668,0.00198247681410348,0.0325839855855239,0.0403552946968096,1.70454247301107e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.0340821402430436,0.00185538144393037,0.0304455926129401,0.0377186878731471,1.8438654095138e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRL,Appetite-regulating hormone,42636,0.149060597647674,0.00817526567862448,0.13303707691757,0.165084118377778,2.15502628709283e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0348843832579172,0.00192776327004936,0.0311059672486205,0.038662799267214,2.4956839257476e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1S,Complement C1s subcomponent,40539,0.0363103741862441,0.00200489129430906,0.0323807872493984,0.0402399611230899,2.71516710747592e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFI,Complement factor I,40539,0.0339122963642859,0.00188444312452804,0.0302187878402109,0.0376058048883608,2.05453656586337e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0467708296077197,0.00260521177720472,0.0416646145243984,0.0518770446910409,3.11615535387813e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJAP1,Tight junction-associated protein 1,42679,0.141702076904908,0.00789756797275943,0.1262228436783,0.157181310131517,3.68427002832415e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EEF1D,Elongation factor 1-delta,40511,0.155606379336256,0.00878433079017617,0.138389090987511,0.172823667685002,2.80119665682787e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.118268786248772,0.00669650568642694,0.105143635103375,0.131393937394168,5.04168042514275e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F13B,Coagulation factor XIII B chain,40479,0.0440252187702338,0.00249805471859704,0.0391290315217836,0.048921406018684,1.33731455844997e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO3,Beta-enolase,40223,0.100046577802253,0.00567626779633561,0.0889210929214356,0.111172062683071,1.36482953579595e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS4,Galectin-4,42618,-0.0954978068537168,0.00544064142143307,-0.106161464039726,-0.084834149667708,3.27366435107356e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REN,Renin,42636,-0.144711508284932,0.00825268091915391,-0.160886762886474,-0.12853625368339,4.42005103417092e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTYMK,Thymidylate kinase,40511,0.114093167942068,0.00653381062246903,0.101286899122029,0.126899436762107,2.12771787143767e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42679,0.152717722960009,0.00875584063446119,0.135556275316465,0.169879170603553,2.17798250158206e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0669376772214789,0.00383852521043085,0.0594141678090344,0.0744611866339233,3.19624347047875e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD4,T-cell surface glycoprotein CD4,42570,0.0516859350157657,0.00298425663059573,0.0458367920197981,0.0575350780117334,1.77647654752488e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0468724104627714,0.00271407266200852,0.0415528280452347,0.0521919928803081,4.01869150749991e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.058215213682672,0.00337950622250734,-0.0648390458787864,-0.0515913814865576,8.56800786121983e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0357961273901068,0.00208490186386021,0.0317097197369408,0.0398825350432729,3.1358992145003e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42594,0.0694708557266385,0.00405690143304878,0.0615193289178629,0.0774223825354141,4.81958980292034e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFM,Afamin,40539,0.0329144686568942,0.00192291836398583,0.0291455486634819,0.0366833886503064,7.21726773410915e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIP2,Cysteine-rich protein 2,42495,0.0600194666891929,0.00352985117119178,0.053100958393657,0.0669379749847288,3.68563213082909e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.129038336168961,0.00759557549399005,0.11415100820074,0.143925664137181,6.22523227088054e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS6,Growth arrest-specific protein 6,42718,-0.0414146264087312,0.00244214689510504,-0.0462012343231371,-0.0366280184943253,7.62722220526886e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.157233260048244,0.00927357172385695,0.139057059469484,0.175409460627004,8.1709426305413e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEFTY2,Left-right determination factor 2,42689,0.0815143589147389,0.00481163040074949,0.0720835633292699,0.0909451545002079,1.01858011757255e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.182471808319334,0.0107591491248553,0.161383876034618,0.203559740604051,1.03096205170269e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.101049253505993,0.00596934851081834,-0.112749176587197,-0.0893493304247892,1.25509908335759e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAT,Tissue-type plasminogen activator,42760,0.0821764488892589,0.00485991002606265,0.0726510252381761,0.0917018725403417,1.7226588284314e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.110253574729478,0.00652488374348385,0.0974648025922501,0.123042346866707,2.18943591104966e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FYB1,FYN-binding protein 1,42590,0.148004505595224,0.00883401427614652,0.130689837613977,0.165319173576471,2.28338482840536e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YES1,Tyrosine-protein kinase Yes,42587,0.182006702174849,0.0108884702911688,0.160665300404158,0.20334810394554,4.29533162085552e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR3,Anterior gradient protein 3,42326,0.0961160216425738,0.00575853861528446,0.0848292859566162,0.107402757328531,6.60640468864543e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAB2,Stabilin-2,40527,0.0451409177855396,0.00270236155331826,0.0398442891410359,0.0504375464300434,6.69459300875944e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SARG,Specifically androgen-regulated gene protein,40456,0.174284246826969,0.0104536255718657,0.153795140706112,0.194773352947826,1.14353935064676e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0601784346698704,0.0036143148900483,-0.0672624918543651,-0.0530943774853758,1.24472344887357e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THPO,Thrombopoietin,42357,0.0624059874627986,0.00375772693210324,0.0550408426758763,0.0697711322497209,2.58879972826816e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0660394385529873,0.00398077248168571,-0.0738417526170913,-0.0582371244888833,3.36861146627425e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC5,Glypican-5,42495,0.0900458232471258,0.00543362660280663,0.0793959151056248,0.100695731388627,4.54616590153699e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON2,Spondin-2,42562,-0.0573952727667163,0.00346377694835915,-0.0641842755855002,-0.0506062699479324,4.65016257423552e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH9,Myosin-9,40527,0.182682394388703,0.0110222008120341,0.161078880797116,0.20428590798029,5.59116020040685e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRP,Gastrin-releasing peptide,40223,0.0896464437426212,0.00541015903019989,0.0790425320434294,0.100250355441813,6.24113785088786e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.0940389748201973,0.00568243169098861,0.0829014087058596,0.105176540934535,6.70326013707874e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZN,Kazrin,40449,0.165817375563105,0.0100218586070049,0.146174532693376,0.185460218432835,8.97395271329039e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0657306490819672,0.00401958722096871,0.0578522581288686,0.0736090400350659,1.59179636480543e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2,Prothrombin,40539,0.0234994417659948,0.00143760501428208,0.0206817359380019,0.0263171475939877,2.20298096108418e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPD52L2,Tumor protein D54,40283,0.168624598962498,0.010324401802507,0.148388771429584,0.188860426495412,2.83869790139905e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOST,Sclerostin,42613,0.0609581517515928,0.00375742360583935,0.0535936014841477,0.068322702019038,1.2440444102862e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHBP1,EH domain-binding protein 1,40511,0.1158467384817,0.00714856130200592,0.101835558329768,0.129857918633631,2.08782706523907e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.0832774314251125,0.00514744782633334,0.0731884336854991,0.0933664291647258,2.57852322985328e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.166293782419058,0.0102750636707893,0.146154657624311,0.186432907213805,2.93294313907052e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFC,Platelet-derived growth factor C,42346,0.0443046684362201,0.00274826540849824,0.0389180682355636,0.0496912686368767,6.51773228779459e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.138015271978451,0.0085715998041176,0.121214936362381,0.154815607594522,8.77193470694334e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP10,Stromelysin-2,42608,-0.0911336831579626,0.00566340617106819,-0.102233959253256,-0.080033407062669,1.0118569019234e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINK1,Misshapen-like kinase 1,40483,0.143607384411951,0.008917725208026,0.12612864300422,0.161086125819682,1.05558151835479e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXIN1,Axin-1,42594,0.146517183098268,0.00910693899973251,0.128667582658792,0.164366783537744,1.06504490555713e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAB2,Disabled homolog 2,42721,0.168668978438945,0.0104935774471642,0.148101566642503,0.189236390235387,1.33472956657391e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42676,0.189882737681298,0.0118744483833545,0.166608818849923,0.213156656512672,4.94548530654728e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPIND1,Heparin cofactor 2,40516,0.0433382641295809,0.0027140242675909,0.0380187765651027,0.048657751694059,8.84507708270061e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES3,Carboxylesterase 3,42587,0.108005636069328,0.00678715404411516,0.0947028141428622,0.121308457995794,1.68830857082622e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.149052421944318,0.00936093355689448,0.130704992172805,0.167399851715832,1.80949682926234e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42587,0.101930541747343,0.00642897053682852,0.0893297594951587,0.114531323999527,4.2091100985039e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.0504019233698896,0.00318282696589561,0.0441635825167342,0.056640264223045,5.69091880167623e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0685277009727465,0.00432492847812995,-0.0770045607898812,-0.0600508411556118,6.10828725115469e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.147337862463929,0.0093268051488336,0.129057324372215,0.165618400555643,1.03407403700695e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.163189131778131,0.0103223399720109,0.14295734543299,0.183420918123272,1.0605665842894e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGL1,Fibrinogen-like protein 1,40532,-0.100418280729563,0.00635393160365322,-0.112871986672723,-0.0879645747864023,1.14301179976235e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADIPOQ,Adiponectin,40539,-0.105462375464124,0.00668266508441962,-0.118560399029587,-0.0923643518986617,1.62250917797648e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.122849329064146,0.00780247610935002,0.10755647588982,0.138142182238472,2.3067960929644e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.126559208357387,0.0080321900226804,0.110816115912933,0.142302300801841,2.46386141154914e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.159276317206637,0.0101807982510379,0.139321952634603,0.179230681778671,1.09787196321993e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.126014260182544,0.00805207401235384,0.11023219511833,0.141796325246757,1.24574371745276e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.12126928873768,0.00775547073822514,0.106068566090759,0.136470011384601,1.53138346425174e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS2,Protein MTSS 2,40451,0.148268485158134,0.00949160234258637,0.129664944566665,0.166872025749603,1.94898546211206e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLTP,Phospholipid transfer protein,42752,-0.0538353185687857,0.00345589938930277,-0.0606088813718191,-0.0470617557657522,3.03990272321916e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0653975561954484,0.00420020601593637,0.0571651524042131,0.0736299599866837,3.46795770954629e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YTHDF3,YTH domain-containing family protein 3,42370,0.126967751602125,0.00817065293305935,0.110953271853328,0.142982231350921,5.64405660929526e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS1,Protein MTSS 1,40449,0.167260925722342,0.0107594185268424,0.146172465409731,0.188349386034953,6.19442185025963e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.157721827969338,0.01014513086905,0.137837371466,0.177606284472676,6.20224795467859e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL16,Pro-interleukin-16,42754,0.0615437108726169,0.00398168882227129,0.0537396007809652,0.0693478209642686,1.94119821126843e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL22,C-C motif chemokine 22,42509,0.078895462069294,0.005105709986721,0.0688882704953208,0.0889026536432671,2.11221986086176e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.153635769424071,0.00997519206439542,0.134084392977856,0.173187145870286,4.53317603659547e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL5,C-X-C motif chemokine 5,42605,0.168064225143516,0.0109173635169424,0.146666192650308,0.189462257636723,5.08158286088518e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.0975595543074904,0.00635043005426805,0.085112711401125,0.110006397213856,8.36842153145896e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL3,C-X-C motif chemokine 3,42620,0.137556181820692,0.00896484938896553,0.119985077018319,0.155127286623064,1.08790349665029e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,40483,0.13099088030294,0.00854326451664611,0.114246081850313,0.147735678755566,1.56336974838435e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0437005684135145,0.00285090834957539,0.0381127880483467,0.0492883487786822,1.65571762091823e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,42311,0.115152818710955,0.00752272526534681,0.100408277190876,0.129897360231035,1.9384571327509e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.151316424029432,0.00987813399147296,0.131955281406145,0.170677566652719,1.99584908324105e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0448113473786141,0.00292842486236412,0.0390716346483805,0.0505510601088478,2.482490963348e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A4,Protein S100-A4,42679,0.0834323855700459,0.00548429204347222,0.0726831731648403,0.0941815979752514,7.80843023861387e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.150272178635388,0.00991681868501098,0.130835214012766,0.169709143258009,1.91428606782055e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,40482,0.16546915094671,0.0109179952738001,0.144069880210062,0.186868421683358,2.22475340812041e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFX1,Transcriptional repressor NF-X1,40116,0.0995560544315433,0.00657306066712581,0.0866728555239767,0.11243925333911,2.66602234345931e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.104802574067962,0.0069331860352561,0.0912135294388602,0.118391618697064,3.41355844659315e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFC,Vascular endothelial growth factor C,42679,0.0808192910000061,0.00534980325011339,0.0703336766297838,0.0913049053702283,3.81742909023165e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.0838071552260046,0.00554741466221802,0.0729342224880573,0.0946800879639519,3.84156643119254e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG16L1,Autophagy-related protein 16-1,40449,0.122738856147898,0.00813534829385754,0.106793573491937,0.138684138803859,6.19066501729219e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGCC,Regulator of cell cycle RGCC,40482,0.109578028148931,0.00726365772120859,0.0953412590153617,0.123814797282499,6.29179369035744e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11,Coagulation factor XI,40383,0.0440162949611397,0.00291835057654243,0.0382963278311165,0.0497362620911628,6.66390512466746e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF9,Protein turtle homolog A,40511,0.120798966114664,0.00801060723531327,0.10509817593345,0.136499756295878,6.84969660266795e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,40283,0.119813023196095,0.00794761693982587,0.104235693994036,0.135390352398154,7.49769316549578e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK10,Kallikrein-10,42636,0.0590505531281224,0.0039225376123586,0.0513623794078995,0.0667387268483453,8.40604483723767e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC3B,Tetranectin,40269,0.0306744869762673,0.00203652248726569,0.0266829029012265,0.034666071051308,9.12543412983521e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOMO1,Nodal modulator 1,42611,0.0335764573593004,0.00223167646288075,0.0292023714920541,0.0379505432265467,9.59403044871721e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLN,Promotilin,42594,0.128915054724626,0.00856836976173888,0.112121049991618,0.145709059457634,9.59661296868944e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.122199721076384,0.00811759042118728,0.106289243850856,0.138110198301911,1.0399071712579e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,42357,0.0506810597279854,0.00338078958888154,0.0440547121337776,0.0573074073221932,2.19240167309388e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFR,Epidermal growth factor receptor,42794,0.0236143758171968,0.00157622382926365,0.0205249771118401,0.0267037745225536,2.44005219465678e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOL1,Apolipoprotein L1,40532,0.0842888771094256,0.00562974785302547,0.0732545713174956,0.0953231829013555,3.37044831178225e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R9B,Neurabin-2,42754,0.134883263049923,0.00901644970465166,0.117211021628805,0.15255550447104,3.38400887860319e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APPL2,DCC-interacting protein 13-beta,40283,0.160276220272333,0.0107101691418715,0.139284288754265,0.181268151790401,3.83982607556555e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNA4,Plexin-A4,42594,0.117750436326955,0.00789803817564554,0.10227028150269,0.133230591151221,7.24615438932501e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINC1,Antithrombin-III,40516,0.0212337835467242,0.00142515575119362,0.0184404782743847,0.0240270888190637,9.8486042250222e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBIN,Erbin,42587,0.145998076377754,0.00981288315513516,0.126764825393689,0.165231327361819,1.13761099842329e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,40449,0.136223418743631,0.00915536670029565,0.118278900011051,0.15416793747621,1.33281535232346e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.159080896217857,0.010704377880911,0.138100315571272,0.180061476864443,1.4578257364018e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0368383537015984,0.00248581299674942,0.0319661602279695,0.0417105471752273,3.25882653750445e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD7B,OTU domain-containing protein 7B,40482,0.0882550709331101,0.00596861210528005,0.0765565912067612,0.099953550659459,5.13825888098479e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN1,Dynactin subunit 1,42721,0.0918048896194043,0.00622911416605288,0.0795958258539406,0.104013953384868,8.77381330447331e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL13,C-X-C motif chemokine 13,42711,0.0889704674733075,0.00604764308685642,0.0771170870230689,0.100823847923546,1.29012902258176e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.0965508914340971,0.0065639692914985,0.0836855116227601,0.109416271245434,1.36526729558518e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.102848681087356,0.00698841338929421,0.0891513908443392,0.116545971330373,1.44571918711515e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99L2,CD99 antigen-like protein 2,42611,0.0344425543928521,0.00234278913364205,0.0298506876909137,0.0390344210947906,1.50325226101215e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXLNA,Alpha-taxilin,42495,0.124292854944434,0.00846184059473115,0.107707647378761,0.140878062510107,1.82635086739661e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA3,Glutathione S-transferase A3,42346,0.107859450896752,0.0073580332279617,0.0934377057699472,0.122281196023557,2.84548316344228e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.160444950597592,0.010948061696988,0.138986749671496,0.181903151523689,3.4691071373574e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.0564011180020102,0.00385471978458541,0.0488458672242228,0.0639563687797976,4.86389856734309e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF15,Growth/differentiation factor 15,42794,-0.0654565954201211,0.00447770303412037,-0.074232893366997,-0.0566802974732452,4.96274598710062e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCK2,Cytoplasmic protein NCK2,42676,0.147075850817681,0.0100634674457295,0.127351454624051,0.166800247011311,5.25938594873685e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.048140849499874,0.00329575138613115,-0.0546005222166911,-0.041681176783057,5.85169912777407e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILPL2,RILP-like protein 2,40511,0.136529735740789,0.00934904058179272,0.118205616200475,0.154853855281103,7.25204960754634e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.102273887315499,0.00700961103221253,0.0885350496923626,0.116012724938636,7.47203519866135e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKBKG,NF-kappa-B essential modulator,42594,0.127819355587679,0.0087667848505359,0.110636457280628,0.145002253894729,8.74524566090628e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD63,CD63 antigen,42475,0.0718191876270454,0.00493145499025853,0.0621535358461386,0.0814848394079521,1.11706872050132e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0539291505023519,0.0037063363366919,0.0466647312824358,0.061193569722268,1.35724618623736e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARF6,ADP-ribosylation factor 6,40449,0.150150723286979,0.0103330398373477,0.129897965205778,0.170403481368181,2.06536991581067e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.152317831662483,0.0104879643136353,0.131761421607758,0.172874241717208,2.3168692442678e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BECN1,Beclin-1,40223,0.0839730350868385,0.0057878660059947,0.0726288177150889,0.0953172524585881,2.91460663679078e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.133389436007827,0.00920563715188794,0.115346387190126,0.151432484825527,3.17231525886755e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBP2,Poly(rC)-binding protein 2,40482,0.10059676561973,0.00694316495627208,0.0869881623054364,0.114205368934023,3.78494069929017e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCTN3,Tectonic-3,40511,0.0419788575443177,0.00289965719693526,0.0362955294383246,0.0476621856503108,4.44499875458166e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF2,Growth/differentiation factor 2,42636,0.0501671910291323,0.00346908207679266,0.0433677901586186,0.0569665918996459,4.80032852984652e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42573,-0.0870923878808995,0.00603686967255378,-0.0989246524391049,-0.0752601233226941,7.88704884718106e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK1,Dickkopf-related protein 1,42711,0.0816264468935017,0.00566033037931645,0.0705321993500414,0.0927206944369619,8.51674253571985e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH1,Somatotropin,42613,-0.23891729918151,0.0165874524406527,-0.271428705965189,-0.20640589239783,1.09622793148989e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42587,0.189838836371238,0.0131873455887383,0.163991639017311,0.215686033725165,1.22985889933533e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,40199,0.134908966000798,0.00936515302946075,0.116553266063055,0.153264665938541,1.26888606799568e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.116421476951186,0.0080818597956562,0.100581031751699,0.132261922150672,1.27315010992181e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMIP,C-Maf-inducing protein,40451,0.11496770407762,0.00798558761617666,0.0993159523499142,0.130619455805327,1.40162058743702e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.0942911572432292,0.00656116824078708,0.0814312674912866,0.107151046995172,2.08028637270726e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR37,Prosaposin receptor GPR37,42357,0.0946816120884287,0.00659825527950924,0.0817490317405906,0.107614192436267,2.3996928130469e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK2,Docking protein 2,42636,0.166329006133092,0.011596580998386,0.143599707376255,0.189058304889928,2.59064083928074e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AAMDC,Mth938 domain-containing protein,40223,0.073665346498682,0.00513778901157212,0.0635952800360006,0.0837354129613634,3.29526445523317e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.15014565973521,0.0105061632470231,0.129553579771045,0.170737739699376,6.27938711537744e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.141568202216348,0.00990691142527875,0.122150655822802,0.160985748609895,6.37927059913816e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP85,Centrosomal protein of 85 kDa,42346,0.0879959889533216,0.00616421890412559,0.0759141199012355,0.100077858005408,6.86776379943155e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPHN1,Oligophrenin-1,40483,0.147035632228852,0.0103058066208382,0.126836251252009,0.167235013205695,8.74560799378836e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLA2,Src-like-adapter 2,40482,0.142525609877312,0.0100077414328119,0.122910436669001,0.162140783085624,1.2561001153996e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USO1,General vesicular transport factor p115,42587,0.123318728923437,0.00866605585239826,0.106333259452737,0.140304198394138,1.28130053880488e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL17,C-C motif chemokine 17,42604,0.125548334332194,0.00883187618622512,0.108237857007193,0.142858811657196,1.57493707740809e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,40483,0.0652849780685792,0.00459208894759618,0.0562844837312907,0.0742854724058677,1.77691943150583e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IST1,IST1 homolog,40375,0.135031385631581,0.00952250268219416,0.116367280374481,0.153695490888682,2.99337864953772e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN2,Prorelaxin H2,40257,0.0682814285442792,0.00483275864853114,0.0588092215931582,0.0777536354954003,6.19421629952068e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM1,Isthmin-1,42594,0.0524750130610349,0.00371814396528266,0.0451874508890809,0.0597625752329889,6.60057524586038e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.146309543293274,0.0103781489585775,0.125968371334462,0.166650715252085,9.37774928065416e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.101324669224034,0.00719381711210459,0.0872247876843092,0.115424550763759,1.14476215041282e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0514461661468234,0.00366082171340358,0.0442709555885524,0.0586213767050944,1.52579800666562e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCR,Breakpoint cluster region protein,42594,0.123404771821702,0.00878524458408962,0.106185692436886,0.140623851206517,1.66617437158888e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.122468126642383,0.00871595718604297,0.105384850557738,0.139551402727027,1.80238286107673e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.100091559164481,0.00712563159048917,0.0861253212471226,0.11405779708184,1.96447618860179e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.0997344970211824,0.00712236714477752,0.0857746574174185,0.113694336624946,3.08215333232954e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0587520984954637,0.00420276635748078,0.0505146764348013,0.066989520556126,4.87079514705787e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42711,0.128164672466506,0.00918534766563137,0.110161391041869,0.146167953891144,6.06959343677286e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP20,Centrosomal protein 20,42346,0.100446174777136,0.00721009350039053,0.0863143915163711,0.114577958037902,8.36560012131002e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,40116,0.0853529139071334,0.00614436068872078,0.0733099669572407,0.0973958608570261,1.67629246592097e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.154254581238442,0.0111270717699468,0.132445520569346,0.176063641907538,2.11626460951752e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.0811864366704973,0.00586416071486533,0.0696926816693613,0.0926801916716334,2.76700505712347e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD6,T-cell differentiation antigen CD6,42746,0.0703489759017994,0.00509749834066433,0.0603578791540973,0.0803400726495015,4.93288636996534e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC4,Syndecan-4,42636,0.0628251179584862,0.00455953724348226,0.053888424961261,0.0717618109557115,6.68592095789699e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.118234862731266,0.0085780720331685,0.101421841546256,0.135047883916276,7.14932251629781e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPB,Natriuretic peptides B,42357,-0.188918105149994,0.0137166004759094,-0.215802642082777,-0.162033568217211,7.34777445748565e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D23,TBC1 domain family member 23,42587,0.118709665986327,0.00862604374024699,0.101802620255443,0.135616711717211,8.45973780562339e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX15,Sorting nexin-15,40283,0.0722642327063698,0.00524853290948657,0.0619771082037761,0.0825513572089634,8.86420047771664e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F9,Coagulation factor IX,42663,0.0239979288056956,0.00174445271543693,0.0205788014834392,0.027417056127952,9.03091664929062e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF1,Pigment epithelium-derived factor,40351,0.0354958543460926,0.00258382560964998,0.0304315561511786,0.0405601525410065,1.33990029720109e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.055835958644105,0.00406736205730148,0.0478639290117941,0.0638079882764159,1.52210239453961e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0655408245804902,0.00478020025919893,0.0561716320724603,0.0749100170885201,1.71175421752856e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6A,Ras-related protein Rab-6A,42594,0.060879296429553,0.00444504030350263,0.0521670174346878,0.0695915754244182,2.06983174208277e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO1,Forkhead box protein O1,42594,0.11197391188647,0.00818469840646739,0.0959319030097934,0.128015920763146,2.54130217673949e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.107383680307894,0.00785504128390033,0.0919877993914496,0.122779561224339,2.9529508006975e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GASK1A,Golgi-associated kinase 1A,40116,0.0573165071038313,0.00419741370944181,0.0490895762333253,0.0655434379743372,4.16420597109435e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.121739511866439,0.00893528105754227,0.104226360993656,0.139252662739221,5.50830178095457e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.145959835171089,0.010738071058625,0.124913215896184,0.167006454445994,8.41587498014237e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,40511,0.118870010223725,0.00874320355155607,0.101733331262675,0.136006689184775,9.03254303312149e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN1,Perilipin-1,42311,0.0458405203436407,0.00337643045106466,0.0392227166595539,0.0524583240277274,1.0540764811152e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.117841869865435,0.00867861873657128,0.100831777141755,0.134851962589115,1.14167534424653e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.128176102521149,0.00945352749759447,0.109647188625864,0.146705016416434,1.31641403761972e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,40482,0.152712607143844,0.0112678528120462,0.130627615632233,0.174797598655454,1.60691827954789e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0359869622181254,0.00265923952614217,0.0307748527468867,0.041199071689364,1.87419951571683e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.0748723406508092,0.00553313134930946,0.0640274032061626,0.0857172780954557,2.17499985239861e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCG,Pro-glucagon,42346,0.164927155031135,0.0121981936404079,0.141018695495936,0.188835614566335,2.23285139118026e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BID,BH3-interacting domain death agonist,42594,0.0876290662503053,0.00648656973350374,0.074915389572638,0.100342742927973,2.56836888556887e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY4,Protein canopy homolog 4,42587,0.0961797004637048,0.00713582216702825,0.0821934890163294,0.11016591191108,3.88397055446218e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCC,Tubulin-specific chaperone C,42495,0.10440687593869,0.00774667791128475,0.0892233872325717,0.119590364644808,3.94241467387613e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HJV,Hemojuvelin,40482,0.0572906119656869,0.00426423088181704,0.0489327194373255,0.0656485044940483,7.74493268295863e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD1,Sushi domain-containing protein 1,42357,0.0639547157888762,0.00476448117806745,0.054616332679864,0.0732930988978884,8.19921134623352e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C4BPB,C4b-binding protein beta chain,42679,0.0522759956204557,0.00389834349838791,0.0446352423636154,0.059916748877296,9.66208485432436e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,40283,0.101136482878976,0.00755645754872905,0.0863258260834666,0.115947139674485,1.5442429796679e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKB,Creatine kinase B-type,40527,-0.0781390724848737,0.00584044956923878,-0.0895863536405817,-0.0666917913291657,1.62828691038079e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MITD1,MIT domain-containing protein 1,42495,0.123476753374463,0.00925038451286576,0.105345999729246,0.14160750701968,2.20431390521558e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBNL,Drebrin-like protein,42676,0.117728376902216,0.00882964870279036,0.100422265444747,0.135034488359685,2.666603255378e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0264365562155269,0.00198319904882674,0.0225494860798265,0.0303236263512273,2.78780068231202e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEC31A,Protein transport protein Sec31A,40223,0.0988870704405786,0.00741701051471896,0.0843497298317294,0.113424411049428,3.06813930126042e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.108335002213938,0.00814449916357916,0.0923717838533232,0.124298220574553,4.11279301633762e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL17,C-X-C motif chemokine 17,42754,0.05209246542509,0.00392437752280592,0.0444006854803904,0.0597842453697896,5.81038642132963e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2B3,SH2B adapter protein 3,42346,0.124379457990717,0.00938697836521041,0.105980980394905,0.14277793558653,8.09533187392548e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL10,C-X-C motif chemokine 10,42676,0.0864823260015762,0.00653129792013622,0.0736809820781092,0.0992836699250432,8.98298008214241e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.0843206166335429,0.00636563837733873,0.071843965413959,0.0967972678531268,9.39078450866465e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.0882887965886081,0.00667775930293023,0.0752003883548648,0.101377204822351,1.3012608155862e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZI2,5-azacytidine-induced protein 2,40482,0.0702985737672881,0.00531813364410759,0.0598750318248372,0.0807221157097389,1.34755453867349e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.0794943283475193,0.00604445048231372,0.0676472054021844,0.0913414512928542,2.94601848689928e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.104301709299645,0.00792750586143011,0.0887637978112421,0.119839620788048,3.02288106590799e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM13A,Protein FAM13A,40449,0.0855189340512812,0.00650346953118868,0.0727721337701514,0.098265734332411,3.32049448702146e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.0902182441747744,0.00686715423007643,0.0767586218838246,0.103677866465724,3.92505320966624e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.131625254168067,0.0100421228709049,0.111942693341093,0.15130781499504,5.17743540643479e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA11,Annexin A11,42570,0.0843498029329551,0.00643927967144234,0.0717288147769281,0.0969707910889821,5.77424179630559e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF2,TNF receptor-associated factor 2,42594,0.0877852337930362,0.00670686419177,0.074639779977167,0.100930687608905,6.60360270548687e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0792087895180534,0.00604777485089794,0.0673551508102934,0.0910624282258133,6.63992297904742e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.126811135977408,0.00969424769593691,0.107810410493372,0.145811861461444,7.307424937699e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42794,0.0292301407957627,0.00223656668000099,0.0248464701029608,0.0336138114885647,8.45741963156876e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELP,P-selectin,42689,0.0706327458462152,0.0054056424243647,0.0600376866944604,0.08122780499797,8.7973845798566e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.119536733309105,0.00915928723257505,0.101584530333258,0.137488936284953,1.08557321425718e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0703472542569702,0.00539135318480328,0.0597802020147557,0.0809143064991846,1.25805131814931e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAMBP,STAM-binding protein,42476,0.0796785542775225,0.0061114614528702,0.0677000898298969,0.0916570187251481,1.2909486759806e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINH1,Serpin H1,40302,0.162683553436902,0.012473631589807,0.13823523552088,0.187131871352924,1.35148912786053e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0691857194820469,0.00531201030535811,0.0587741792835451,0.0795972596805488,1.51395148660569e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRKL,Crk-like protein,42636,0.130953156469415,0.0100847342708958,0.111187077298459,0.150719235640371,2.52080913769376e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.0959738973665124,0.00739674450531905,0.0814762781360871,0.110471516596938,2.87815302158288e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL13,C-C motif chemokine 13,42734,0.0866355020057849,0.00667751084271457,0.0735475807540644,0.0997234232575055,2.89636023982157e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYNU,Kynureninase,42754,0.0556992050312785,0.00429614725801588,0.0472787564055674,0.0641196536569896,3.26265528461009e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST13,Hsc70-interacting protein,40283,0.0708285033915081,0.00546097305295958,0.0601249962077073,0.0815320105753088,3.43270418910172e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,40283,0.156002597062081,0.0120375385531612,0.132409021497885,0.179596172626276,3.91662496646322e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0498298592218742,0.00384760800229769,0.0422885475373707,0.0573711709063777,3.93498433047953e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3B1,AP-3 complex subunit beta-1,40449,0.0956474326210222,0.00738786862772243,0.0811672101106862,0.110127655131358,4.59237296744935e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM17,Splicing factor 45,40482,0.0955134301232567,0.00737859304087712,0.0810513877631375,0.109975472483376,4.69635236341239e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,42370,0.048238842766276,0.00373586410200168,0.0409165491263527,0.0555611364061993,6.50820952458647e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,40532,0.0339859726542109,0.0026317923056895,0.0288276597350595,0.0391442855733623,6.97232823483198e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.0991567195241,0.00768377783623637,0.0840965149650767,0.114216924083123,7.83843627831438e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FST,Follistatin,42654,0.0612224168955707,0.00475170324824935,0.0519090785290019,0.0705357552621394,9.22174003290947e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK1,Docking protein 1,40483,0.169114812642187,0.0131208814706222,0.143397884959768,0.194831740324607,9.58041024415472e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,40483,0.0251076055789635,0.00194863628182104,0.0212882784665943,0.0289269326913328,1.01184069531157e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTBS,Di-N-acetylchitobiase,40383,0.0334660644897368,0.00259754486513736,0.0283748765540676,0.038557252425406,1.0301049723168e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC1,Stanniocalcin-1,42711,0.0562690401562175,0.00437057002201009,0.0477027229130777,0.0648353573993572,1.04288082392477e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN2,CCN family member 2,42624,0.0684727497021828,0.0053217125424786,0.0580421931189248,0.0789033062854409,1.15688721412194e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42636,0.107621235586044,0.00836701951409888,0.0912218773384107,0.124020593833678,1.21893706387934e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNMBP,Dynamin-binding protein,42495,0.0745203104698395,0.00580090690755798,0.0631505329310258,0.0858900880086531,1.50785339543938e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TWF2,Twinfilin-2,40527,0.103050852650873,0.00801974157729504,0.0873321591593743,0.118769546142371,1.57882430196936e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPK2,SRSF protein kinase 2,42594,0.103301514776422,0.00804855555295972,0.0875263458926208,0.119076683660223,1.74031781519997e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR,GMP reductase 1,42754,0.0611458796908833,0.00477101092034754,0.0517946982870021,0.0704970610947645,2.19466366128872e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRAP,BRCA1-associated protein,40342,0.134780739379148,0.0105239328461735,0.114153831000647,0.155407647757648,2.74033240501011e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAXX,Protein PAXX,40283,0.0563124658918561,0.00440294991574642,0.0476826840569931,0.0649422477267191,3.42632197735163e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR2,Cadherin-related family member 2,42587,0.0871860948176637,0.00682354514520129,0.0738119463330692,0.100560243302258,3.62096710868596e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPART,Spartin,40283,0.094778756040506,0.00741411104109716,0.0802470983999556,0.109310413681056,3.70413743631752e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTPBP2,GTP-binding protein 2,40182,0.0997602565074034,0.00780554927715062,0.0844613799241882,0.115059133090619,3.8629379323848e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF19,Fibroblast growth factor 19,42676,0.0956243356434213,0.00749519991958122,0.0809337438010421,0.1103149274858,4.60305740521139e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.0954885621502,0.00748059294066531,0.080826599986496,0.110150524313904,4.64652588078982e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.088389374297195,0.00693216563060706,0.0748023296612051,0.101976418933185,5.05925582441778e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4D,Semaphorin-4D,42711,0.0368436024399877,0.00288990503727084,0.0311793885669369,0.0425078163130386,5.15332081391022e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.0928138202376941,0.00729348636315061,0.078518586965919,0.107109053509469,7.0325362592353e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.111344683499756,0.00875128106236384,0.0941921726175227,0.128497194381989,7.17688544320245e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7,Interleukin-7,42594,0.0780196866542266,0.00613668226913219,0.0659917894067275,0.0900475839017257,8.10150999968152e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH2,Neutral ceramidase,42495,0.0659398782634573,0.00518720689800801,0.0557729527433616,0.076106803783553,8.30101451787132e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.0816352933825903,0.00643700257764009,0.0690187683304157,0.0942518184347649,1.21785746132232e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPM,Carboxypeptidase M,42655,0.0413099329838141,0.00326109299641019,0.0349181907108501,0.047701675256778,1.44705579340436e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42679,0.030905609322111,0.00244017530899706,0.0261228657164768,0.0356883529277452,1.48622796362157e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLA,Alpha-galactosidase A,40267,0.0457844758245674,0.00361265598951634,0.0387036700851154,0.0528652815640194,1.48987876908198e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR4,Complement factor H-related protein 4,40509,0.0918601379015752,0.00725251478935939,0.0776452089144308,0.10607506688872,1.61470598632314e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP2,Methionine aminopeptidase 2,42689,0.0695726840820564,0.00550326810462289,0.0587862785969956,0.0803590895671173,1.99074971797044e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1R,Complement C1r subcomponent,40539,0.0238060531411208,0.00188799917046596,0.0201055747670076,0.0275065315152341,3.28779820877021e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0878788501205497,0.00698164472887003,0.0741948264519644,0.101562873789135,4.33101553127803e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.0868747300069239,0.00690337599371196,0.0733441130592485,0.100405346954599,4.49977294126052e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0356102843609267,0.00283236047073374,0.0300588578382886,0.0411617108835648,4.73634959299811e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPY30,Protein dpy-30 homolog,42651,0.0732128500463851,0.0058240626552694,0.0617976872420571,0.0846280128507131,4.87388787303116e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.0356991887314547,0.00284112376930209,0.0301305861436226,0.0412677913192868,5.71979542425946e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYTL4,Synaptotagmin-like protein 4,40511,0.0896786320370299,0.00713754200635316,0.0756890497045777,0.103668214369482,5.76025152443384e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9,Complement component C9,40532,-0.0645848094518774,0.00514515161910596,-0.0746693066253251,-0.0545003122784298,6.66619295383983e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",42357,0.111963663485338,0.00892856378187458,0.094463678472864,0.129463648497812,7.23467849062924e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.0977023565112086,0.00778840305774423,0.0824370865180299,0.112967626504387,7.37890207659499e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,40482,0.0911237213053404,0.00727054155578209,0.0768734598560075,0.105373982754673,8.49471377674029e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEG1,Protein HEG homolog 1,40283,0.0327577726375228,0.00261566552888629,0.0276310682009057,0.03788447707414,9.66435819908796e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBPL,FK506-binding protein-like,40449,0.0708051370245107,0.00566338708168753,0.0597048983444031,0.0819053757046182,1.25084131960715e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB2,BPI fold-containing family B member 2,40473,0.0834783490095484,0.00667813159285952,0.0703892110875438,0.0965674869315531,1.28087440089201e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLSCR3,Phospholipid scramblase 3,40457,0.0700668692965073,0.0056061197250561,0.0590788746353973,0.0810548639576172,1.31360867784012e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5E,5'-nucleotidase,42679,0.068324561255905,0.00547557821730526,0.0575924279499867,0.0790566945618233,1.54529259547389e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,40283,0.0899827316574292,0.00721075014622011,0.0758496613708378,0.104115801944021,1.68300827130278e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.107566971549116,0.00862748315813463,0.0906571045591722,0.12447683853906,1.93713352652472e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK11,Serine/threonine-protein kinase STK11,42357,0.0871810640168217,0.00699834106323411,0.0734643155328828,0.100897812500761,2.01863713374229e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIFBP,KIF-binding protein,42587,0.0981006682586106,0.00788159790135577,0.0826527363719533,0.113548600145268,2.28367147572115e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.1315837553843,0.0105741145828856,0.110858490801844,0.152309019966756,2.35870913903026e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK13,Kallikrein-13,42381,0.0554397655686745,0.00446135093549996,0.0466955177350945,0.0641840134022544,2.9497013583904e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BACH1,Transcription regulator protein BACH1,42594,0.0875397415080928,0.00705504600354406,0.0737118513411464,0.101367631675039,3.68400959933481e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB3,Plexin-B3,42597,0.0561677945072404,0.00452727419684571,0.0472943370814228,0.065041251933058,3.75558222593317e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2AP,CD2-associated protein,42636,0.0762954441422635,0.00615187731333493,0.0642377646081271,0.0883531236764,3.96790764244632e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0672580100242941,0.00542750684064268,0.0566200966166344,0.0778959234319537,4.49126381869315e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.127721594539945,0.0103247632706502,0.10748505852947,0.147958130550419,6.52799738739286e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP43,Centrosomal protein 43,42255,0.0824919742817163,0.00667947604265298,0.0694002012381164,0.0955837473253161,7.61513930222331e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDHD2,Phospholipase DDHD2,40482,0.078284199558439,0.00633807715630048,0.0658615683320901,0.090706830784788,8.03115762086815e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRADD,Death domain-containing protein CRADD,42476,0.0893912672708081,0.00724236282980119,0.0751962361243978,0.103586298417218,8.26167679395256e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0617591367776943,0.00500522920157294,0.0519488875426113,0.0715693860127773,8.61817973504504e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHD3,EH domain-containing protein 3,40223,0.140215198737679,0.0113634188742203,0.117942897744207,0.162487499731151,9.44380304617403e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42594,0.101380432313018,0.00824071200009044,0.0852286367928409,0.117532227833195,1.35148481500905e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS1BP3,HCLS1-binding protein 3,40223,0.105440710647328,0.00857162904618237,0.0886403177168107,0.122241103577846,1.50401582438368e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.051809251623365,0.00421464639271467,0.0435485446936443,0.0600699585530858,1.53445704388313e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.0797824629105189,0.00648764814666031,0.0670666725430647,0.0924982532779731,1.5518765114092e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LG,CMRF35-like molecule 9,42611,-0.045743950088032,0.00372376909974783,-0.0530425375235377,-0.0384453626525262,1.68506394068714e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.101060934590307,0.00822250782079399,0.0849448192615512,0.117177049919064,1.70333108668721e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.0658645695162878,0.00536420245238455,0.055350732709614,0.0763784063229615,1.82313809696253e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.116315619082774,0.00947704712553133,0.0977406067167323,0.134890631448815,1.94189347753117e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.0815490327462037,0.00664441506583632,0.0685259792171646,0.0945720862752429,2.11153895752862e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.0820607504355373,0.00670316039701122,0.0689225560573953,0.0951989448136793,2.84273716985984e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.039626411014085,0.00323860423899541,0.033278746705654,0.0459740753225159,3.36997349882164e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES2,Cocaine esterase,42587,0.0647672456399397,0.00530797378318187,0.0543636170249033,0.0751708742549762,4.60547569042801e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEXIM1,Protein HEXIM1,42594,0.0950288727204962,0.00779089980505916,0.0797587091025803,0.110299036338412,4.86066661608339e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.142400212924133,0.0116749269785611,0.119517356046154,0.165283069802113,4.94269513683872e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD1,COMM domain-containing protein 1,40223,0.0713899438105884,0.00585099001537961,0.0599220033804444,0.0828578842407325,5.06389337293099e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42676,0.100410471182363,0.00824836257092105,0.0842436805433579,0.116577261821368,6.49026708502931e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,42346,0.106613896847793,0.00875766491063267,0.0894488736229533,0.123778920072633,6.52521223268247e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,40199,0.10395973446655,0.00853647433170837,0.0872282447764015,0.120691224156698,6.70092932127877e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.10315123792267,0.00848019982299088,0.0865300462696079,0.119772429575732,7.31123998413328e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.130319883229096,0.0107132801854279,0.109321854065658,0.151317912392535,7.32478423274811e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.0925910930936721,0.0076140310057766,0.0776675923223499,0.107514593864994,7.59726257516887e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH9,Protocadherin-9,40449,0.0406648283885089,0.00334238094685273,0.0341137617326775,0.0472158950443402,7.65066724791727e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD5,Programmed cell death protein 5,42711,0.0675692650441944,0.00556335625103468,0.0566650867921664,0.0784734432962224,9.09653698359392e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EREG,Proepiregulin,42476,0.0945460410577167,0.00779406344489445,0.0792696767057236,0.10982240540971,1.09682622773195e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42676,0.152337784844242,0.0125731277224276,0.127694454508284,0.1769811151802,1.29690609712126e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42594,0.0388521667394323,0.00320878008477144,0.0325629577732803,0.0451413757055843,1.43282254350195e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT2,Signal transducer and activator of transcription 2,40199,0.0892763725479031,0.00737327598899074,0.0748247516094813,0.103727993486325,1.56273940977084e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGLL,Monoglyceride lipase,42654,0.100190582943909,0.00827971837155334,0.0839623349356642,0.116418830952153,1.56290041660036e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL5,C-C motif chemokine 5,42689,0.11622629367435,0.00962684052772939,0.0973576862400009,0.1350949011087,2.17590183937232e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYDGF,Myeloid-derived growth factor,40511,0.114745603497086,0.0095041812937707,0.096117408161295,0.133373798832876,2.34618792722924e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTBDN,Retbindin,42587,0.0349108832439738,0.0028938272990014,0.029238981737931,0.0405827847500165,2.43868255787301e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPOCK1,Testican-1,42495,0.0301710778380799,0.00250150795094073,0.025268122254236,0.0350740334219237,2.52772413492547e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0711447896818341,0.00590542687407048,0.0595701530086559,0.0827194263550122,3.23603126737668e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEXN,Nexilin,40532,0.0804701810615216,0.00668127999394868,0.0673748722733822,0.093565489849661,3.3203545337597e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42679,0.0260505380547696,0.00216439801274967,0.0218083179497803,0.030292758159759,3.4030341178375e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0600664815354851,0.00498994875700734,0.0502861819717507,0.0698467810992195,3.59540077302179e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.114961390932969,0.00957231177154918,0.0961996598607325,0.133723122005205,4.66566842207599e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.0613693818931064,0.00511110275736927,0.0513516204886626,0.0713871432975501,5.22008838446414e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLG,Plasminogen,40285,0.0249780846070468,0.00208230910617764,0.0208967587589387,0.029059410455155,6.00582275888782e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GLB2,Endophilin-B2,40483,0.0773581982767753,0.00645229271685238,0.0647117045517446,0.0900046920018059,6.40797319177109e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLG4,Disks large homolog 4,40483,0.0811999316037642,0.00677487038226742,0.0679211856545201,0.0944786775530084,6.70471863244477e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53,Cellular tumor antigen p53,42346,0.0498241315993977,0.00416162642237298,0.0416673438115466,0.0579809193872487,7.35595477015164e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.077754560275269,0.00649337102949985,0.0650275530574493,0.0904815674930887,7.63536642656127e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.0960274413885479,0.00802389149180325,0.0803006140646136,0.111754268712482,7.70415783072272e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11R,Junctional adhesion molecule A,42611,0.0641263833856345,0.0053669278907536,0.0536072047197575,0.0746455620515116,9.69754218530582e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.0882861395281812,0.00739482663379802,0.073792279325937,0.102779999730425,1.08747311746071e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NSFL1C,NSFL1 cofactor p47,42711,0.0747843910018898,0.00626779964529249,0.0624995036971165,0.0870692783066631,1.18255604214648e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASC3,Protein CASC3,40182,0.0484788705858355,0.00406120456290806,0.0405189096425357,0.0564388315291353,1.20687526539318e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42603,0.125455761760414,0.0105230172923654,0.104830647867378,0.146080875653451,1.3277146694385e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT1,Deaminated glutathione amidase,40223,0.0548509616020413,0.00460254308973369,0.0458299771461633,0.0638719460579193,1.51881566523009e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNST,Consortin,42636,0.124757867963371,0.010487475126009,0.104202416716393,0.145313319210348,1.80894765820084e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUCB2,Nucleobindin-2,42683,0.0424818691864227,0.00357444002930585,0.0354759667289832,0.0494877716438621,2.05785968409869e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.108134456831645,0.00912426235481567,0.0902509026162065,0.126018011047084,3.08960759554254e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBXN1,UBX domain-containing protein 1,40283,0.0783958505367719,0.00662706128158612,0.0654068104248631,0.0913848906486807,4.27593263714168e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP1,Syntaxin-binding protein 1,40482,0.0878722746252005,0.00743082445561773,0.0733078586921898,0.102436690558211,4.46207029810913e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMVK,Phosphomevalonate kinase,42303,0.123506842707433,0.0104533739396106,0.103018229785796,0.143995455629069,4.74664087220388e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.110970490804744,0.0093972931765463,0.0925517961787129,0.129389185430774,5.42343352514124e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGFR,Opioid growth factor receptor,42587,0.0371299227339938,0.00314586435273505,0.0309640286026331,0.0432958168653545,5.43969862522719e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RWDD1,RWD domain-containing protein 1,42711,0.071723179538773,0.00607706617081102,0.0598121298439834,0.0836342292335626,5.45377944531252e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLGA3,Golgin subfamily A member 3,40482,0.0892598001369846,0.00757898820170722,0.0744049832616384,0.104114617012331,7.84858954598845e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.112939486980908,0.00959228973097634,0.094138599108194,0.131740374853621,8.26681120014919e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.165604793826993,0.0140923587963792,0.13798377058609,0.193225817067897,1.06388171695092e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB9,Serpin B9,42495,0.0373263721120115,0.00318459800236401,0.031084560027378,0.043568184196645,1.42395347736056e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.0717097015517142,0.00612253779370763,0.0597095274760473,0.0837098756273812,1.67296099656494e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.0881320669770073,0.00753739188924589,0.0733587788740854,0.102905355079929,2.10601937899306e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT2,Omega-amidase NIT2,40462,0.0826857980696597,0.00707473706674634,0.0688193134188369,0.0965522827204825,2.24070471373671e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0702058844991589,0.00600952714524695,0.0584272112944749,0.0819845577038429,2.40726766917381e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,40451,0.0623614506857122,0.00534632818719543,0.0518826474388092,0.0728402539326153,2.93250708979928e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGT1,Protein SGT1 homolog,42346,0.0901087397875649,0.00774055329105467,0.0749372553370977,0.105280224238032,3.62003062827728e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,40482,0.0686594993452443,0.00590212578402733,0.0570913328085508,0.0802276658819379,4.21259279800986e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICA1,Islet cell autoantigen 1,42370,0.0884217365076032,0.0076057559080558,0.0735144549278139,0.103329018087393,4.32974870107661e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.0948043950204588,0.00816325846781115,0.0788044084235489,0.110804381617369,4.98366934640166e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA2,Integrin alpha-2,40283,0.0393912892886889,0.00339099860707307,0.0327449320188257,0.0460376465585521,5.14077813086373e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDC,Nuclear migration protein nudC,42754,0.0695597882937084,0.00599232203142056,0.0578148371121241,0.0813047394752927,5.25002301854168e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0359775836416251,0.00309763170907066,0.0299062254918466,0.0420489417914036,5.26557706478105e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42587,0.0940067310345464,0.0081065003375604,0.078117990372928,0.109895471696165,6.03558176490283e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAX,Protein max,42311,0.117545298179984,0.0101381989973291,0.097674428145219,0.137416168214749,6.23275242352132e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,42357,0.0844906092628028,0.00729115870035199,0.0701999382101129,0.0987812803154927,6.68826492893588e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42618,-0.10582482281361,0.0091330215861416,-0.123725545122447,-0.087924100504772,6.72383372420449e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASHC3,WASH complex subunit 3,40483,0.0839217354564305,0.00724159891225498,0.0697282015884107,0.0981152693244502,7.01860462811252e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0529353553199341,0.00457057277635346,-0.0618936779615869,-0.0439770326782813,7.13012536117854e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF21,Fibroblast growth factor 21,42689,0.131198136833064,0.011338993385074,0.108973709798319,0.153422563867809,8.12353585815573e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2L,Ataxin-2-like protein,40482,0.0540552466404359,0.00467198682402699,0.044898152465343,0.0632123408155288,8.71374106892211e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.0804262620822655,0.0069546567371188,0.0667951348775127,0.0940573892870183,9.40611955685751e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0410114703517578,0.00355229336060508,0.0340489753649719,0.0479739653385438,1.17015138325998e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,42475,0.0454630283252928,0.00394010963507658,0.0377404134405427,0.0531856432100429,1.18105749494086e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.0700400476262824,0.006071021532909,0.0581408454217807,0.081939249830784,1.20886092400405e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.115739303865979,0.0100368442397977,0.096067089155975,0.135411518575982,1.2774265738598e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSB,Arylsulfatase B,42587,0.0612909400735449,0.00531594037701849,0.0508716969345887,0.0717101832125011,1.3042564396462e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.0977789418142703,0.00847842340901657,0.0811612319325978,0.114396651695943,1.34109790349225e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAX1BP1,Tax1-binding protein 1,40483,0.07035864539607,0.0061173072445257,0.0583687231967997,0.0823485675953404,1.91386579007997e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED8,Protein TMED8,40449,0.113533353776524,0.00987798962984364,0.0941724941020309,0.132894213451018,2.09995031042636e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN3,Centrin-3,40449,0.0842535707565834,0.00733134452762635,0.0698841354824357,0.098623006030731,2.13212990391363e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB27B,Ras-related protein Rab-27B,40511,0.0916449929744764,0.00797812846005764,0.0760078611927634,0.107282124756189,2.25832537469842e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42495,0.0877128558725617,0.00764007842560332,0.0727383021583792,0.102687409586744,2.29470406935953e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.0442004109590661,0.00384996781177539,0.0366544740479864,0.0517463478701459,2.29920835251456e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIN2,Bridging integrator 2,42611,0.100115920275983,0.00873430402510814,0.0829966843867713,0.117235156165195,2.81947677279062e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFP,Alpha-fetoprotein,42459,0.0745004042916441,0.00650599167031853,0.0617486606178198,0.0872521479654684,3.22137622455471e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0277061655430054,0.00242051880342482,0.0229619486882928,0.0324503823977181,3.38737004811397e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL16,C-C motif chemokine 16,42794,0.0578487009364854,0.00505649839166047,0.0479379640888309,0.0677594377841399,3.60613020470043e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS15,Enteropeptidase,42587,0.100957247417544,0.00883271246560975,0.0836451309849487,0.118269363850139,4.08688954567229e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FETUB,Fetuin-B,42663,0.0355448381069232,0.00311431699589643,0.0294407767949662,0.0416488994188802,4.92698758373703e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR2,GMP reductase 2,40283,0.0744906748949352,0.00652803426770905,0.0616957277302255,0.0872856220596449,5.42241387854578e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0257360973564548,0.00225757564446536,0.0213112490933027,0.0301609456196069,5.75127382413918e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGA,Protein O-GlcNAcase,40449,0.0771050087396466,0.0067795917001952,0.063817009007264,0.0903930084720292,8.27851028827545e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCS1,Neuronal calcium sensor 1,42721,0.031818516051841,0.00280060867231511,0.0263293230541034,0.0373077090495786,8.89288307498505e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPI,Mannose-6-phosphate isomerase,42587,0.0927024173929705,0.0081630355324632,0.0767028677493426,0.108701967036598,9.43208646132842e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPP,Lipoma-preferred partner,40116,0.0726028356455629,0.00638991128638124,0.0600786095242556,0.0851270617668701,9.4832719463942e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42616,-0.10873432063495,0.00958054838422425,-0.127512195468029,-0.08995644580187,1.01896653021673e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.0723981772263608,0.00637735586323611,0.059898559734418,0.0848977947183036,1.05184081251352e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.0781611477264586,0.00689266057072248,0.0646515330078426,0.0916707624450747,1.13814045873961e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7,Complement component C7,40251,-0.0363706345892158,0.0032075392038436,-0.0426574114287493,-0.0300838577496823,1.22417409254224e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0521263184960977,0.00459823692241144,0.0431137741281713,0.0611388628640241,1.25608063410144e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.0835949129611078,0.00738761934281541,0.0691151790491896,0.098074646873026,1.49612863863743e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,40199,0.0537572992239699,0.00475722182509101,0.0444331444467915,0.0630814540011483,1.90284690192241e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHBG,Sex hormone-binding globulin,40532,-0.0553865985276582,0.00490267337487806,-0.0649958383424192,-0.0457773587128972,1.94519860878869e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.0843597789815859,0.00747037190698832,0.0697178500438888,0.0990017079192829,1.95049657748699e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0798863166663746,0.00708019751651091,0.0660091295340133,0.093763503798736,2.17305217826342e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,40449,0.0639361307769775,0.005667242477724,0.0528283355206384,0.0750439260333165,2.32249937346914e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOE,Apolipoprotein E,40539,0.079763777354205,0.00707361619473538,0.0658994896125237,0.0936280650958864,2.46252709851628e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1B,Meprin A subunit beta,42636,0.129123134781594,0.0114595356261357,0.106662444954368,0.15158382460882,2.56269745392337e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD36,Platelet glycoprotein 4,40199,0.049071306726325,0.00435281404537735,0.0405397911973854,0.0576028222552646,2.56849255485808e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP2B,DNA topoisomerase 2-beta,40199,0.0869935913691582,0.00772663851206401,0.0718493798855127,0.102137802852804,3.02411803348871e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.0925465816088889,0.00822571604460483,0.0764241781614634,0.108668985056314,3.27911175741762e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTF1,Cardiotrophin-1,42357,0.0913972478994988,0.00813382801560712,0.0754549449889088,0.107339550810089,3.65581943982873e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42586,0.070221862107193,0.00625366847432968,0.0579646718975068,0.0824790523168791,3.96828264657485e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,40283,0.128690459064352,0.0114724304494904,0.106204495383351,0.151176422745353,4.80259539113794e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.0915514999546165,0.00816780618258513,0.0755425998367497,0.107560400072483,4.9692630286297e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC27,Cell division cycle protein 27 homolog,42346,0.0652301271734059,0.00582041963382797,0.0538221046911031,0.0766381496557088,5.09254876916453e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.05609738774904,0.00500448306413635,0.0462886009433327,0.0659061745547472,5.22033298297729e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.100978595926012,0.00901635875596728,0.0833065327643158,0.118650659087708,5.82759694808716e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0533518970177109,0.00476414964331134,0.0440141637168206,0.0626896303186011,5.91769672210463e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42495,0.0516013413773597,0.00461176227324592,0.0425622873217977,0.0606403954329217,6.21003190407264e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACYBP,Calcyclin-binding protein,40267,0.110592605307466,0.00988863398415052,0.0912108826985309,0.129974327916401,6.9882569217751e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNLR1,Interferon lambda receptor 1,42594,0.0394405934520933,0.0035288066391304,0.0325241324393978,0.0463570544647889,7.11047775178046e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.0686745468656022,0.00615596412089236,0.0566088571886531,0.0807402365425512,9.48432674622241e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN1,Pantetheinase,40532,0.0785734806178724,0.00706902417173939,0.0647181932412632,0.0924287679944816,1.486257504173e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0505229610600242,0.00455232240991664,0.0416004091365876,0.0594455129834608,1.79656112969788e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT,Linker for activation of T-cells family member 1,42754,0.0807618242569118,0.00728119429232648,0.0664906834439519,0.0950329650698717,1.82186822287667e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.099775900855473,0.00900423165186728,0.0821276068178131,0.117424194893133,2.06133576342607e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0612566739279673,0.00552723097508094,0.0504233012168087,0.072090046639126,2.1506184648636e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D5,TBC1 domain family member 5,42594,0.0840093454156385,0.00758867450556751,0.0691355433847262,0.0988831474465508,2.31857145797535e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP4,Dipeptidyl peptidase 4,42441,0.0302871539990677,0.00273957133937134,0.0249175941738999,0.0356567138242356,2.74311555709154e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXJ3,Forkhead box protein J3,40199,0.0469750775915197,0.00424835153587351,0.0386483085812076,0.0553018466018317,2.84824485816524e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0334873629401388,0.00302924347926517,-0.0394246801594985,-0.027550045720779,2.92200977235492e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0547540839843842,0.00495862167343003,0.0450351855044613,0.064472982464307,3.18347357612172e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MESD,LRP chaperone MESD,42611,0.12840582339823,0.0116343577658044,0.105602482177254,0.151209164619207,3.3581487173815e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",42311,0.0584810303570671,0.0053089810221557,0.0480754275536419,0.0688866331604923,4.27243326852057e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA2,Apolipoprotein A-II,40532,-0.0525479765133764,0.00478096047763132,-0.0619186590495338,-0.043177293977219,5.83653870929433e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRY2,Protein sprouty homolog 2,42370,0.0977207822014589,0.0089011570463241,0.0802745143906637,0.115167050012254,6.4108362651341e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0602305880718778,0.00548880522856598,0.0494725298238885,0.0709886463198671,6.78886045910891e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FIS1,Mitochondrial fission 1 protein,42624,0.079820344711466,0.00727750400315571,0.0655564368652808,0.0940842525576512,7.14315051873661e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42689,0.0490284046555469,0.00447509323728861,0.0402572219104612,0.0577995874006326,8.15866047170704e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRAP2,GRB2-related adapter protein 2,42636,0.134544282861654,0.0122875383757866,0.110460707645112,0.158627858078196,8.73947425739388e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42663,-0.0297060997863232,0.0027147623467196,-0.0350270339858936,-0.0243851655867527,9.45280026755891e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.0895559988640053,0.00818065215549159,0.0735219206392417,0.105590077088769,9.49289921676699e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.02741538643479,0.00250861931337839,0.0224984925805683,0.0323322802890116,1.10155712337843e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0348791239155541,0.00319594073137682,0.0286150800820555,0.0411431677490526,1.29512277766321e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPING1,Plasma protease C1 inhibitor,40516,0.0194435612369078,0.00178178858917352,0.0159512556021277,0.0229358668716879,1.37982807421848e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELN,Elastin,40511,0.0388587229951716,0.00356148257513627,0.0318782171479046,0.0458392288424387,1.40359984634294e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.0781322475043792,0.00716514082549757,0.0640885714864039,0.0921759235223544,1.51262527340481e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0774937265520357,0.00710866862891267,0.0635607360393669,0.0914267170647046,1.56971214549882e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.0982068427679965,0.00901616453976697,0.0805351602700532,0.11587852526594,1.63353978264658e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICALL2,MICAL-like protein 2,40182,0.0726342053546924,0.00667347011034208,0.0595542039384219,0.0857142067709629,1.89611249591933e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0912917046428963,0.00840252580612555,0.0748227540628902,0.107760655222902,2.20693188515353e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.109215288654545,0.0100483999079788,0.089520424834906,0.128910152474183,2.2271968624452e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCB,Tubulin-folding cofactor B,42495,0.104721058714447,0.00963953569060618,0.0858275687608591,0.123614548668035,2.23649431158047e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAN,Aggrecan core protein,42488,0.0293255040397521,0.00269975842949433,0.0240339775179432,0.034617030561561,2.27190106672881e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0636068143379052,0.00586142169109634,0.0521184278233564,0.0750952008524541,2.53657195592049e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS8,Galectin-8,42711,0.0627807553734809,0.00578871197144569,0.0514348799094474,0.0741266308375145,2.71712555540254e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CERT,Ceramide transfer protein,42311,0.0641817434482995,0.00592060519205415,0.0525773572718734,0.0757861296247256,2.89014826200739e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORD,Sorbitol dehydrogenase,42658,0.0700414118594616,0.00646930944407018,0.057361565349084,0.0827212583698391,3.32894015484232e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL24,C-C motif chemokine 24,42654,0.0867974892726966,0.00801730218059495,0.0710835769987305,0.102511401546663,3.345452864496e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.0502862004494383,0.00464551438989498,0.0411809922452441,0.0593914086536324,3.57854185323964e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.0902772542314566,0.00835594373917322,0.0738996045026771,0.106654903960236,4.49609255606157e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42636,0.0821285501991125,0.00761454158200099,0.0672040486983906,0.0970530516998344,5.18460338533496e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKA,Diacylglycerol kinase alpha,40199,0.0573071817923718,0.00531272609343027,0.0468942386492484,0.0677201249354951,5.42298449440284e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42794,0.0429886681540571,0.00398887525022839,0.0351704726636095,0.0508068636445047,5.67222654180182e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL8,C-C motif chemokine 8,42706,0.0631036993276738,0.00585786289925927,0.0516222880451257,0.074585110610222,5.97410846179285e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0463277430786995,0.00429900363308637,0.0379016959578503,0.0547537901995488,6.0599681268494e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD276,CD276 antigen,42618,-0.0383245074389808,0.00355892876375585,-0.0453000078159422,-0.0313490070620193,6.24238238275007e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YJU2,Splicing factor YJU2,40451,0.0338625446983667,0.00314470423801496,0.0276989243918573,0.040026165004876,6.58275181576754e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPC,C-type natriuretic peptide,42594,0.0523467894518775,0.00486340278155409,0.0428145200000315,0.0618790589037235,6.60069940261964e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0603441460946435,0.00560400248064536,0.0493603012325786,0.0713279909567084,6.61791139777157e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLK1,Protein delta homolog 1,42794,0.057373309893728,0.00533515376513858,0.0469164085140564,0.0678302112733997,7.29050508981035e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.130916819927065,0.0121742272207802,0.107055334574336,0.154778305279794,7.68702048540827e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.106235109465246,0.00988412664645564,0.0868622212381934,0.125607997692299,8.21599369615005e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0461039123325493,0.00429605080704606,0.037683652750739,0.0545241719143596,9.28216902278821e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP4,Secreted frizzled-related protein 4,40283,0.0420389243264289,0.00391631313123208,0.034362950589214,0.0497148980636438,9.50444299884364e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0215613014416029,0.00201017626391025,-0.025501246918867,-0.0176213559643388,9.84300291108611e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YWHAQ,14-3-3 protein theta,40283,0.0764885391619313,0.00712787836159552,0.0625178975732041,0.0904591807506585,9.85836780660477e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB1,Heat shock protein beta-1,42448,0.0703253572421951,0.00655842315858052,0.0574708478513773,0.0831798666330129,1.02265352028326e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.0927859963915882,0.00866541503555636,0.0758017829218977,0.109770209861279,1.25708317747851e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAG1,Dystroglycan,42676,0.0474196170306742,0.00443305424345595,0.0387308307135006,0.0561084033478479,1.34645646396754e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD226,CD226 antigen,40199,0.0441055211399792,0.00412320498787747,0.0360240393637394,0.052187002916219,1.42131672771656e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0620730821515374,0.00581667871331412,0.0506723918734418,0.0734737724296331,1.77360328871338e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTD,Deoxycytidylate deaminase,40283,0.0972916492001629,0.00912166329447191,0.0794131891429979,0.115170109257328,1.97165134157559e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP2B1,AP-2 complex subunit beta,40182,0.049878922649022,0.00468623970193733,0.0406938928332249,0.0590639524648192,2.50621889840069e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0610457518710632,0.00574853664057913,0.0497786200555281,0.0723128836865983,3.09357152537926e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,A1BG,Alpha-1B-glycoprotein,40539,0.0175547900089429,0.0016533689693807,0.0143141868289567,0.020795393188929,3.27650457367971e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0334462113274015,0.00315181264260202,-0.0396237641069014,-0.0272686585479015,3.33445340807575e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMN,Protein amnionless,42370,0.0484448358365151,0.00456500603727142,0.0394974240034631,0.057392247669567,3.33565697068208e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3F,Semaphorin-3F,42636,0.0279080435544735,0.00263143711211972,0.0227504268147189,0.0330656602942282,3.56015939398678e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP7,Caspase-7,40483,0.0858819663023958,0.00809484164073097,0.0700160766865631,0.101747855918228,3.57598306937512e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.120763670270459,0.0113949519214121,0.0984295645044909,0.143097776036427,3.85756358934625e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR5,Complement factor H-related protein 5,40382,0.0435908513024267,0.00411515606881652,0.0355251454075464,0.0516565571973071,4.27894798506231e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42603,-0.030978097420376,0.0029289859679366,-0.0367189099175318,-0.0252372849232203,4.85579713249804e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAV,Integrin alpha-V,42721,0.0168041578372193,0.00159112424194217,0.0136855543230126,0.019922761351426,5.6911083796119e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POMC,Pro-opiomelanocortin,40223,0.0718988306383883,0.0068047445361164,0.0585615313476002,0.0852361299291765,5.70094830999068e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA1,Ephrin type-A receptor 1,42658,0.0337204806621203,0.00319524417050007,0.0274578020879402,0.0399831592363005,6.1898708476789e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0321928224986209,0.00305104901207664,0.0262127664349507,0.0381728785622911,6.30984609759342e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA1,Glutathione S-transferase A1,42611,0.0840944839180501,0.00798034277605634,0.0684530120769797,0.0997359557591205,7.30570943714513e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2,Microtubule-associated protein 2,40483,0.047438733185459,0.00450548329194226,0.0386079859332522,0.0562694804376658,8.35313942345658e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.109751450997427,0.0104286652059331,0.0893112671937979,0.130191634801056,8.81965793637809e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0262173641839394,0.00249132798353913,0.0213343613362027,0.0311003670316761,8.85363290287249e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THTPA,Thiamine-triphosphatase,40436,0.0894959345498269,0.00851555686276189,0.0728054430988136,0.10618642600084,1.0255287003826e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42676,0.0879491251973365,0.00837434374122012,0.0715354114645451,0.104362838930128,1.06033004887323e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42794,0.06696778822073,0.00639265717627398,0.054438180155233,0.079497396286227,1.39729393068503e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLB,Beta-klotho,42311,-0.0759286103706645,0.00724757311409411,-0.090133853674289,-0.0617233670670401,1.39876588040445e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.106455943569319,0.0101620639601529,0.0865382982074193,0.126373588931219,1.40129877739963e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L1,Bcl-2-like protein 1,40483,0.100522106828824,0.00959927445791687,0.0817075288913065,0.119336684766341,1.5232854650671e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBP,Lipopolysaccharide-binding protein,42689,-0.0596904891635148,0.00570322817412727,-0.0708688163848043,-0.0485121619422254,1.5486386583683e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EZR,Ezrin,42711,0.0241965661782837,0.00231247452229534,0.0196641161145848,0.0287290162419825,1.59069341040315e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.079104978110846,0.0075633710064275,0.0642807709382481,0.0939291852834439,1.67413909340467e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RP2,Protein XRP2,42587,0.0425226859623296,0.00406632965436808,0.0345526798397682,0.0504926920848911,1.70141919222409e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F12,Coagulation factor XII,40539,0.0421765747145952,0.00403675177547437,0.0342645412346654,0.0500886081945249,1.94889166463702e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN9,Septin-9,42587,0.028824987649226,0.00275991970963959,0.0234155450183324,0.0342344302801196,1.95177855130681e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.0706517725094444,0.00676534051607084,0.0573917050979455,0.0839118399209432,1.96882143983396e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.0821023217077214,0.0078811912393991,-0.0975494565369437,-0.0666551868784992,2.5775794861031e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP2,Caspase-2,42594,0.0678089690790129,0.00651703786174343,0.0550355748699958,0.0805823632880301,2.93971121746681e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPL,N-acetylneuraminate lyase,40511,0.0460163686329371,0.00442277944635469,0.0373477209180819,0.0546850163477923,3.07641929484556e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,40500,0.0481082040678856,0.00462446837556656,0.0390442460517752,0.0571721620839961,3.12332600680096e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMTN,Smoothelin,40460,0.0930204401464739,0.00894361328770627,0.0754909581025696,0.110549922190378,3.19862184698307e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRAS,Ras-related protein R-Ras,40182,0.130444726008874,0.0125621299760739,0.10582295125577,0.155066500761979,3.83360936530068e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.0487534016621404,0.00469713062436227,0.0395470256383904,0.0579597776858905,3.84128966847106e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0699297447406696,0.0067365215174929,0.0567261625663835,0.0831333269149557,3.96611504787416e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0268295684995351,0.00258627007538891,0.0217604791517728,0.0318986578472974,4.05104843006911e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0530030475288412,0.00510849844893093,0.0429903905689366,0.0630157044887458,4.16072668082959e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRZB,Secreted frizzled-related protein 3,42454,0.0251088542662865,0.00242190272106645,0.0203619249329963,0.0298557835995768,4.34990532029284e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PF4,Platelet factor 4,40463,0.0988433122559751,0.00953725630403476,0.080150289900067,0.117536334611883,4.68840462619655e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGF,Pro-epidermal growth factor,42597,0.10277518574283,0.00992386842211986,0.0833244036354751,0.122225967850185,4.86656719100405e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0515096178158191,0.00498792512290266,0.0417332845749299,0.0612859510567083,6.63592106217246e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIAPIN1,Anamorsin,42679,0.0619335745389598,0.00599833878512692,0.0501768305201111,0.0736903185578086,6.71632940534265e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,40449,0.0973621235162492,0.00942596541396197,0.0788872313048837,0.115837015727615,6.71996598632923e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM20A,Pseudokinase FAM20A,40511,0.0283168445796079,0.00274422448869039,0.0229381645817747,0.033695524577441,7.47376912331801e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMFG,Glia maturation factor gamma,40511,0.071518958548316,0.00693246270880795,0.0579313316390524,0.0851065854575795,7.64340922035635e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0271012648852133,0.00262958892522449,0.0219472705917733,0.0322552591786534,8.16528611607471e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP25,Synaptosomal-associated protein 25,40136,0.0474572724948986,0.00460872866128467,0.0384241643187807,0.0564903806710166,9.40274563023966e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.0938136096730284,0.00911902648372388,0.0759403177649296,0.111686901581127,1.0302293179007e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42611,0.0502850802816601,0.00489158383173316,0.0406975759714631,0.0598725845918571,1.07182090590812e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAP,Prolyl endopeptidase FAP,42794,0.0271985132632912,0.00265256827281813,0.0219994794485677,0.0323975470780147,1.40020052588268e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGLAP,Osteocalcin,40527,0.0902559542164809,0.00879899089097646,0.073009932070167,0.107501976362795,1.40179329741157e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP170,Centrosomal protein of 170 kDa,40223,0.0768829742254021,0.00749751589994669,0.0621878430615066,0.0915781053892976,1.45653089943689e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,40449,0.086342068871948,0.00842508343898073,0.0698289053315458,0.10285523241235,1.5449725803966e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0378953819388827,0.00370169868421327,0.0306400525178247,0.0451507113599407,1.72774794436812e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUB1,NEDD8 ultimate buster 1,42594,0.0822339284896608,0.00804015204343868,0.0664752304845209,0.0979926264948006,1.82892375329813e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB6,Serpin B6,42679,0.057213852985315,0.00560161174473801,0.0462346939656285,0.0681930120050015,2.10992004110913e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLMH,Bleomycin hydrolase,42794,0.030939519624151,0.00303621705261832,0.0249885342010191,0.0368905050472829,2.68261530160734e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLB1,Beta-galactosidase,42495,0.0409121115744093,0.00401553798250533,0.0330416571286988,0.0487825660201197,2.74195135305639e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42602,0.0343886120023902,0.00337745071671405,0.0277688085976306,0.0410084154071497,2.92894129731762e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42569,0.0873947552367802,0.00858516429384139,0.0705678332208511,0.104221677252709,2.99332519613762e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0592825463983006,0.0058252692685207,0.047865018632,0.0707000741646012,3.21595590068597e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0331935630642533,0.00326490075405325,0.0267943575863089,0.0395927685421977,3.41471866264266e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADD1,Alpha-adducin,40283,0.0702280122620402,0.00690723049774005,0.0566898404864697,0.0837661840376107,3.54129248590725e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROD,Uroporphyrinogen decarboxylase,40283,0.0678917318226335,0.00668999940781594,0.0547793329833143,0.0810041306619528,4.29867878622688e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.0889209091464232,0.00876422364335067,0.0717430308054559,0.106098787487391,4.41030586876629e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0716947651647282,0.00706755146839869,0.0578423642866668,0.0855471660427896,4.4563325445528e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0646944340025435,0.00639930981670902,0.0521517867617938,0.0772370812432931,6.08974368242887e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.108532222885733,0.010738991658959,0.0874837992341737,0.129580646537293,6.29987946422e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.0895158922531348,0.00885504748306436,0.0721599991863286,0.106871785319941,6.40743096152441e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QDPR,Dihydropteridine reductase,42581,0.041596711853506,0.00411661782711427,0.033528140912362,0.0496652827946499,6.42287750004149e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKN3,Serine/threonine-protein kinase N3,40302,0.0733004708296603,0.00726918360522435,0.0590528709634205,0.0875480706959,8.25450244322872e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42600,0.01942032452024,0.00192756586334805,0.0156422954280778,0.0231983536124022,8.65534349772646e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP3,Caspase-3,42794,0.0845088475964037,0.00839804659157876,0.0680486762769093,0.100969018915898,9.7557314457549e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD22,B-cell receptor CD22,42754,0.0425533432949801,0.00422910786934513,0.0342642918710637,0.0508423947188966,9.8505102063587e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1RL,Complement C1r subcomponent-like protein,40519,0.0194346485231839,0.00193117422892549,0.01564954703449,0.0232197500118779,1.00617060239913e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA4,Protein disulfide-isomerase A4,40527,0.0584258627990841,0.00580742394201504,0.0470433118727346,0.0698084137254336,1.03786591990141e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.0464401779646017,0.0046178069024252,-0.0554910794933551,-0.0373892764358483,1.04071165548341e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0514099040793741,0.00512632191146208,0.0413623131329084,0.0614574950258398,1.38203883897347e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTDH,Protein LYRIC,40199,0.0915000493751133,0.0091215872384036,0.0736217383878423,0.109378360362384,1.40409097248142e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,42346,0.0445872195078642,0.00444823140637793,0.0358686859513635,0.053305753064365,1.45877133288027e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBN1,Drebrin,40199,0.0487684367729291,0.00486450897063775,0.0392339991904791,0.0583028743553791,1.48820013310084e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,42346,0.050104697716648,0.00500129308762166,0.0403021632649095,0.0599072321683864,1.537511766523e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.0890693916689869,0.00889035752977211,0.0716442909106336,0.10649449242734,1.59091345491352e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD244,Natural killer cell receptor 2B4,42754,0.0265544123620988,0.00265724225804396,0.0213462175363327,0.031762607187865,1.96670500462801e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK7,Kallikrein-7,40009,0.0380484664148061,0.00381047049679629,0.0305799442410854,0.0455169885885268,2.23270022944425e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0670980827160773,0.00672063578395605,0.0539256365795234,0.0802705288526311,2.25793507628802e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP5,Fatty acid-binding protein 5,42678,0.0653351847475906,0.00654995025872282,0.0524972822404939,0.0781730872546874,2.3646958413126e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN3,Ataxin-3,40483,0.0601929185434747,0.00603516209548268,0.0483640008363286,0.0720218362506207,2.48119586688348e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THOP1,Thimet oligopeptidase,42571,0.0298202177383559,0.00299285523347915,0.0239542214807368,0.0356862139959751,2.64631596797931e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.0541435904262075,0.00544588171761897,-0.0648175185927407,-0.0434696622596743,3.42450905475741e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACTB2,Endoribonuclease LACTB2,42636,0.0624932462343923,0.0063047829652336,0.0501358716225344,0.0748506208462501,4.42831576599585e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.115413819367467,0.011656471274775,-0.138260503066026,-0.0925671356689085,4.91963955525472e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.114689434786148,0.0115831211557179,0.0919865173209407,0.137392352251355,4.9232937784167e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO9B,Unconventional myosin-IXb,42370,0.063312433856694,0.00639848781961072,0.050771397730257,0.075853469983131,5.2686628095408e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.0951210591924665,0.00962269299624604,0.0762605809198243,0.113981537465109,5.98841971849566e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRGN,Neurogranin,40532,0.0871283820545992,0.00881649741809437,0.0698480471151342,0.104408716994064,6.14184280642746e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0452618111493942,0.00458186551136781,0.0362813547471133,0.0542422675516751,6.39301922692784e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42679,0.0361240465026344,0.00365889357814082,0.0289526150894784,0.0432954779157904,6.52243649232074e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM3,Dynamin-3,40482,0.052577714602827,0.00532483031354787,0.0421410471882732,0.0630143820173809,6.67775039361626e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0765681498055227,0.00776373047974036,0.0613512380652316,0.0917850615458139,7.5427262525851e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPACT,Protein IMPACT,40483,0.0535190026153672,0.00543330961537418,0.0428697157692338,0.0641682894615006,8.45523653398645e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB1,Beta-crystallin B1,40511,0.0610116368485658,0.00619478397029084,0.0488698602667957,0.0731534134303359,8.55938204595965e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP5,Platelet glycoprotein V,40283,0.0346164584848416,0.00351533861219657,0.0277263948049363,0.0415065221647468,8.73401852418861e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0581503642000402,0.00591424475008197,0.0465584444898795,0.0697422839102008,1.01456037861802e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.0631974536063798,0.00643988921717305,0.0505752707407207,0.075819636472039,1.17878548540373e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.0906460480744928,0.00924612878825618,0.0725236356495107,0.108768460499475,1.29333791726559e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA3,Annexin A3,42681,0.0659467549015604,0.00672685491117981,0.052762119275648,0.0791313905274728,1.29405684024826e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,40429,0.0822750270436496,0.00839368323541276,0.0658234079022406,0.0987266461850586,1.35942134007873e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC22D1,TSC22 domain family protein 1,40482,0.0618992728561816,0.00632099930054552,0.0495101142271123,0.0742884314852508,1.48900582896318e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARC,SPARC,42679,0.0660995221239725,0.00677791135924455,0.0528148158598532,0.0793842283880919,2.14056434446447e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TADA3,Transcriptional adapter 3,40451,0.0373907553167957,0.00383567084352013,0.0298728404634962,0.0449086701700951,2.30246028341386e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG6,Large proline-rich protein BAG6,42357,0.0335873585694604,0.00345223897658787,0.0268209701753482,0.0403537469635726,2.69225143784038e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.0322334842910195,0.00331374883383881,-0.0387284320053435,-0.0257385365766954,2.73925024756986e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATOX1,Copper transport protein ATOX1,42679,0.0655206219464993,0.00673665261907956,0.0523167828131034,0.0787244610798953,2.76522498193099e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDS,Iduronate 2-sulfatase,42754,0.0082499774584023,0.000848850854144953,0.00658622978427819,0.0099137251325264,2.95777570825016e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIF,Macrophage migration inhibitory factor,42586,0.0636517352596679,0.00655712472620449,0.0507997707963071,0.0765036997230287,3.32296972417858e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0472756548141206,0.0048689255116421,0.0377325608113021,0.0568187488169391,3.36624074161597e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0627642312720828,0.00647596321961228,0.0500713433616428,0.0754571191825229,3.85739344859085e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42679,0.078264647077194,0.00807645626618001,0.0624347927954812,0.0940945013589068,3.90846690570964e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COCH,Cochlin,40511,0.0441488762487407,0.00455698204088716,0.0352171914486019,0.0530805610488795,4.12472701929331e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42636,0.0288062835463954,0.00297444022531768,0.0229763807047727,0.034636186388018,4.13984663398855e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0916205012216392,0.00946115103461427,0.0730766451937953,0.110164357249483,4.16762487384381e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0650419713932482,0.00671473501457011,0.0518810907646908,0.0782028520218056,4.20064232895408e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,40182,0.0756823332395938,0.00781934140878118,0.0603564240783827,0.0910082424008049,4.54173084611074e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0505870535721477,0.00523033984004767,0.0403355874856543,0.0608385196586411,4.85241246276599e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0455486207802417,0.00471954660156299,0.0362983094411783,0.0547989321193052,5.91071986867466e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD2,Polycystin-2,40116,0.054784725513155,0.00567638442512458,0.0436590120399108,0.0659104389863992,5.93597628206589e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHK,Ketohexokinase,40223,0.0587359383794978,0.0060950475941184,0.0467896450950258,0.0706822316639699,6.82717735200464e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0591426240005925,0.00614337606409781,0.0471016069149608,0.0711836410862242,7.46125271480972e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.035474440475352,0.00368777983391234,0.0282463920008838,0.0427024889498202,7.77109953978368e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.0870079605151043,0.00905088280498097,0.0692682302173416,0.104747690812867,8.27967120436043e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GET3,ATPase GET3,40511,0.0504842069304193,0.00525251170020191,0.0401892839980235,0.060779129862815,8.66443780050381e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO3,Forkhead box protein O3,42346,0.0882458004181431,0.00919318854548984,0.070227150868983,0.106264449967303,9.508161324927e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM106A,Transmembrane protein 106A,40451,0.0651063743813541,0.0067979260743024,0.0517824392757214,0.0784303094869868,1.20343029415296e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTF2,Transcription termination factor 2,40182,0.0454790625279214,0.00475531732557746,0.0361586405697896,0.0547994844860532,1.37688841875441e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMT,Catechol O-methyltransferase,42214,0.0769454841194727,0.00804965581347148,0.0611681587250686,0.0927228095138768,1.40152859486506e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0602208699398564,0.00629883978836349,0.0478751439546639,0.0725665959250488,1.4172548059445e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0699335530773473,0.00732902395806137,0.0555686661195471,0.0842984400351476,1.63860320412659e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABHD14B,Protein ABHD14B,42460,0.0527485418469063,0.00553564961168551,0.0418986686080027,0.0635984150858099,1.86213265445555e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK24,Serine/threonine-protein kinase 24,42311,0.0567510560505741,0.00595994123929681,0.0450695712215524,0.0684325408795958,1.99073427109647e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA13,Carbonic anhydrase 13,42483,0.0948264408780923,0.00996210228972152,0.0753007203902381,0.114352161365946,2.05159067308419e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42754,0.061533979880977,0.00646666472700932,0.0488593170160387,0.0742086427459153,2.10770891714587e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL26,C-C motif chemokine 26,42594,0.0861569308325714,0.00906093030776401,0.068397507429354,0.103916354235789,2.25643866759966e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH2,Cadherin-2,42636,0.0327746258638149,0.00344767322608317,0.0260171863406919,0.039532065386938,2.30576380300418e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0485689535544967,0.0051086490475757,0.0385560014212483,0.0585819056877451,2.35412210191575e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE2,Glia-derived nexin,40511,0.0592688253878934,0.00623724879354404,0.0470438177525471,0.0714938330232397,2.4632677075488e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0218962115468271,0.00230780059067693,0.0173729223891004,0.0264195007045539,2.74852481914279e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0520220408700219,0.00548992654408086,0.0412617848436234,0.0627822968964204,3.08102933801748e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAP1,Proline-rich acidic protein 1,40527,0.0382135004622354,0.00403178480453085,0.0303112022453549,0.0461157986791158,3.1045737610766e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0746922431303871,0.00789149605297832,0.0592249108665496,0.0901595753942246,3.42199197462594e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0612807841152468,0.00647555033438215,0.0485887054598578,0.0739728627706358,3.46635475630349e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARK7,Parkinson disease protein 7,42611,0.0474675126177626,0.00501947336735482,0.0376293448177471,0.057305680417778,3.69962498332155e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0631608368149036,0.00667937273290526,0.0500692662584093,0.0762524073713979,3.85004211425271e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0526896005625708,0.00557617951914149,0.0417602887050535,0.0636189124200881,3.9916904416108e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.0714176842658483,0.00756074956227371,0.0565986151237918,0.0862367534079048,4.1142664594863e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD4B,FERM domain-containing protein 4B,40116,0.0645159650370009,0.00683174098578984,0.0511257527048528,0.077906177369149,4.33589560333725e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSC2,Desmocollin-2,42488,-0.032442166252353,0.00344428207276921,-0.0391929591149807,-0.0256913733897254,5.28769755653552e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCXR,L-xylulose reductase,42679,0.0479111740141785,0.00509060686980139,0.0379335845493677,0.0578887634789892,5.66192297723182e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,40223,0.0510576509926802,0.00542551727183384,0.0404236371398858,0.0616916648454745,5.90794060481221e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD69,Early activation antigen CD69,42585,0.079732217068169,0.00847606538009049,0.0631191289231916,0.0963453052131464,5.9383037652219e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0448548950101231,0.0047672484456673,0.0355110880566152,0.054198701963631,6.00246542876188e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.0644806386421595,0.00685843525456879,-0.0779231717411144,-0.0510381055432047,6.23262212570619e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.0792385886284764,0.00843530301069759,-0.0957717825294437,-0.0627053947275091,6.71272666477528e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD207,C-type lectin domain family 4 member K,42365,0.0362314869618658,0.00385788583084949,0.0286700307334008,0.0437929431903308,6.87211866034314e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0554230336035652,0.0059043604695414,0.043850487083264,0.0669955801238663,7.16677214992287e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FADD,FAS-associated death domain protein,42636,0.068674018204955,0.00732113527025106,0.0543245930752629,0.0830234433346471,7.62150641408438e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0423958813875034,0.00452649024866127,0.0335239605001273,0.0512678022748795,8.72911676046448e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM1,Dynamin-1,40449,0.103681728532238,0.0110674632399509,0.0819895005819346,0.125373956482542,8.78440086593067e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0553205807878063,0.00590967957621647,0.043737608818422,0.0669035527571906,9.38546213546391e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REEP4,Receptor expression-enhancing protein 4,40482,0.0562366850103719,0.00600969563555246,0.0444576815646891,0.0680156884560547,9.68991818487088e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0669089391266925,0.00715875883390718,0.0528777718122344,0.0809401064411506,1.05072250648132e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42711,0.0601886041040149,0.00644440075461757,0.0475575786249645,0.0728196295830654,1.11522397738306e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0434858078997117,0.00465590249312139,0.0343602390131938,0.0526113767862296,1.14431685040964e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB2B,Ras-related protein Rab-2B,40451,0.0548117190342691,0.00587748246893347,0.0432918533951595,0.0663315846733787,1.30790200988654e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX2,Heme oxygenase 2,42311,0.0413420405027219,0.0044353087953202,0.0326488352638943,0.0500352457415495,1.33286026293555e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL1,Growth-regulated alpha protein,42607,0.0861931929622926,0.00925647806341636,0.0680504959579965,0.104335889966589,1.45155217594383e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.039635119637635,0.00425672229803991,-0.0479782953417933,-0.0312919439334768,1.45831843976956e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0297941092403804,0.00320040736496928,-0.0360669076757202,-0.0235213108050406,1.47867686199559e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSHB,Thyrotropin subunit beta,42636,0.0717634776147061,0.0077100806720922,0.0566517194974054,0.0868752357320068,1.50523730972059e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0470774323035434,0.00506222770519229,0.0371554660013665,0.0569993986057203,1.62719270445547e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.0814609899831703,0.00876064341376035,0.0642901288922,0.0986318510741405,1.68487681889987e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0471448306369144,0.0050727549788027,0.0372022308784611,0.0570874303953677,1.71619025636588e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS10,Regulator of G-protein signaling 10,40482,0.0535377719317505,0.00576239876723032,0.0422434703479791,0.064832073515522,1.81001567600829e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.1077132612566,0.0116095590376399,0.0849585255428252,0.130467996970374,1.98843765746926e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOF,Apolipoprotein F,40532,0.0215233956900844,0.00231919948875639,0.0169777646921219,0.0260690266880469,1.99193706773077e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA5,Integrin alpha-5,42611,0.0225203712558116,0.00242902496569691,0.0177594823230457,0.0272812601885776,2.11457037151564e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18R1,Interleukin-18 receptor 1,42754,0.0296272161464056,0.0031996715619851,0.0233558598849148,0.0358985724078964,2.35904861283588e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP10,Caspase-10,42311,0.0641531337726816,0.00693572124287179,0.0505591201366529,0.0777471474087103,2.59581359469696e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS1,Galectin-1,42636,0.0314750070930487,0.00340620106816196,0.0247988529994512,0.0381511611866461,2.81698706022201e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0240546719801065,0.00260422421782388,-0.0291589514470413,-0.0189503925131717,2.99070275987945e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RFC4,Replication factor C subunit 4,40451,0.018949235660019,0.00205198592338238,0.0149273432501895,0.0229711280698484,3.05638768074702e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0300251116016482,0.00325292785126913,0.0236493730131607,0.0364008501901357,3.10177168055161e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF3,Trefoil factor 3,42613,-0.0386462703553072,0.00418851298157598,-0.0468557557991961,-0.0304367849114183,3.20185753926119e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLM2,Protein GOLM2,42711,0.0206341533687202,0.00223805796500618,0.0162475597573081,0.0250207469801323,3.41501700674678e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP6,Platelet glycoprotein VI,42590,0.0777179002118123,0.00843450033213381,0.06118627956083,0.0942495208627946,3.594029519282e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARFIP1,Arfaptin-1,40482,0.0611617245684642,0.0066363789483483,0.0481544218297015,0.0741690273072268,3.62444777852742e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.0530870975704837,0.00577085139569161,0.0417762288349282,0.0643979663060393,4.24126480447021e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0772414418998031,0.00842592689112178,0.0607266251932044,0.0937562586064018,5.72087687288766e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0576713165576131,0.00629747417025432,0.0453282671839146,0.0700143659313115,6.06725448142702e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.0864355509726001,0.00944339830026113,0.0679264903040883,0.104944611641112,6.48411368543549e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0614693025916155,0.00671848183384471,0.0483010781972799,0.0746375269859511,6.74834042698625e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0514543177384184,0.00562937128434849,0.0404207500210953,0.0624878854557414,7.12794427415606e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0337037864077902,0.00368909925742495,-0.0409344209523431,-0.0264731518632373,7.39560944506849e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.0408211132558784,0.00447161431020371,0.0320567492078791,0.0495854773038777,7.88515721224594e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0400069785270169,0.00438742499068552,0.0314076255452733,0.0486063315087605,8.68198660700498e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.0966207659764299,0.0106172289668503,0.0758109972014032,0.117430534751456,1.02809159943956e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.0469052400134308,0.00515802238417067,0.0367955161404563,0.0570149638864053,1.09319655572941e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPI,Glucose-6-phosphate isomerase,40532,0.0414397397242464,0.00456138437042571,0.032499426358212,0.0503800530902808,1.20959689918345e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDRKH,Tudor and KH domain-containing protein,42311,0.0744399073359757,0.00819932090709116,0.058369238358077,0.0905105763138744,1.25288766416401e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C8B,Complement component C8 beta chain,40539,0.0269023656273763,0.00296248369762714,0.0210958975800271,0.0327088336747255,1.25314643931026e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C3,Complement C3,39989,0.0416154836346874,0.00458407344852038,0.0326306996755874,0.0506002675937873,1.294849755746e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42495,0.0352885777607847,0.003891038490361,0.0276621423196772,0.0429150132018923,1.36506620316305e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPN,Asporin,40511,0.0248435088838369,0.00273978442739812,0.0194735314061365,0.0302134863615372,1.41558655574148e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRN,Agrin,42676,0.0319361159477686,0.00352538327056424,0.0250263647374627,0.0388458671580745,1.49667211927685e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTC,Probetacellulin,42346,0.065672272060275,0.00725306520255559,0.051456264263266,0.0798882798572839,1.56411263076788e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0313220892554658,0.00345846225848094,-0.0381006752820884,-0.0245435032288431,1.5664937957326e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.104031732631604,0.0115023607976431,0.081487105468223,0.126576359794984,1.70846744470466e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL,Podocalyxin,42587,0.0134102780733883,0.00148466363470879,0.010500337349359,0.0163202187974175,1.90408813706667e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0454543174119953,0.00503124058758181,0.0355930858603349,0.0553155489636556,1.91729303303563e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0483690759440685,0.00535568110038249,0.0378719409873188,0.0588662109008182,1.93084892273007e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PENK,Proenkephalin-A,40283,0.0288333812230695,0.00319179849339827,0.0225774561760088,0.0350893062701301,1.93615258213415e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAD,Chondroadherin,40283,0.0457661891883004,0.00506687850398038,0.0358351073204988,0.0556972710561019,1.9566689526057e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0431889949191786,0.00478197002852119,0.033816333663277,0.0525616561750801,1.97387230575432e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0277108721241461,0.00306997695346213,0.0216937172953603,0.0337280269529318,2.01070282517288e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AREG,Amphiregulin,42587,-0.0373529420552905,0.00413918373741453,-0.045465742180623,-0.029240141929958,2.05328993273526e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIAE,Sialate O-acetylesterase,42646,0.0401003932916659,0.00444422556995057,0.0313897111745628,0.048811075408769,2.07456039640824e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT2,Angiopoietin-2,42721,-0.0330661621426758,0.00367371790017273,-0.0402666492270143,-0.0258656750583372,2.53755597988399e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0577948301524543,0.00642855500907918,0.0451948623346591,0.0703947979702495,2.86431788286659e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0187160538947911,0.00208298354393897,0.0146334061486707,0.0227987016409114,2.92203503241265e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0332443384849113,0.00369999718296183,0.0259923440063061,0.0404963329635164,2.99865915054287e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0534191166566349,0.00594801061019708,0.0417610158606486,0.0650772174526212,3.03333999502107e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.073841279526661,0.00822566252557402,0.0577189809765359,0.0899635780767861,3.14873024839558e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB33A,Ras-related protein Rab-33A,40116,0.0573246285455385,0.0063890810274129,0.0448020297318092,0.0698472273592678,3.37866196174759e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESYT2,Extended synaptotagmin-2,40483,0.0714600399745877,0.00798021559233503,0.055818817413611,0.0871012625355643,3.94088435563378e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1A,Lithostathine-1-alpha,42575,-0.0454654508003768,0.00507901847521825,-0.0554203270118046,-0.0355105745889491,3.95932146512418e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TALDO1,Transaldolase,40499,0.0382993215378165,0.00427824743722043,0.0299139565608645,0.0466846865147686,4.03135320139582e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2,Complement C2,42663,0.0198976997779453,0.00222564011165505,0.0155354451591014,0.0242599543967892,4.38398078124029e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH17,Cadherin-17,42636,-0.0603950938462198,0.00676492793139518,-0.0736543525917544,-0.0471358351006853,4.90819113177509e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42582,0.029557121883025,0.00331133996515552,0.0230668955513202,0.0360473482147299,4.98374849608977e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0660671338122724,0.00741115377796688,0.0515412724074573,0.0805929952170875,5.66795527724817e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP5,Retinol-binding protein 5,42587,0.0482101931714521,0.00540980430028619,0.0376069767428912,0.0588134096000131,5.67091866239438e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPBP,Platelet basic protein,40471,0.0729222742164478,0.00818188223200758,0.0568857850417129,0.0889587633911826,5.74696482904516e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD27,CD27 antigen,42679,-0.0383394218007169,0.00430442155733942,-0.0467760880531022,-0.0299027555483317,5.90739880283136e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG2,Bone marrow proteoglycan,40527,-0.0458219661791151,0.00514676536998694,-0.0559096263042895,-0.0357343060539407,6.25799702478837e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0606768950316454,0.0068235408772545,0.0473027549122266,0.0740510351510642,6.8923768012755e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",40483,0.090981612786902,0.0102352825287337,0.0709204590305839,0.11104276654322,7.09928853259316e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0497902658010416,0.00562997857960765,0.0387555077850107,0.0608250238170726,1.04207230604796e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTX3,Pentraxin-related protein PTX3,42594,-0.0420233721897433,0.00475579466065604,-0.0513447297246291,-0.0327020146548574,1.11184461182917e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.073264170421683,0.00830543157494041,0.0569855245347998,0.0895428163085662,1.29843902762544e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN2,Centrin-2,42311,0.0574047596863565,0.00652298613780844,0.0446197068562519,0.070189812516461,1.5324580320684e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,40451,0.0371309300577295,0.00422174459482436,0.0288563106518737,0.0454055494635852,1.63599389719524e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0245653323700547,0.00279606006874068,0.0190850546353229,0.0300456101047864,1.7451862566755e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO1A,Coronin-1A,42353,0.0760486910892473,0.00865629393822475,0.0590823549703268,0.0930150272081678,1.74966879990018e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6AP2,Renin receptor,42346,0.0343632991844476,0.00391604123672893,0.0266878583604589,0.0420387400084363,1.91748366915246e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLUL1,Clusterin-like protein 1,42621,-0.0382182813273132,0.00435956437678587,-0.0467630275058135,-0.0296735351488129,2.06161636883904e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.0679474583296399,0.00775277040424212,0.0527520283373254,0.0831428883219544,2.15517588878019e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.0444412259036737,0.00507228253635524,0.0344995521324174,0.05438289967493,2.15877236252077e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLNK,B-cell linker protein,40199,0.034877365000485,0.00397992340024935,0.0270767151359962,0.0426780148649737,2.17366711896979e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0388864949448951,0.00444040311062263,-0.0475896850417155,-0.0301833048480747,2.23439289521679e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42594,0.0545747516925057,0.00623916457185239,0.042345989131675,0.0668035142533364,2.44705413950772e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPA1,Inositol monophosphatase 1,42495,0.0514011779765773,0.00587672354701782,0.0398827998244224,0.0629195561287322,2.46106398519456e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF7,SLAM family member 7,42594,-0.0505323097048014,0.00578756678829298,-0.0618759406098556,-0.0391886787997471,2.81560000321653e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DXO,Decapping and exoribonuclease protein,40483,0.0386410634096832,0.00443388007827004,0.0299506584562739,0.0473314683630925,3.31425329167756e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG4A,Cysteine protease ATG4A,42346,0.0496522503430552,0.0057039273312511,0.038472552773803,0.0608319479123073,3.55303656851163e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECE1,Endothelin-converting enzyme 1,42311,0.0301237395987953,0.00346187129660569,0.0233384718574482,0.0369090073401425,3.65987575389855e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLU,Clusterin,40539,0.0267448593307812,0.00307730515812314,0.0207133412208598,0.0327763774407025,4.085114357909e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP2,Retinol-binding protein 2,42587,-0.0652133013160893,0.00750733248179112,-0.0799276729803999,-0.0504989296517787,4.16269052363986e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRN1,Secernin-1,42594,0.0465560559796062,0.00536482655699083,0.0360409959279042,0.0570711160313082,4.48748162422577e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42594,0.0485774027103778,0.0056014536748836,0.0375985535076059,0.0595562519131496,4.71797784068395e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA12,Serpin A12,42249,0.0871419715572699,0.0100577938122651,0.0674286956852303,0.106855247429309,5.08081344556113e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILP,Rab-interacting lysosomal protein,42674,0.0499489287310074,0.00577098835252525,0.0386377915600579,0.0612600659019569,5.47422252247765e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0216141880160749,0.00250056318538986,0.0167130841727108,0.0265152918594391,6.17594267193241e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.0197914229469702,0.00229326115526966,0.0152966310826417,0.0242862148112987,6.79476784155849e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42794,0.0598962159359965,0.00695300807745208,0.0462683201041904,0.0735241117678026,7.79590972723808e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0377243184512621,0.00438471998064255,0.0291302672892027,0.0463183696133215,8.59499224682866e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0531670448391142,0.00618316450772228,0.0410480424039786,0.0652860472742499,8.97096802133223e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX4,Syntaxin-4,42587,0.0494157077301263,0.00576080495883253,0.0381245300108146,0.0607068854494381,1.07132049815907e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0556326331216449,0.00648504635528063,0.0429219422652949,0.0683433239779949,1.09010117469578e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0227447708763193,0.0026556970470656,0.0175396046640708,0.0279499370885679,1.20246348767452e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYAL1,Hyaluronidase-1,42544,-0.0193057687145867,0.00225612616047615,-0.02372777598912,-0.0148837614400535,1.28331328838512e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0379895800685132,0.00444801325381929,0.0292714740910274,0.046707686045999,1.50799809245808e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP3,Stromelysin-1,42611,-0.0419150041709845,0.00490919052479449,-0.0515370175995817,-0.0322929907423873,1.51042946138305e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX6,Peroxiredoxin-6,42721,-0.0503166866705055,0.00589429219813222,-0.0618694993788447,-0.0387638739621664,1.52955797224921e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0251223084733118,0.00294658414430462,0.0193470035504747,0.0308976133961488,1.71006954354652e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C5,Complement C5,40539,0.0125047568860201,0.00146848143454118,0.00962653327431942,0.0153829804977209,1.86855126252286e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNAS,Neuroendocrine secretory protein 55,40482,0.0711429878723077,0.00835546856645862,0.0547662694820488,0.0875197062625666,1.88402186915609e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0200576775998026,0.00236124343858875,0.0154296404601686,0.0246857147394366,2.19369579116746e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0436136717659573,0.00513587043489714,-0.0536799778183557,-0.0335473657135589,2.24268509442367e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0212091947703338,0.00249875584597284,0.0163116333122271,0.0261067562284406,2.32291350918595e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0448535636449117,0.00528611336825706,0.0344927814431279,0.0552143458466956,2.4298799362798e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42587,0.0598049218580116,0.00705936596173111,0.0459685645730186,0.0736412791430046,2.66831428720753e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.072092769663862,0.00851757106301858,0.0553983303803456,0.0887872089473784,2.85466109564829e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0333772324522546,0.00394715780868607,0.0256408031472299,0.0411136617572792,3.1186665715334e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP6,Bone morphogenetic protein 6,42342,0.033322669031747,0.00394262193140672,0.0255951300461898,0.0410502080173041,3.16527057468692e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1F,Protein phosphatase 1F,40511,0.0427578690826734,0.00506218701973221,0.0328359825239982,0.0526797556413485,3.36718561662722e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0471314276635921,0.00558632621034142,0.0361822282913229,0.0580806270358613,3.58613309710681e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42587,0.0192362820140887,0.0022815970312113,0.0147643518329146,0.0237082121952629,3.77293965849043e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP1,Secreted frizzled-related protein 1,42457,0.0362555564206361,0.00430076063164799,0.027826065582606,0.0446850472586662,3.80960469654171e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP3,Syntaxin-binding protein 3,42346,0.0353710197050629,0.00420367031987882,0.0271318258781004,0.0436102135320254,4.35706888689565e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCA,Tubulin-specific chaperone A,40283,0.0692480132887969,0.00823731919008524,0.0531028676762298,0.085393158901364,4.73557060599434e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAN,Brevican core protein,42495,0.028354177392057,0.00337432465709983,0.0217405010641413,0.0349678537199727,4.79400286980038e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME1,Proteasome activator complex subunit 1,42480,0.0302850584277271,0.00360698820030738,0.0232153615551247,0.0373547553003296,5.07454994937092e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1,Allograft inflammatory factor 1,42346,0.042407827256696,0.00505200510240116,0.0325058972559898,0.0523097572574023,5.16452616887187e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0317739023355243,0.00378915966419213,0.0243471493937077,0.0392006552773408,5.55299717368195e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0321172434695453,0.00383216192695858,0.0246062060927065,0.0396282808463842,5.76845337587465e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42618,-0.0279067565036738,0.00333404714321017,-0.0344414889043657,-0.0213720241029818,6.31511561455782e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSP1,Lymphocyte-specific protein 1,42594,0.0322526916098338,0.00385873087289711,0.0246895790989555,0.0398158041207121,6.9812544788262e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.022448750581554,0.00268626985643884,0.0171836616629338,0.0277138395001741,7.06917906882335e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAN,Neurocan core protein,42711,0.0308706316818175,0.00369599817846617,0.0236264752520238,0.0381147881116112,7.3325191514351e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0526968672328778,0.00630964770108411,0.0403299577387529,0.0650637767270026,7.37312199745278e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0459394878745837,0.00550113943671409,0.0351572545786241,0.0567217211705433,7.43358897717295e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE4,Ribonuclease 4,40169,0.0237783138561198,0.002847326303175,0.0181975543018968,0.0293590734103428,7.5755006735148e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA14,Carbonic anhydrase 14,42721,0.0291784414532775,0.0034987205306857,0.0223209492131335,0.0360359336934215,8.15955133229394e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0420377386003294,0.00504149804222166,0.032156402437575,0.0519190747630839,8.40972912219521e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.043077115745224,0.00516869819480247,0.0329464672834111,0.0532077642070368,8.55487384886298e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL7,C-C motif chemokine 7,42594,0.0478216452163779,0.00574341107476569,0.0365645595098372,0.0590787309229187,9.1401350397943e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0321580606729141,0.00386193164389096,0.0245886746508878,0.0397274466949404,9.25239436822219e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BDNF,Brain-derived neurotrophic factor,40527,0.0678743900171309,0.00815393900774228,0.0518926695619561,0.0838561104723058,9.46928354556146e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40LG,CD40 ligand,42754,0.0625559263869202,0.00752170741294966,0.0478133798575389,0.0772984729163016,9.89910487347421e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH7,Protocadherin-7,40449,0.0293738514357287,0.00353219993090819,0.0224507395711487,0.0362969633003088,1.01424888016498e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPSE,Heparanase,40408,0.0756369344825653,0.00910046299302299,0.0578000270162403,0.0934738419488904,1.05534979527727e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0555089425003784,0.00668548251151202,0.0424053967778149,0.068612488222942,1.13496311451595e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN6,Dynactin subunit 6,42311,0.057772628538535,0.00696870870607933,0.0441139594746195,0.0714312976024505,1.23896089189679e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGA,Chromogranin-A,40527,-0.0790722043126784,0.00954366934065133,-0.0977777962203551,-0.0603666124050018,1.31050787207866e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,40511,0.0220705232763648,0.00266570148163448,0.0168457483723612,0.0272952981803683,1.37644246646548e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB4,Ephrin type-B receptor 4,42794,-0.0212450903950124,0.00256812765826892,-0.0262786206052195,-0.0162115601848053,1.43169548396961e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LARP1,La-related protein 1,40451,0.0491415275862981,0.00594807764227376,0.0374832954074416,0.0607997597651547,1.5961368191357e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOT,Angiomotin,40283,0.0311582919437235,0.00377328153557735,0.0237626601339919,0.0385539237534551,1.65473801568599e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0295222346942398,0.00358031570762036,0.0225048159073039,0.0365396534811757,1.7927433844756e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID1,Nidogen-1,42652,0.0306770960975815,0.00372594775431271,0.0233742384991286,0.0379799536960344,1.98682221592916e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0446029460678558,0.00542536723490357,0.0339692262874448,0.0552366658482668,2.19925253514336e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0386925063422454,0.00470673200618704,0.0294673116101188,0.047917701074372,2.24477744860112e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0342465011753119,0.00417787717216351,0.0260578619178714,0.0424351404327524,2.73596619198628e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0579552322377526,0.00708189247707849,0.0440747229826788,0.0718357414928265,3.00469407846967e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0226417856428342,0.00276730390618049,0.0172178699867205,0.028065701298948,3.09280085150359e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX8,Syntaxin-8,42594,0.0379259583816803,0.00464031812187846,0.0288309348627985,0.0470209819005621,3.27273619428468e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEP,Leptin,42636,0.0526322379622051,0.0064436186078211,0.0400027454908757,0.0652617304335345,3.41017544915486e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0304462372171792,0.00372756078473092,-0.0377522563552518,-0.0231402180791066,3.41765918457924e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML2,Trem-like transcript 2 protein,42611,0.0275993391182013,0.00338092086286441,0.0209727342269871,0.0342259440094156,3.55005542664595e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPB1,Beta-ureidopropionase,40511,0.0711904901342048,0.00874100179207502,0.0540581266217378,0.0883228536466719,4.21027875859821e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0272030222130122,0.00334174379502671,0.0206532043747599,0.0337528400512646,4.35549451149178e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT1,Angiopoietin-1,42554,0.066098222735189,0.00812331140341377,0.0501765323844981,0.08201991308588,4.41314022127931e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN2,Matrilin-2,42638,0.0233243891718646,0.00287256525863434,0.0176941612649413,0.0289546170787879,5.07749111839459e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXN,Paxillin,42311,0.0403127447015537,0.00496642808604522,0.030578545652905,0.0500469437502023,5.20001683062551e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0604737037763337,0.00745450308725677,0.0458628777253104,0.0750845298273569,5.4791807128367e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSTN,Growth/differentiation factor 8,42357,0.0420421818667637,0.00518544514606901,0.0318787093804684,0.0522056543530589,5.61094317481635e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.0516567902906895,0.00639647625341143,0.0391196968340031,0.0641938837473759,7.28173197915813e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42587,0.0463421326247522,0.00574463496043011,0.0350826481023092,0.0576016171471952,7.81230764777647e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL18,C-C motif chemokine 18,42477,0.0545207029029692,0.00676791091599245,0.041255597507624,0.0677858082983144,8.56833179795042e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.028634532311595,0.00355572399082365,0.0216653132895806,0.0356037513336094,8.74304131343092e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2R,Proteinase-activated receptor 1,42654,0.0435949194650511,0.00542032997017836,0.0329710727235015,0.0542187662066007,9.50664496079801e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA6,Integrin alpha-6,42594,0.0397344691476159,0.00494193691937352,0.0300482727856438,0.049420665509588,9.71232181096709e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42590,-0.0183641000491097,0.00229286390885656,-0.0228581133104685,-0.0138700867877508,1.24896538991788e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRD2,Protein ZNRD2,40449,0.0542516969139513,0.00677634322185674,0.0409700641991121,0.0675333296287906,1.30098364488316e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0312742516462076,0.0039095543050821,0.0236115252082467,0.0389369780841685,1.37154626090272e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF2,Scavenger receptor class F member 2,42711,-0.0235241259623936,0.00294702648992946,-0.0293002978826554,-0.0177479540421319,1.55124704248866e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUS,RNA-binding protein FUS,42336,0.0308006487923001,0.00385902687788666,0.0232369561116422,0.0383643414729579,1.56561604948761e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCA2A,Guanylin,42563,-0.0282836539111623,0.00354633171620521,-0.0352344640749245,-0.0213328437474001,1.64083201320758e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0680421710413431,0.00853288782574758,0.0513177109028778,0.0847666311798083,1.68320982137202e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0387940905878985,0.00488204135697916,0.0292252895282194,0.0483628916475777,2.0746991395901e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPMT,Thiopurine S-methyltransferase,42346,0.0561154308279111,0.00706596758301998,0.0422661343651919,0.0699647272906302,2.15641861921143e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACYP1,Acylphosphatase-1,40250,0.0506469602026634,0.00637747715410505,0.0381471049806175,0.0631468154247093,2.19030296499745e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0240011380645801,0.00302399678864036,-0.0299281717703152,-0.018074104358845,2.24014384985254e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0295516884340436,0.00372468754832183,0.0222513008393328,0.0368520760287544,2.32216431564147e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGFAC,Hepatocyte growth factor activator,40428,0.0214659737021234,0.00270612800287262,0.0161619628164931,0.0267699845877537,2.3540508345984e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD84,SLAM family member 5,42594,0.0241471948228056,0.00304741816099522,0.018174255227255,0.0301201344183562,2.48419284510969e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBP,Protein AMBP,42706,0.0160861838712839,0.00203341803792921,0.0121006845169427,0.0200716832256252,2.75290361484404e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARD3,Partitioning defective 3 homolog,40302,0.0572118301969513,0.00723648065644937,0.0430283281103105,0.0713953322835921,2.90865443214445e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR2,Folate receptor beta,42711,-0.0227262474776431,0.00287970641025168,-0.0283704720417364,-0.0170820229135498,3.20512934473599e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0334326556757205,0.00423665805074635,0.0251288058962576,0.0417365054551833,3.2239065741316e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO2,Gamma-enolase,42711,0.0492120593865036,0.00625455479081933,0.0369531319964977,0.0614709867765095,3.87016853757296e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0289348483114546,0.00367976787620825,0.0217225032740864,0.0361471933488227,4.08418261386519e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN4,Cerebellin-4,42721,0.024729616769724,0.00316374304194262,0.0185286804075165,0.0309305531319316,5.82779221287092e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0377799358448367,0.00483576200518769,0.0283018423146688,0.0472580293750046,6.10699146699176e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0696800453477644,0.00892389208902023,0.0521892168532848,0.0871708738422441,6.31096917672337e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY1,Aminoacylase-1,42636,0.0457934007382557,0.0058700307920641,0.0342881403858101,0.0572986610907013,6.58177228637275e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.0905327430119764,0.0116579059991259,-0.113382238770263,-0.0676832472536897,8.70620269892348e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0493823409710462,0.00636691231534571,-0.0618614891091238,-0.0369031928329686,9.38000718886748e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB10,Ras-related protein Rab-10,40511,0.0403364074436915,0.00520190498375914,0.0301406736755236,0.0505321412118594,9.65496061937689e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.039736775782937,0.00513634516295346,0.0296695392635482,0.0498040123023258,1.11195750593137e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.0437192359548193,0.00565942021632332,0.0326267723308256,0.054811699578813,1.19707530362525e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS27,Serine protease 27,42603,0.030262389159635,0.00392242209595267,0.0225744418515677,0.0379503364677022,1.29269937388518e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,40223,0.040695756599929,0.00527526341206666,0.0303562403122783,0.0510352728875796,1.31976108335764e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.0592053031885529,0.00769825969764349,-0.0742938921959341,-0.0441167141811717,1.56433528172616e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0272860425392641,0.0035540042525018,0.0203201942043606,0.0342518908741676,1.7345122942862e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17D,Interleukin-17D,42370,0.0257442407510836,0.00335383802600382,0.0191707182201161,0.0323177632820511,1.75589808765298e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0471929321689204,0.00615394185106676,0.0351312061408295,0.0592546581970112,1.87908627487129e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBI,Acyl-CoA-binding protein,42562,0.0567585441516615,0.00740504364401506,0.0422446586093919,0.071272429693931,1.91359209382343e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCG,Gamma-synuclein,42495,0.0511880457810928,0.00669930185530319,0.0380574141446985,0.064318677417487,2.30610862113601e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1B,Lithostathine-1-beta,42794,-0.043552908219808,0.00570127175901861,-0.0547274008674845,-0.0323784155721315,2.3322779616963e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSR,"Glutathione reductase, mitochondrial",40490,0.0167364418541874,0.00219295337107397,0.0124382532468824,0.0210346304614924,2.49892639929166e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.0364187012375128,0.00477363874450848,0.0270623692982762,0.0457750331767494,2.5223096519579e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0355565980428469,0.00466218460525606,-0.0446944798691488,-0.026418716216545,2.57046375909047e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42495,0.0226053407496636,0.00296653992441386,0.0167909224978125,0.0284197590015148,2.70590384187079e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL2,C-C motif chemokine 2,42475,0.0393688851505056,0.00517592860791129,0.0292240650789995,0.0495137052220117,3.01341426058289e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0289514690631128,0.00380894487194973,-0.0364170010121343,-0.0214859371140913,3.17326236773552e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.0220560651998521,0.0029036225551437,0.0163649649917704,0.0277471654079337,3.25716158412537e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0471520897388889,0.00621695605489009,0.0349668558713043,0.0593373236064734,3.60232617497059e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGED1,Melanoma-associated antigen D1,42346,0.0355322235810434,0.00469217790850847,0.0263355548803668,0.04472889228172,3.90043647037092e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SWAP70,Switch-associated protein 70,40449,0.0262214590834101,0.00347117179217721,0.0194179623707428,0.0330249557960775,4.54551513297419e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSNAX,Translin-associated protein X,40116,0.0290961547482369,0.00385184441815579,0.0215465396886516,0.0366457698078223,4.56424573042151e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TST,Thiosulfate sulfurtransferase,42277,0.0547201689258851,0.00724624559778922,0.0405175275542182,0.068922810297552,4.58694737931946e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSPN,Persephin,42594,0.0683698352145873,0.00905796890953329,0.050616216151902,0.0861234542772725,4.70381131079646e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0449075606208262,0.00595043121512897,0.0332447154391734,0.0565704058024789,4.74313857498564e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0648087120795187,0.0085879430876519,0.047976343627721,0.0816410805313164,4.82218024953757e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXN,"Frataxin, mitochondrial",42721,0.0535745049085284,0.00710281584536239,0.0396529858516181,0.0674960239654386,4.89603495806567e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX16,Syntaxin-16,42346,0.0423608556399276,0.00561762115104973,0.0313503181838701,0.0533713930959851,4.98023238682195e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX9,Sorting nexin-9,42636,0.0490045623778137,0.00650281393937885,0.0362590470566311,0.0617500776989962,5.15945161717945e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA10,N-alpha-acetyltransferase 10,40116,0.0378134016571641,0.00501801636818494,0.0279780895755216,0.0476487137388066,5.24833336916966e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0260709593519899,0.0034609522060634,-0.0328544256758742,-0.0192874930281056,5.28641909830318e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0321562074656679,0.00426921349705336,0.0237885490114433,0.0405238659198925,5.31186594295609e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,40058,0.0389679966601681,0.00517598977266259,0.0288230567057494,0.0491129366145868,5.53477557415177e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA4,Annexin A4,42584,0.0522222156698497,0.00693906163117617,0.0386216548727444,0.065822776466955,5.57260628248339e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,40283,0.0277254573136374,0.00368414914696419,0.0205045249855876,0.0349463896416873,5.65402353596991e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGLN1,Egl nine homolog 1,42594,0.0404840346958123,0.0053820881813269,0.0299351418604116,0.051032927531213,5.73775430652473e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB6,Integrin beta-6,42370,0.0228165005469256,0.00304031710490923,0.0168574790213035,0.0287755220725476,6.5543502395249e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0439279152250185,0.00585480324959131,0.0324525008558196,0.0554033295942175,6.64336453026706e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0182779377310414,0.00243702065675408,0.0135013772438034,0.0230544982182793,6.77705223268462e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0276400193887969,0.00370026973459455,0.0203874907089916,0.0348925480686022,8.54186862901399e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.02931776705112,0.00393406569436486,0.0216069982901649,0.0370285358120751,9.86205453421224e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0497493530918875,0.00668033745231726,0.0366558916853457,0.0628428144984294,1.02458051912783e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42611,-0.024168722247037,0.00324786648512297,-0.030534540557878,-0.0178029039361959,1.05668794020276e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDUA,Alpha-L-iduronidase,42721,0.033417720730533,0.00449848236435207,0.0246006952964029,0.042234746164663,1.16266927002978e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOTL2,Angiomotin-like protein 2,40404,0.0348438627533519,0.00469872649874415,0.0256343588158134,0.0440533666908904,1.29811444965055e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA4,Carbonic anhydrase 4,42794,-0.0173912767406652,0.00234645523190541,-0.0219903289951998,-0.0127922244861306,1.32023928987846e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL32,Interleukin-32,42594,-0.0318952120099161,0.0043054953944194,-0.0403339829829781,-0.023456441036854,1.35859050789306e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.0615871663112662,0.00831561183993594,0.0452885671049917,0.0778857655175406,1.37968229533594e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDHB,Succinate dehydrogenase,40449,0.0478664964652318,0.0064659100629788,0.0351933127417934,0.0605396801886703,1.42745077697636e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM3,Junctional adhesion molecule C,40283,0.0364851672538225,0.0049406127277056,0.0268015663075195,0.0461687682001255,1.63699927960971e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSV,Cathepsin L2,42677,0.030094344464463,0.00407725772469354,0.0221029193240636,0.0380857696048623,1.66268761327624e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHI3L1,Chitinase-3-like protein 1,42416,-0.0589706612683907,0.00802157755693445,-0.0746929532799823,-0.0432483692567992,2.07505111995312e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42701,-0.0156815287664198,0.00214361053804849,-0.0198830054209948,-0.0114800521118447,2.70928255038282e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0346667777230144,0.00474356432423267,0.0253693916475183,0.0439641637985104,2.89134680643087e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGN,Secretagogin,42370,-0.0321953731909618,0.00440617290606185,-0.040831472086843,-0.0235592742950805,2.89150690219259e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0202086565424526,0.00276707079297723,0.0147851977882172,0.025632115296688,2.96561924935525e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRK5,G protein-coupled receptor kinase 5,42357,0.0360453844898732,0.00494074701520852,0.0263615203400645,0.0457292486396819,3.14505581558544e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0584558002056572,0.00802423162211914,0.0427283062263036,0.0741832941850107,3.43399779368907e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP8,Caspase-8,42674,0.043306111322969,0.00595241402925657,0.0316393798256261,0.0549728428203119,3.64512237850045e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFAP,Glial fibrillary acidic protein,42326,0.034609057321525,0.00475922242202841,0.0252809813743493,0.0439371332687007,3.74268421549344e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOA,Elongin-A,42587,0.0377828301605223,0.00519785492274654,0.027595034511939,0.0479706258091055,3.82430695686409e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL3,Myosin light chain 3,40223,-0.0520588585826706,0.00716681404319555,-0.0661058141073339,-0.0380119030580073,4.01520420861399e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.0410331029509834,0.00565067995229942,0.0299577702444765,0.0521084356574903,4.03570906553076e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR1,Complement receptor type 1,40509,0.0255969300987805,0.00352701599124568,0.0186839787559389,0.032509881441622,4.20463274200343e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0338290157705852,0.00466256864756842,0.024690381221351,0.0429676503198193,4.22737513565588e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML1,Trem-like transcript 1 protein,40532,0.0370381623930843,0.00511085118938686,0.027020894061886,0.0470554307242825,4.53892166178075e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WDR46,WD repeat-containing protein 46,40451,0.0253320245807181,0.00349645607902893,0.0184789706658214,0.0321850784956148,4.60506482496639e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0470889909875337,0.00650320604359033,0.0343427071420966,0.0598352748329707,4.74736460775668e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APP,Amyloid-beta precursor protein,42592,0.0466192103311817,0.00644887646529755,0.0339794124591985,0.0592590082031649,5.12757168797112e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0247853213383783,0.00343042201147559,0.0180616941958862,0.0315089484808705,5.33684680284302e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,42370,0.0465991513350798,0.00645123307160459,0.0339547345147348,0.0592435681554248,5.35307074753987e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0265878320807346,0.00368046612312477,0.01937411847941,0.0338015456820591,5.37760851918254e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0307023365604314,0.00425274457125904,0.0223669572007637,0.0390377159200992,5.56461019834776e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOB,Apolipoprotein B-100,40532,0.0156969642249556,0.00217809309030879,0.0114279017679503,0.0199660266819608,6.09433828651992e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAYN,Layilin,42476,-0.0265976010702311,0.00369172800963795,-0.0338333879691215,-0.0193618141713407,6.13317495306189e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRBP,Acrosin-binding protein,40451,0.0274512505339683,0.00381369210819652,0.0199764140019032,0.0349260870660335,6.49549305595525e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.040427043338019,0.00562194572043979,-0.051446056950081,-0.029408029725957,6.77615103871436e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0470950214266195,0.00655079057855061,0.0342554718926603,0.0599345709605787,6.94243365560729e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM3,Myomesin-3,40283,-0.0649793775631043,0.00904142605386668,-0.082700572628683,-0.0472581824975256,7.05623923526638e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL16,C-X-C motif chemokine 16,42778,0.0166748691444832,0.00232209513398001,0.0121235626818824,0.021226175607084,7.28239106041517e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0332937816388698,0.00464067985044248,0.0241980491320025,0.042389514145737,7.65515500319442e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCLY,Selenocysteine lyase,42674,0.0324550683092312,0.00453595919491125,0.0235645882872051,0.0413455483312573,8.79553332732602e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PQBP1,Polyglutamine-binding protein 1,42346,0.0395218554709177,0.0055288428790417,0.028685323427996,0.0503583875138395,9.24921836972484e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0193914764878395,0.00271259450769675,0.0140747912527539,0.0247081617229252,9.31740314557306e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANG,Angiogenin,42618,0.0232928407179945,0.00326089111661978,0.0169014941294197,0.0296841873065692,9.59574822003706e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0399791765233132,0.0056005071441367,0.0290021825208053,0.0509561705258211,9.92555669762768e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA12,Carbonic anhydrase 12,42587,-0.022975784490112,0.00322247413346869,-0.0292918337917106,-0.0166597351885134,1.05622869578733e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0319756558245764,0.00448665819196399,0.023181805768327,0.0407695058808258,1.08987488367397e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.0514403289427157,0.00722108731098504,0.0372869978131851,0.0655936600722464,1.1150539904574e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL3,C-C motif chemokine 3,42594,0.0397299050043965,0.00558756904805409,0.0287782696702104,0.0506815403385825,1.21562406482202e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0230705130218127,0.00324513552071628,0.0167100474012088,0.0294309786424166,1.22501256869062e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASSF2,Ras association domain-containing protein 2,42346,0.0391362174013838,0.00551272463791987,0.0283312771110609,0.0499411576917068,1.31873182784694e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMNL1,Formin-like protein 1,42311,0.0426769065264547,0.00601347447423738,0.0308904965569494,0.0544633164959599,1.34163864940503e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0298209774017404,0.00420916033091069,0.0215710231531554,0.0380709316503253,1.4623623218785e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0261146634595902,0.00368868803989868,0.0188848349013888,0.0333444920177916,1.51690589714018e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",40223,0.0597959126585706,0.00844586697929634,0.0432420133791498,0.0763498119379915,1.53027707289087e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL4,C-C motif chemokine 4,42642,0.0469175336544697,0.00663782225779636,0.0339074020291888,0.0599276652797506,1.64680238049149e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC79,Protein unc-79 homolog,40080,0.0382669014788201,0.00542277299768233,0.0276382664033627,0.0488955365542774,1.8086765806674e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42754,0.04942439664305,0.00702917013002289,0.0356472231882052,0.0632015700978949,2.14370736566402e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42594,-0.0239972874051201,0.00342183855998943,-0.0307040909826993,-0.0172904838275408,2.44479708353625e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZD2,PDZ domain-containing protein 2,40116,0.0413553779777829,0.00589737438832539,0.0297965241766651,0.0529142317789007,2.47918228943555e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKZ,Diacylglycerol kinase zeta,42370,0.023789740913963,0.00339370462930385,0.0171380798405274,0.0304414019873985,2.49990950425244e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0188835650464757,0.00269668031844759,0.0135980716223184,0.024169058470633,2.63382425002418e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0108434826769353,0.00155292261112154,0.00779975435913709,0.0138872109947335,3.03152845378892e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSB,Cathepsin B,42659,0.0365028202227924,0.00522911273354783,0.0262537592650386,0.0467518811805461,3.07489127883589e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42611,0.0362749973203648,0.0052047000407001,0.0260737852405927,0.046476209400137,3.32544761257653e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFB,Complement factor B,40344,0.0220118020619732,0.00315909460548984,0.0158199766352131,0.0282036274887333,3.40191671299411e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42676,0.0169785416332614,0.00244264260428853,0.0121909621288559,0.0217661211376669,3.79677828708889e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE,Angiotensin-converting enzyme,40532,-0.0182146590306457,0.00262126799250379,-0.0233523442959531,-0.0130769737653383,3.88610695570629e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.0189644062016351,0.00272986723320892,-0.0243149459787246,-0.0136138664245456,3.90404614195374e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.026536212477273,0.00382387058815869,0.0190414261244819,0.034030998830064,4.1111400763898e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.0365589124730762,0.00527793469482293,0.0262141604712233,0.0469036644749292,4.50293431218239e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0475591183362978,0.00687420786929495,0.0340856709124797,0.0610325657601159,4.81646677297985e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRH,Corticoliberin,42322,0.0577810594170369,0.00835568950426331,0.0414039079886808,0.074158210845393,4.8891128845301e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0343557327314201,0.00497398110547785,0.0246067297646835,0.0441047356981566,5.16906404106816e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRG1,Scrapie-responsive protein 1,40511,0.0192357117577291,0.00278452513419395,0.0137780424947089,0.0246933810207492,5.17622543847415e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0276406140559665,0.00400335991187733,0.0197940286286869,0.035487199483246,5.26875837741977e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.0201676055509124,0.00292208427255748,0.0144403203766997,0.0258948907251251,5.41544227275704e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0457683383508515,0.00666416825751377,0.0327065685661245,0.0588301081355785,6.80421398104115e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7orf50,Uncharacterized protein C7orf50,40483,0.015209011331208,0.00221632305867269,0.0108650181362095,0.0195530045262065,7.13225365124971e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,40532,0.0179832118988117,0.00262956099134453,0.0128292723557765,0.023137151441847,8.39275666956515e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMS,Spermine synthase,40136,0.0425214331564838,0.00621970246280259,0.0303308163293907,0.0547120499835768,8.54307888850697e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0338501339229612,0.00495692086762058,0.0241345690224249,0.0435656988234975,8.93502690496971e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAP3,Cytosol aminopeptidase,42370,0.0321205833649874,0.00470953339532486,0.0228898979101506,0.0413512688198241,9.47930620020222e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MILR1,Allergin-1,42370,-0.0341987699354325,0.00501830010006878,-0.0440346381315673,-0.0243629017392977,9.84922314836338e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POF1B,Protein POF1B,40199,-0.0311050507982893,0.00456462465301648,-0.0400517151182016,-0.022158386478377,9.9623389703983e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,40302,0.0231472275753416,0.00340172124178826,0.0164798539414366,0.0298146012092466,1.06571802888845e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAL,Galanin peptides,42676,0.042497467877296,0.00624749524846409,0.0302523771903064,0.0547425585642856,1.07288598114489e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL2,Chordin-like protein 2,42636,0.0312383809221223,0.00459692013071447,0.0222284174659219,0.0402483443783227,1.12483480014694e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK4,Serine/threonine-protein kinase 4,42636,0.0562448925834464,0.00832243829621654,0.039932913522862,0.0725568716440308,1.45452362771499e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0535079005064553,0.00792260880290385,0.0379795872527638,0.0690362137601468,1.49937734281346e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.0593990292458939,0.00885836636251666,0.0420366311753612,0.0767614273164265,2.10577823757704e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0157933536284257,0.00235598163062846,0.011175629632394,0.0204110776244575,2.11551901422793e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAP18,Chromatin complexes subunit BAP18,40483,0.0441655275903805,0.0065896101096366,0.0312498917754928,0.0570811634052682,2.14940955235197e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0437041976485754,0.00654383110669116,0.0308782886794608,0.0565301066176901,2.52804997447996e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRDT,Bromodomain testis-specific protein,40116,0.0242477996602078,0.00363572972648097,0.017121769396305,0.0313738299241105,2.69428542450653e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAM,Signal transducing adapter molecule 1,40451,0.0243049235383253,0.00364479653166586,0.0171611223362602,0.0314487247403904,2.7073255766024e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPY,Pancreatic prohormone,42600,0.0670672115902492,0.0100632184543537,0.0473433034197159,0.0867911197607825,2.75782996335216e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0184763752194508,0.00278099616504587,0.0130256227359609,0.0239271277029407,3.2024522813537e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP9,Caspase-9,40199,0.0405817114246742,0.00610944791109486,0.0286071935189283,0.0525562293304202,3.23059514856736e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BP1,SH3 domain-binding protein 1,40449,0.0309019467859265,0.00465603226514244,0.0217761235462473,0.0400277700256057,3.34908416346276e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBI3_IL27,Interleukin-27,42689,-0.0199049823906352,0.00300386114996828,-0.025792550244573,-0.0140174145366974,3.56868485499972e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC3,Membrane primary amine oxidase,42689,-0.0193922508069277,0.00294289076724321,-0.0251603167107244,-0.0136241849031311,4.57614783671137e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEMIP2,Cell surface hyaluronidase,40199,0.0221620438353228,0.00336294694977384,0.0155706678137661,0.0287534198568795,4.59719532444358e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0357906701325619,0.00543691840641788,0.0251343100559829,0.0464470302091409,4.82112776973525e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0488789938653465,0.00742658025241132,0.0343228965706203,0.0634350911600727,4.86277636714265e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0338941147490746,0.00515223975790628,0.0237957248235783,0.043992504674571,4.93136113999511e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0723897848220724,0.0110128301139287,0.0508046377987721,0.0939749318453726,5.14144350500342e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0163768258246797,0.00249211996165977,0.0114922706998265,0.0212613809495328,5.16664914091913e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39838,-0.072618520808273,0.0110517694540464,-0.0942799889382039,-0.0509570526783422,5.23983364108337e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0184954789711093,0.00281768520843401,-0.02401814197964,-0.0129728159625787,5.42804623390875e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42679,0.0279140239571727,0.0042569036123451,0.0195704928769763,0.0362575550373691,5.67661013986156e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,40527,0.0179058135153058,0.00273253036377457,0.0125500540023076,0.0232615730283039,5.8903619035378e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0156310655968358,0.00238587117729405,0.0109547580893395,0.0203073731043322,5.90403013807272e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0351654827704864,0.00537362772393273,0.0246331724315783,0.0456977931093946,6.24596029556016e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.0233518680458487,0.00357812730158588,-0.030364997556957,-0.0163387385347404,6.98448193943232e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRIB,Protein scribble homolog,40223,0.0576673186598382,0.00885396289648752,0.0403135513827227,0.0750210859369538,7.67852092118871e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0294813820821219,0.00452823689968607,0.0206060377587372,0.0383567264055066,7.81045399943933e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL1,Follistatin-related protein 1,40223,-0.0143844947426821,0.00221303899696856,-0.0187220511767405,-0.0100469383086237,8.38513499914106e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0299691969751627,0.00462198079430869,0.0209101146183176,0.0390282793320077,9.24775613326355e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF2,Fibroblast growth factor 2,42594,0.0431189151700273,0.00665128197956722,0.0300824024900756,0.0561554278499791,9.31915182604818e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM1,Probable carboxypeptidase X1,42679,0.0437360876651715,0.00675338786219094,0.0304994474552773,0.0569727278750657,9.73416249441615e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.0189148483508448,0.00292724273722279,-0.0246522441158014,-0.0131774525858881,1.07137006137555e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.0403843971714619,0.00625339651170189,0.0281277400085262,0.0526410543343976,1.09830868010567e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMM2,Phosphomannomutase 2,40116,0.0378483970643635,0.00586657916058775,0.0263499019096115,0.0493468922191155,1.15412870269333e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0204789083911239,0.00318009575083448,-0.0267118960627595,-0.0142459207194883,1.24648654532815e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRG,Histidine-rich glycoprotein,40479,0.0194196728703348,0.00301583125968406,0.0135086436013541,0.0253307021393156,1.24946492398265e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.0284834102680325,0.00445810822828731,-0.0372213023954756,-0.0197455181405894,1.72285913162189e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD274,Programmed cell death 1 ligand 1,42495,0.0217926114170343,0.00341129367114915,0.015106475821582,0.0284787470124866,1.73244679888209e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.0255732107576378,0.00400425013713624,-0.0334215410264248,-0.0177248804888507,1.75255858222943e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0422587381214823,0.00662759504805873,-0.0552488244156775,-0.0292686518272872,1.87520386600982e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0200420701323761,0.00314288652410909,0.0138820125451223,0.0262021277196299,1.87689461712839e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP6,Gastrotropin,42334,0.03643372103271,0.00572314825536284,0.0252163504521988,0.0476510916132212,2.00435965906177e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0522942519052132,0.00821605444064797,0.0361907852015432,0.0683977186088832,2.01939310663262e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0469658216310236,0.00737998381008043,0.0325010533632659,0.0614305898987812,2.04275925900478e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0291123759461724,0.00457589462042132,0.0201436224901466,0.0380811294021982,2.06692347009942e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGH,Gamma-glutamyl hydrolase,42437,0.0211651707222829,0.00332873575896935,0.014640848634703,0.0276894928098628,2.10666712695302e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42636,0.038963094209099,0.00612865116161866,0.0269509379323264,0.0509752504858716,2.11647449316072e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0449796362076295,0.00707619775898283,0.0311102886000232,0.0588489838152359,2.13278442789645e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMSB10,Thymosin beta-10,42611,0.0457150665503293,0.00719279890260567,0.0316171807012221,0.0598129523994364,2.14229847837625e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0219319117329701,0.0034502524442768,-0.0286944065237527,-0.0151694169421876,2.14398334692312e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.0428934290935024,0.00675901869581761,-0.0561411057373049,-0.0296457524496999,2.27946405104346e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLTA,Clathrin light chain A,42357,0.0293390239680656,0.00463804312477323,0.0202484594435101,0.0384295884926211,2.60189516072546e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0209108101692838,0.00330685454224824,0.0144293752664772,0.0273922450720903,2.63786338954896e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO2,Roundabout homolog 2,42711,0.0143895850592418,0.00227934978731415,0.00992205947610603,0.0188571106423775,2.82191288413662e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.0641518539931502,0.0101670002097906,0.0442245335819607,0.0840791744043398,2.89869612022983e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0254652851038795,0.00403834851156176,0.0175501220212184,0.0333804481865405,2.97345135996675e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICOSLG,ICOS ligand,42587,0.0118741303071839,0.00188458136771201,0.00818035082646832,0.0155679097878994,3.05633849660604e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42594,-0.0148096378762358,0.00235229344711783,-0.0194201330325867,-0.0101991427198849,3.15298213044068e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL11,Eotaxin,42754,0.0224377984395158,0.00356628048878466,0.0154478886814979,0.0294277081975338,3.23758587636618e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0167593852762293,0.00266697819872323,0.0115321080067317,0.0219866625457268,3.42087322183644e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0334611402053972,0.0053257316639335,0.0230227061440876,0.0438995742667069,3.44848346482998e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY75,Lymphocyte antigen 75,42594,0.0237731814740887,0.00379249834618125,0.0163398847155734,0.0312064782326039,3.75779177932112e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0196823908254727,0.00314020821232299,0.0135275827293197,0.0258371989216258,3.7935480005186e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0256000731842676,0.00408871561558379,0.0175861905777233,0.0336139557908118,3.96272942373339e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRL,Prolactin,42711,-0.0455353214164054,0.00728825113213792,-0.0598202936353957,-0.031250349197415,4.28840802556779e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18,Interleukin-18,42566,0.0281443095704086,0.00450521932654215,0.019314079690386,0.0369745394504312,4.30968008570556e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.0335749756369102,0.00537626076766584,0.0230375045322851,0.0441124467415352,4.39338220044434e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERI1,3'-5' exoribonuclease 1,40302,0.02093264181667,0.00335697040930154,0.014352979814439,0.0275123038189011,4.66468771660734e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMA,Granzyme A,42754,0.0214925275387738,0.00345417295705657,0.0147223485429429,0.0282627065346047,5.04678154853209e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI1,Neuroserpin,40267,0.018381100515976,0.00295421257494783,0.0125908438690782,0.0241713571628738,5.08598861850222e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0198364268854461,0.00318893350717428,0.0135861172113845,0.0260867365595077,5.1340706849388e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APRT,Adenine phosphoribosyltransferase,42480,0.0286399275263322,0.00460667177444645,0.0196108508484172,0.0376690042042473,5.21738694928963e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.0242097336205028,0.00389673232325166,-0.031847328974076,-0.0165721382669295,5.3576236522724e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,42292,0.0401528146340073,0.00646421050912532,0.0274829620361217,0.0528226672318929,5.40496475000442e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1A,Meprin A subunit alpha,40449,0.0437842577288863,0.00705521356723587,0.029956039137104,0.0576124763206686,5.6281664590832e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS8,Prostasin,42568,-0.0252227189352549,0.00407479197988363,-0.0332093112158268,-0.017236126654683,6.19459318760923e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GC,Vitamin D-binding protein,40539,0.0156476417143836,0.00252796092202508,0.0106928383072144,0.0206024451215527,6.23096263259681e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFAP1,Actin filament-associated protein 1,40283,0.0501242464673072,0.00811233954391859,0.0342240609612267,0.0660244319733876,6.68712899646808e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIPF,Gastric triacylglycerol lipase,40223,0.0375337962670854,0.00608425171549208,0.0256086629047209,0.0494589296294499,7.11290489045115e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTNB,Dystrobrevin beta,40430,0.0256848814247993,0.00416426610460493,0.0175229198597737,0.033846842989825,7.1570657884426e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPLAH,5-oxoprolinase,40223,0.0406481561168228,0.00659301619650815,0.0277258443716668,0.0535704678619787,7.27938811364545e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA2,Adenosine deaminase 2,42572,-0.0266175876812807,0.00432352555964531,-0.0350916977781855,-0.0181434775843759,7.65188599539001e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG3,Desmoglein-3,42651,0.0210771135641766,0.00342514882587835,0.014363821865455,0.0277904052628982,7.7875831607483e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBN,Nibrin,42370,0.0320329656138791,0.00520641889823256,0.0218283845733433,0.042237546654415,7.8435333461041e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1A,Protein phosphatase 1A,42346,0.0190469870230411,0.00309864732078675,0.0129736382742991,0.0251203357717831,8.13110524074955e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAM,Basal cell adhesion molecule,42611,-0.0147560329105915,0.00240111281100826,-0.0194622140201677,-0.0100498518010153,8.19700109062077e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA4,Laminin subunit alpha-4,42676,0.0196625124914161,0.00321782050087149,0.013355584309708,0.0259694406731242,1.02051143999685e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCA,Calcitonin,42476,0.0376514567386266,0.00616173319631824,0.0255744596738428,0.0497284538034103,1.02077598001385e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0349290756593979,0.00572378564038296,0.0237104558042472,0.0461476955145485,1.07975202603961e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA9,Carbonic anhydrase 9,42721,-0.0287870852937074,0.00472099369896725,-0.0380402329436832,-0.0195339376437316,1.10552265023837e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN2,Transcobalamin-2,42771,-0.0183197950838192,0.00300440005380647,-0.0242084191892799,-0.0124311709783585,1.10555127553469e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0246715172738058,0.00406274246101771,-0.0326344924974006,-0.0167085420502111,1.29257772028401e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0393465928690525,0.00648385237199846,0.0266382422199355,0.0520549435181695,1.32753104342236e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDK2,Protein sidekick-2,40283,0.0239615430319298,0.00394968148694272,0.016220167317522,0.0317029187463375,1.34823410503286e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC1,MANSC domain-containing protein 1,42679,-0.0165840317908659,0.00273412053543226,-0.0219429080403132,-0.0112251555414187,1.34993502015633e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1,Integrin beta-1,42638,0.0126259205147256,0.00208224310099896,0.00854472403676764,0.0167071169926835,1.36661920383921e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF6,SLAM family member 6,42346,0.0228660514204546,0.00377446831583038,0.0154680935214271,0.0302640093194822,1.41511741569757e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0349779496098813,0.00578379290663123,0.0236417155128841,0.0463141837068785,1.50895297251364e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164,Sialomucin core protein 24,42611,0.016065223516887,0.00266103417544681,0.0108495965330113,0.0212808505007628,1.6093936936548e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF1,Scavenger receptor class F member 1,42794,0.0245390149497094,0.00406608383746379,0.0165694906282804,0.0325085392711384,1.63045658712955e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ING1,Inhibitor of growth protein 1,42292,0.0276685296463781,0.00458707757968052,0.0186778575902043,0.036659201702552,1.66468861664627e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPAG1,Sperm-associated antigen 1,40482,0.0336800368840989,0.00558409752805778,0.0227352057291056,0.0446248680390921,1.67615130832266e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA6,Corticosteroid-binding globulin,40539,0.00925283651921039,0.0015346972361814,0.00624482993629485,0.0122608431021259,1.70009091479945e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECM1,Extracellular matrix protein 1,40269,0.0220062771883248,0.00365211336647692,0.0148481349900301,0.0291644193866196,1.73812016754441e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VGF,Neurosecretory protein VGF,40482,0.0185372021971321,0.00307680452314109,0.0125066653317756,0.0245677390624886,1.74573904506454e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTPN,Myotrophin,42357,0.0194810259273523,0.00323594215426075,0.0131385793050013,0.0258234725497034,1.78834655608902e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,40302,0.0409649504655859,0.00681049217258051,0.0276163858073281,0.0543135151238437,1.85578201815336e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0221869661784723,0.00372043570338082,0.0148949121998459,0.0294790201570987,2.53181354082213e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSO,Cathepsin O,42754,0.0177882918327304,0.00298680944146385,0.0119341453274613,0.0236424383379996,2.65504807025968e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAC1,Cartilage acidic protein 1,42794,0.0173242391409413,0.00291051190180302,0.0116196358134074,0.0230288424684752,2.70909891910182e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFA,Vascular endothelial growth factor A,42716,0.0338003046062515,0.00568667575948912,0.0226544201176528,0.0449461890948502,2.85395243936092e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0280303341821105,0.00471809839826583,0.0187828613215095,0.0372778070427115,2.90437256873093e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENR,Density-regulated protein,40199,0.0330666363735624,0.00556697833916866,0.0221553588287919,0.043977913918333,2.94034295414103e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0251434883281368,0.00423350288554812,0.0168458226724625,0.0334411539838112,2.94937287414425e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPA,Apolipoprotein(a),40324,-0.105279691611767,0.0177611376627451,-0.140091521430748,-0.0704678617927867,3.16644774713258e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUOM,Fucose mutarotase,40283,0.036558074863251,0.00616847173053641,0.0244678702713996,0.0486482794551024,3.18469526525713e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPQ,Carboxypeptidase Q,40516,0.0206024710950973,0.00348441162197869,0.013773024316019,0.0274319178741755,3.46144326463868e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL11,C-X-C motif chemokine 11,42711,0.0458234164317526,0.00775897166820981,0.0306158319620614,0.0610310009014438,3.59233576025716e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17C,Interleukin-17C,42370,-0.0429985027306054,0.00728278194235706,-0.0572727553376253,-0.0287242501235856,3.63236862694825e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0245596911633187,0.00417047263360698,0.016385564801449,0.0327338175251884,4.00095773646277e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0174051827635755,0.00295978362702566,0.0116040068546052,0.0232063586725458,4.20439011880139e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGF,Hepatoma-derived growth factor,42700,0.0531727462417237,0.00904491179428152,0.035444719124932,0.0709007733585155,4.23143149310943e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0344615433080368,0.00586745704643957,0.0229613274970153,0.0459617591190584,4.39126134202322e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,40504,0.0283213778704877,0.00482771070305007,0.0188590648925095,0.0377836908484658,4.57779927112891e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42663,0.0171724438527241,0.00293237578784908,0.0114249873085399,0.0229199003969083,4.84754898790074e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX6,Syntaxin-6,42346,0.0376352396197444,0.00642887897299361,0.0250346368326769,0.0502358424068119,4.91067253524588e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA3,Protein disulfide-isomerase A3,40283,0.014140634413327,0.00241541116969817,0.00940642852071856,0.0188748403059354,4.92488356583866e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0279810771568066,0.00478446406780835,0.0186035275839023,0.037358626729711,5.08103429480452e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.0296633660009782,0.00507463444101076,0.0197170824965971,0.0396096495053592,5.17308298576635e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA1,BolA-like protein 1,40136,0.0308958043354737,0.00528611124051502,0.0205350263040642,0.0412565823668831,5.21927480329518e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C19orf12,Protein C19orf12,42311,0.0361266355918827,0.00618801887279196,0.0239981186012105,0.048255152582555,5.40297544428431e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP7,Matrilysin,42333,0.0286428028430238,0.004913078453429,0.019013169074303,0.0382724366117446,5.67601344834101e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWF,von Willebrand factor,42794,-0.0406836793255175,0.00699975264086581,-0.0544031945016145,-0.0269641641494205,6.3054438536044e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLF4,Krueppel-like factor 4,40136,0.022723786012332,0.00391386804538534,0.0150526046433767,0.0303949673812873,6.5775437710211e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIGR,Polymeric immunoglobulin receptor,42464,-0.0202400092950512,0.00348853861394928,-0.0270775449783918,-0.0134024736117106,6.7080240541421e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL3,Insulin-like 3,40483,0.044189716576661,0.00763164452503567,0.0292316933075911,0.0591477398457309,7.21223501125237e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL5,Fc receptor-like protein 5,42611,-0.0332124472859046,0.00574487816344808,-0.0444724084862629,-0.0219524860855464,7.58077719089415e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.0324582925326137,0.00561573308759904,0.0214514556809196,0.0434651293843078,7.64473476699493e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC4,Apical endosomal glycoprotein,40451,0.0307795619795614,0.00535102041093266,0.0202915619741333,0.0412675619849894,9.04417567862217e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS9,Galectin-9,42620,0.0179678687015727,0.00313050567709351,0.0118320775744694,0.0241036598286759,9.69484142614274e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0130267776484724,0.002271424295057,0.00857478603016064,0.0174787692667841,9.99644651703408e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELL,L-selectin,40539,0.01336001432671,0.0023329435262487,0.00878744501526251,0.0179325836381574,1.05017907848057e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF5,Fibroblast growth factor 5,42370,-0.0184316799033616,0.00322214142814615,-0.0247470771025281,-0.0121162827041952,1.08635154429394e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN2,Dynactin subunit 2,42587,0.0520295136640581,0.00910043853784825,0.0341926541298755,0.0698663731982406,1.10569836800062e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENAH,Protein enabled homolog,42370,0.0262599553556525,0.00459667057819082,0.0172504810223985,0.0352694296889065,1.13522012989666e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAL,Integrin alpha-L,40199,0.0248749255073577,0.00436113021376205,0.0163271102883841,0.0334227407263314,1.20200569083424e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0171188808961286,0.00300855390376346,-0.023015646547505,-0.0112221152447522,1.30266505758645e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0312620527421815,0.00550002541827698,0.0204820029223587,0.0420421025620044,1.34388468175494e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTB,Lymphotoxin-beta,40451,0.0198502367583042,0.00349459987648366,0.0130008210003962,0.0266996525162122,1.37824182590402e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN2,Alpha-actinin-2,40116,-0.0330512773015507,0.00582414344654807,-0.0444665984567849,-0.0216359561463165,1.42325510665373e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMB1,Laminin subunit beta-1,40223,0.016815028590406,0.00296773773099297,0.0109982626376598,0.0226317945431523,1.49883576996674e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEPR,Leptin receptor,42636,-0.0171852287928588,0.00303394103624646,-0.0231317532239018,-0.0112387043618157,1.5063003930813e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGF,Hepatocyte growth factor,42754,0.0190930327746846,0.00338311540858487,0.0124621265738583,0.025723938975511,1.69842245536643e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPK2,Death-associated protein kinase 2,40199,0.0298332096446053,0.00529115667989173,0.0194625425520175,0.0402038767371931,1.75952651372209e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNMT,Histamine N-methyltransferase,42439,0.0263263679231639,0.00467723096898448,0.0171589952239543,0.0354937406223734,1.85341532440967e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRD1,Natural killer cells antigen CD94,42754,0.0257576560410113,0.00457882835910377,0.016783152457168,0.0347321596248547,1.88759305902658e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.0176589280575747,0.0031471659810624,-0.023827373380457,-0.0114904827346924,2.05074318113323e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN3,Calsyntenin-3,40483,0.0167829618529234,0.00299154430717628,0.0109195350108579,0.022646388694989,2.0693085620047e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42638,0.0130293792658924,0.00233086259189632,0.00846088858577558,0.0175978699460091,2.31570360078921e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL1,Fc receptor-like protein 1,42636,0.0255902393961341,0.00457884465690379,0.0166157038686027,0.0345647749236656,2.33093252162141e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXN,Thioredoxin,40384,0.0242739691291453,0.00434415974810466,0.0157594160228602,0.0327885222354305,2.3544362286368e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0319904219496449,0.00573363851309467,0.0207524904639793,0.0432283534353105,2.460234856792e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNLY,Granulysin,42611,0.0290908157268856,0.00521561609495784,0.0188682081807683,0.039313423273003,2.48520786978159e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEPD,Xaa-Pro dipeptidase,40532,0.0143796636305858,0.00258255971815555,0.00931784658300091,0.0194414806781707,2.63560909061093e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS2,Thrombospondin-2,42611,-0.0210333195592598,0.00378228738671708,-0.0284466028372252,-0.0136200362812943,2.7335080120641e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0211179601685576,0.00379757397813339,0.0136747151714162,0.0285612051656991,2.7463722109703e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPM3,Tropomyosin alpha-3 chain,40116,-0.0238560988855301,0.00429210059699944,-0.032268616055649,-0.0154435817154112,2.79062847580745e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0183540342320482,0.00330821615621823,0.0118699305658605,0.024838137898236,2.94411116363025e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR3,Toll-like receptor 3,42754,0.0329237722762532,0.00593895808813725,0.0212834144235042,0.0445641301290022,3.01685639220236e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.023870691413015,0.00431267801364702,0.0154178425062668,0.0323235403197631,3.18292592515767e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0234512770257371,0.0042410362637543,0.0151388459487787,0.0317637081026955,3.28268939190714e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0217227377336876,0.00393377892549593,-0.0294329444276596,-0.0140125310397156,3.41369259435213e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVALB,Parvalbumin alpha,42654,0.0589748513201736,0.0106896976252992,0.0380230439745871,0.07992665866576,3.51241817059686e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF1,Trefoil factor 1,42556,-0.0445747157649347,0.00808137949288701,-0.0604142195709933,-0.0287352119588762,3.53787938276276e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,42346,0.0213358956328684,0.00387109233810147,0.0137485546501895,0.0289232366155473,3.62290179915962e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,40482,0.0194378158593286,0.00352867555078798,0.0125216117797842,0.026354019938873,3.69772775453535e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDM1,Nuclear protein MDM1,40182,0.0168321381005182,0.00305695909081437,0.010840498282522,0.0228237779185143,3.74968523038717e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL3A1,Collagen alpha-1(III) chain,40527,-0.0125465445770955,0.00228048373267689,-0.0170162926931422,-0.00807679646104878,3.84310999155171e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF22,Kinesin-like protein KIF22,40116,0.0671607947230045,0.0122070910042219,0.0432348963547295,0.0910866930912795,3.84442529947925e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN5,Contactin-5,42640,0.0204159887714881,0.00371244676836729,0.0131395931054882,0.027692384437488,3.88184670363079e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDT,D-dopachrome decarboxylase,40527,0.0222307065029418,0.00404923107611419,0.014294213593758,0.0301671994121256,4.10347793861609e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD93,Complement component C1q receptor,42141,-0.0172530362953305,0.00314379616741185,-0.0234148767834577,-0.0110911958072033,4.14243555451539e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FEN1,Flap endonuclease 1,42346,0.0339044284272741,0.00618830247582914,0.021775355574649,0.0460335012798992,4.36113605249714e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42679,0.0156155390937597,0.00285117271651492,0.0100272405693904,0.0212038376181289,4.40636949704337e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM,Paralemmin-1,40384,0.0168527705734709,0.0030767135539234,0.010822412007781,0.0228831291391608,4.40648299791379e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,40223,0.012706087230584,0.00232106836041569,0.00815679324416927,0.0172553812169988,4.49011450045388e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.039063912239842,0.00714025049132239,0.0250690212768502,0.0530588032028339,4.57351911353839e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42594,0.0259049080078825,0.00473702555708192,0.0166203379160019,0.035189478099763,4.61726904340158e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0187156305859897,0.00342818701678654,0.011996384033088,0.0254348771388913,4.86444453693331e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS7_LGALS7B,Galectin-7,42524,0.0230344385878746,0.00422284851839137,0.0147576554918275,0.0313112216839217,4.99261091587958e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG4,Desmoglein-4,42543,0.0265809496647228,0.00487810896710273,0.0170198560892015,0.0361420432402442,5.15443557286192e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARCO,Macrophage receptor MARCO,42636,0.0138625748120631,0.00255477033206376,0.00885522496121811,0.018869924662908,5.85793220973246e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRB1,Chymotrypsinogen B,42611,0.0306151003866135,0.00564569673426088,0.0195495347874622,0.0416806659857648,5.97113814580918e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0114677362800274,0.00211545370943766,0.0073214470095296,0.0156140255505252,6.03154574540062e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0306951870131417,0.00566952523475404,0.0195829175530238,0.0418074564732596,6.26901004274758e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0228243044329417,0.00421601442356516,0.014560916162754,0.0310876927031295,6.28116979032278e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBKS,Ribokinase,42317,0.0261651462980981,0.00483930887403874,0.0166801009049822,0.035650191691214,6.52860572050151e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.0615719671036292,0.0113958955555489,0.0392360118147534,0.083907922392505,6.68728736410172e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACRT,Extracellular glycoprotein lacritin,40419,0.027174889725469,0.00503316205135991,0.0173098921048036,0.0370398873461344,6.83147828883467e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR2,Complement factor H-related protein 2,40451,0.0304923933540238,0.00565692691796682,0.0194048165948089,0.0415799701132388,7.17701036416226e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK1D,Casein kinase I isoform delta,40199,0.0330527327672577,0.0061464419535361,0.021005706538327,0.0450997589961885,7.70560683942498e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM2,Myomesin-2,40116,-0.0265333956394485,0.00493610186371693,-0.0362081552923337,-0.0168586359865633,7.79972044197203e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL1,Delta-like protein 1,42679,-0.0164279675518583,0.00306483489825782,-0.0224350439524436,-0.010420891151273,8.45231604220889e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42711,0.0240338231922801,0.00448507015410088,0.0152430856902423,0.0328245606943178,8.52321902488949e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL5A1,Collagen alpha-1(V) chain,40283,-0.021616044481496,0.00403774545033188,-0.0295300255641464,-0.0137020633988455,8.79937101340949e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CABP2,Calcium-binding protein 2,40182,0.0337518352476577,0.00630636627883487,0.0213913573411414,0.0461123131541741,8.87248428237196e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0436720361864865,0.00818537316455365,0.0276287047839613,0.0597153675890117,9.72538830657741e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42689,-0.0173954229060055,0.00326941675133071,-0.0238034797386137,-0.0109873660733973,1.0504990758589e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH1,Acid ceramidase,40418,0.0237062379320004,0.00445585632843742,0.0149727595282631,0.0324397163357377,1.05622614051511e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LF,CMRF35-like molecule 1,42721,0.0315589857351874,0.00593423674148726,0.0199278817218724,0.0431900897485024,1.06513580563674e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0343026713607497,0.00645247268984272,0.021655824888658,0.0469495178328414,1.07974318289672e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42721,0.0306856969049094,0.00578617558361078,0.0193447927610322,0.0420266010487865,1.15532510776791e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42587,0.0307547123005149,0.00579931716223081,0.0193880506625425,0.0421213739384872,1.15624453051623e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42594,0.0263902376211645,0.00497673074545776,0.0166358453600673,0.0361446298822617,1.158990833495e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0472998627207802,0.0089244244222008,0.0298079908532667,0.0647917345882938,1.18007055578588e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMD,Dystrophin,40223,0.0266177552834757,0.00503113061815518,0.0167567392718915,0.0364787712950599,1.24244179961061e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.015449318805526,0.00292399129286887,0.00971829587150297,0.021180341739549,1.28623293579504e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0298633893781769,0.00565800942111962,0.0187736909127825,0.0409530878435714,1.32970151414411e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0196141576298962,0.00373844250846411,0.0122868103133065,0.0269415049464858,1.57779150052713e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0349587027726734,0.00666939194024348,0.0218866945697962,0.0480307109755506,1.61554362422245e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.0158099352971756,0.00301836814415531,-0.0217259368597201,-0.00989393373463124,1.65338836826283e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS1,Nephrin,40199,0.0172304052937377,0.00329045193394295,0.0107811195032095,0.0236796910842659,1.66681850368619e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDHB15,Protocadherin beta-15,40451,-0.0205945921916773,0.00393401924245978,-0.0283052699068984,-0.0128839144764561,1.67956142866727e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN1,Ficolin-1,40515,0.0284282567635281,0.00543540986071873,0.0177748534365194,0.0390816600905368,1.72352465843355e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN5,CCN family member 5,42611,0.0196683645005123,0.00376161301254913,0.012295602995916,0.0270411260051086,1.73266066407489e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.0191800137654477,0.00367490243325318,0.0119772049962715,0.0263828225346239,1.82906255328376e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0120283838561773,0.00230737926086792,-0.0165508472074784,-0.00750592050487616,1.89164736596191e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL12,Stromal cell-derived factor 1,42370,0.0204295063287292,0.00392011217712699,0.0127460864615603,0.0281129261958981,1.90190589394907e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0169278477953441,0.0032515788419499,0.0105547532651223,0.0233009423255659,1.96295803553106e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0319224136916609,0.00613790930102156,0.0198921114616587,0.0439527159216632,2.01280711090475e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,40223,0.0266113219457292,0.0051165022342389,0.0165829775666209,0.0366396663248374,2.01688918725416e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTL1,Cytokine-like protein 1,40527,0.0129782374922571,0.00249740946839926,0.00808331493419455,0.0178731600503197,2.06406325991078e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYGD,Gamma-crystallin D,40483,0.0492927284537997,0.00949003698294709,0.0306922559672234,0.067893200940376,2.09233580307186e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSN,Gelsolin,40488,0.00984196549417365,0.00189661102110456,0.00612460789280871,0.0135593230955386,2.14819846615466e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH5,Cadherin-5,42794,-0.0152173251023884,0.00293502003228089,-0.0209699643656589,-0.00946468583911784,2.19414872062177e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR15L,Protein GPR15L,40449,0.0307182809860914,0.00593523308463492,0.0190852241402069,0.0423513378319758,2.31117460657111e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGA,Fibrinogen alpha chain,40284,0.0156707161442084,0.00302851020377765,0.00973483614480419,0.0216065961436126,2.32642663758358e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC51B,Organic solute transporter subunit beta,40116,-0.0390148586735828,0.00754726755940629,-0.0538075030900191,-0.0242222142571465,2.38995964636738e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.0409040250914354,0.00791960527300566,0.0253815987563443,0.0564264514265265,2.44073699613647e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0231075358147364,0.00448994444921805,0.014307244694269,0.0319078269352038,2.69197430422786e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIT,Vitrin,40511,0.0193665754218304,0.00376441647459861,0.0119883191316171,0.0267448317120437,2.72518316026611e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCT,Secretin,40182,0.0250942696688825,0.00487981769343881,0.0155298269897424,0.0346587123480226,2.75832061793517e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHCY,Adenosylhomocysteinase,42636,0.0334790861861863,0.00652940297981958,0.0206814563457399,0.0462767160266327,2.97798835225315e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPT,Dermatopontin,42794,0.0126184295808012,0.00246322233788409,0.00779051379854841,0.017446345363054,3.05260402927478e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSDE1,Cold shock domain-containing protein E1,40116,0.0583086963304701,0.011395524667655,0.0359734679818662,0.0806439246790739,3.16030857177639e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0207956857047843,0.00406675417764685,0.0128248475165964,0.0287665238929721,3.21408907762613e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELE,E-selectin,42794,0.0252111167144354,0.00493416868299871,0.015540146095758,0.0348820873331129,3.27395285283049e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPO,Erythropoietin,42594,-0.0367984883572362,0.00720290015883571,-0.0509161726685542,-0.0226808040459182,3.28592345239384e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,40511,-0.01845810596508,0.00361425316791147,-0.0255420421741864,-0.0113741697559735,3.32582945384418e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR2,Anterior gradient protein 2 homolog,42215,-0.0502730946795638,0.0098841837822364,-0.0696460948927471,-0.0309000944663805,3.70357296578714e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,40502,0.00754543201194179,0.00148625508133954,0.00463237205251628,0.0104584919713673,3.89935013436505e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID2,Nidogen-2,42611,0.0363369460788935,0.00719434587571758,0.022236028162487,0.0504378639953,4.45824050862062e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT2A1,Bile salt sulfotransferase,42594,0.0275268099960797,0.00545567889182234,0.0168336793681079,0.0382199406240515,4.58180503640515e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.043312672180168,0.00858775136141262,0.0264806795117993,0.0601446648485368,4.62944574911318e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MB,Myoglobin,42794,-0.0260228904982847,0.00517366826849526,-0.0361632803045355,-0.015882500692034,4.97063203992693e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARA5,Scavenger receptor class A member 5,42711,0.0150937017494315,0.00300364788301575,0.0092065518987206,0.0209808516001423,5.09537789079393e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBD,Thrombomodulin,42636,0.0147801818383093,0.00294274705639475,0.00901239760777557,0.020547966068843,5.16358846851506e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXT,Oxytocin-neurophysin 1,42711,0.0671082944289308,0.0134448008353339,0.0407564847916764,0.0934601040661852,6.0691464013428e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,40199,-0.0612636212684723,0.0122798079589491,-0.0853320448680125,-0.037195197668932,6.16288829482811e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY96,Lymphocyte antigen 96,42495,-0.0173772325831347,0.00348499968163026,-0.02420783195913,-0.0105466332071393,6.23241894390707e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PER3,Period circadian protein homolog 3,40199,0.0600132245870687,0.0120411987348876,0.0364124750666891,0.0836139741074484,6.32340709895205e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0181735743804149,0.00364799467555936,0.0110235048163186,0.0253236439445112,6.37788349275702e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.0264422416354259,0.00530998903685326,0.0160346631231935,0.0368498201476582,6.4470292364209e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0221043215629493,0.00443942313128031,0.0134030522256399,0.0308055909002587,6.46764528975216e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX,Glutaredoxin-1,42546,0.0271363184132305,0.00545533676111883,0.0164438583614376,0.0378287784650235,6.63085297397277e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17A,Interleukin-17A,42347,-0.0208695749010788,0.0042121762684122,-0.0291254403871667,-0.0126137094149909,7.33870456621969e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.019160992255801,0.00386819914153046,-0.0267426625732007,-0.0115793219384013,7.39551459635482e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0184547941914478,0.00372709241901324,0.0111496930501819,0.0257598953327138,7.47163889178596e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA,Lymphotoxin-alpha,42594,0.019681576705735,0.00397652672850612,0.011887584317863,0.027475569093607,7.53323292974515e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0346706556019626,0.00700621026366343,-0.0484028277187429,-0.0209384834851823,7.58405660361805e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD14,Monocyte differentiation antigen CD14,42416,0.0201157025463643,0.00406970395831594,0.012139082788065,0.0280923223046635,7.79551985208957e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0193728142754729,0.00391959141935556,0.0116904150935361,0.0270552134574098,7.82141268818482e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST5,Cystatin-D,42357,0.0274537902572148,0.00556531175300957,0.016545779221316,0.0383618012931135,8.19572961521248e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.0219835299298679,0.00447451226579642,0.0132134858889069,0.0307535739708289,9.09684788449166e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,42346,0.0274696356454578,0.0055937303410333,0.0165059241770325,0.0384333471138831,9.18000010387399e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0278700505825807,0.00570341664475143,0.0166913539588679,0.0390487472062935,1.04060099499599e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSR,Insulin receptor,40199,0.00830629680755702,0.00170052709272033,0.00497326370582518,0.0116393299092889,1.05128626329901e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFIC,Nuclear factor 1 C-type,40482,0.0226427295994737,0.00463571149796573,0.0135567350634608,0.0317287241354865,1.05160756312231e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF16,Fibroblast growth factor 16,40199,0.0226313593168582,0.00463738494823578,0.0135420848183161,0.0317206338154003,1.07465801225942e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA1,Alpha-1-antitrypsin,40327,-0.00390343801427801,0.000800386776625235,-0.00547219609646347,-0.00233467993209255,1.0923451965806e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QL2,Complement C1q-like protein 2,40199,0.0210054748837625,0.00431697636400153,0.0125442012103195,0.0294667485572055,1.15584998083904e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.0326390245626796,0.00672925519413218,0.0194496843821805,0.0458283647431786,1.24659747518038e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0475242624911682,0.00985591619747497,0.0282066667441172,0.0668418582382191,1.43770354994039e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.0231831061420018,0.00480844445938699,-0.0326076572824003,-0.0137585550016033,1.4416315925137e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0261818993152526,0.00543848450518022,0.0155224696850994,0.0368413289454058,1.49720916064325e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0249993091709181,0.00519918707730979,0.0148089024993909,0.0351897158424453,1.54226812060374e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0477439930287744,0.0099354643251301,0.0282704829515194,0.0672175031060294,1.56428855136092e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERMAP,Erythroid membrane-associated protein,40199,0.0210119672863337,0.00437319901403287,0.0124404972188292,0.0295834373538381,1.57020183582052e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0266364158616327,0.00556607982012295,0.0157268994141917,0.0375459323090736,1.72762678784366e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK6,Kallikrein-6,42656,0.0147801835082735,0.00308980780827737,0.00872416020404987,0.0208362068124972,1.74070961555925e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDF1,Endothelial differentiation-related factor 1,40482,0.0311920099480477,0.0065285368457498,0.0183960777303781,0.0439879421657173,1.79460690224581e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS2,Trypsin-2,42689,0.0259365611557982,0.00543466147979061,0.0152846246554086,0.0365884976561878,1.83921216980956e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.0449018466967627,0.00945744280705968,0.0263652587949257,0.0634384345985996,2.08250980879964e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL4,Delta-like protein 4,40223,0.0397943685663044,0.0083876737057915,0.023354528102953,0.0562342090296557,2.117635853088e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,40223,0.0183602598202219,0.00387262356656875,0.0107699176297472,0.0259506020106967,2.15286068355898e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.0150403095470438,0.00317433550485453,0.00881861195752887,0.0212620071365586,2.183658620038e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD1,Bromodomain-containing protein 1,40302,-0.0141695566798793,0.00299168700339084,-0.0200332632065254,-0.00830585015323326,2.20338888207511e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS53,Serine protease 53,40483,0.017243535051234,0.0036435635335115,0.0101021505255515,0.0243849195769166,2.24351663734902e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENSA,Alpha-endosulfine,40451,0.024500895801658,0.00518101882589709,0.0143460989028997,0.0346556927004163,2.28398648956049e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX7,Syntaxin-7,40199,0.0231147243640149,0.00488936072901496,0.0135315773351456,0.0326978713928842,2.30058088986684e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPPK1,Epiplakin,40223,0.0334333301713309,0.00708496574529726,0.0195467973105483,0.0473198630321135,2.40023824636918e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRELP,Prolargin,42618,0.0111765632649994,0.00236926122665072,0.00653281126076395,0.0158203152692348,2.41379860182393e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0296651272097502,0.00628800085340181,0.0173406455370827,0.0419896088824178,2.41412421550905e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH1,Protocadherin-1,42721,0.00997548172357134,0.00211467240124334,0.00583072381713441,0.0141202396300083,2.41420020271346e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5,T-cell surface glycoprotein CD5,42706,0.0164587605105368,0.00350881587562984,0.00958148139430233,0.0233360396267713,2.74954990244094e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM25,Transmembrane protein 25,40482,-0.0208882344850141,0.00445492438078357,-0.0296198862713499,-0.0121565826986783,2.78035924632322e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN4,CCN family member 4,42721,0.0182494228419954,0.00389760914344576,0.0106101089208417,0.0258887367631491,2.86556554124194e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2orf69,UPF0565 protein C2orf69,40182,0.0278657081661823,0.00595199892077438,0.0161997902814645,0.0395316260509001,2.87854929460542e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42587,0.0119227160087942,0.00254788169354867,0.00692886788943885,0.0169165641281496,2.90444754074811e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD109,CD109 antigen,42611,-0.0153340611876223,0.0032791953360526,-0.0217612840462854,-0.00890683832895916,2.95137353239556e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSZ,Cathepsin Z,42648,0.0146540215158849,0.00313552672120031,0.00850838914233228,0.0207996538894375,2.98918045324136e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYM,Ketimine reductase mu-crystallin,40136,0.0345883799404898,0.00740484629650131,0.0200748811993472,0.0491018786816324,3.03239066702245e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42587,0.0164280294337939,0.00351929132121844,0.00953021844420579,0.0233258404233821,3.07105479033757e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4R,Reticulon-4 receptor,42721,0.0156063086861208,0.00334761238351046,0.00904498841444032,0.0221676289578013,3.16262812627154e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHPS,Deoxyhypusine synthase,40451,0.0183641336418409,0.00394250043927779,0.0106368327808565,0.0260914345028254,3.22966411908465e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL2A1,Collagen alpha-1(II) chain,40223,0.0367484262789098,0.00789520983688189,0.0212738149986212,0.0522230375591983,3.28519011474934e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA7,Carbonic anhydrase 7,40302,-0.0160126247440147,0.00344446026721724,-0.0227637668677605,-0.00926148262026893,3.37709252209598e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPB2,Coatomer subunit beta',40116,0.0196970848633077,0.0042417032775917,0.011383346439228,0.0280108232873875,3.46261525266466e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MME,Neprilysin,42587,0.0365702079907107,0.00789193446947006,0.0211020164305494,0.052038399550872,3.62274353140022e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0159209537770113,0.00343924652667536,0.0091800305847276,0.022661876969295,3.71283688464199e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0123419637938464,0.00268371932495253,0.00708187391693947,0.0176020536707534,4.29624263026602e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDA,Cytidine deaminase,40494,0.0210251399681417,0.00457699733475285,0.0120542251920261,0.0299960547442572,4.40262370830416e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0150026498426681,0.003268815320403,0.00859577181467818,0.0214095278706579,4.48838325673066e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROK1,Prokineticin-1,42594,0.0246797854242599,0.005387216767443,0.0141208405600716,0.0352387302884482,4.66539506405471e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSH,Pro-cathepsin H,42332,0.0332402146263849,0.00725972305542836,0.0190111574377453,0.0474692718150245,4.72132241618602e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2,Ataxin-2,40136,0.0494003987952389,0.0107986568665219,0.028235031336856,0.0705657662536218,4.82191570280668e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,40519,-0.011314050792229,0.00247842034861891,-0.0161717546755221,-0.00645634690893598,5.04695689115612e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0146679053689896,0.00321422992238145,0.008368014721122,0.0209677960168573,5.08700283344306e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSD,Cathepsin D,41747,0.0187246233001768,0.00410709517810452,0.010674716751092,0.0267745298492617,5.18609471609085e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.031716625207903,0.00696264293757779,0.0180698450502505,0.0453634053655555,5.27912237519295e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDCP1,CUB domain-containing protein 1,42495,0.0241168145649006,0.00529723177547083,0.0137342402849778,0.0344993888448234,5.34264288569336e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX1,Peroxiredoxin-1,42261,-0.0396993699067727,0.0087308777656162,-0.0568118903273804,-0.0225868494861649,5.49029659834793e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.0177956357007722,0.00392265952582496,-0.0254840483713891,-0.0101072230301552,5.77513527737062e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XRCC4,DNA repair protein XRCC4,42311,0.0162874067175057,0.00359074917254994,0.00924953833930779,0.0233252750957036,5.78573165810882e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3D,Protein FAM3D,40449,-0.0379750586374723,0.00837552688048174,-0.0543910913232165,-0.0215590259517281,5.84607488513507e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0123296490684648,0.00272237170902991,-0.0176654976181635,-0.00699380051876623,5.98665814761572e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0242664848457737,0.00537064306163643,0.0137400244449663,0.0347929452465811,6.29756287746185e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42559,0.00951421773354236,0.0021089173216411,0.0053807397831258,0.0136476956839589,6.49431365700612e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0290439726627136,0.00645004771351901,0.0164018791442163,0.0416860661812108,6.75959165021393e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREH,Trehalase,40527,0.0325855078178175,0.0072415097179407,0.0183921487706537,0.0467788668649813,6.86876120729543e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA1,Carboxypeptidase A1,42794,0.0273465822898583,0.00607784258881695,0.0154340108157771,0.0392591537639396,6.87138654374644e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP9,Matrix metalloproteinase-9,42594,-0.0262917752764092,0.00585485477824161,-0.0377672906417627,-0.0148162599110556,7.16180719394164e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF2,Trefoil factor 2,42654,-0.0253448385114877,0.00566776730534941,-0.0364536624299725,-0.0142360145930028,7.82168568962292e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KITLG,Kit ligand,42636,-0.0163501511493431,0.00365665464159014,-0.0235171942468597,-0.00918310805182639,7.8367121860972e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGES2,Prostaglandin E synthase 2,40102,0.0237778892824211,0.00531792915515915,0.0133547481383091,0.034201030426533,7.85422774730753e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIT2,Slit homolog 2 protein,42311,0.0228893945863488,0.00512177406852336,0.012850717412043,0.0329280717606546,7.92309745112542e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.011439745594642,0.00255969417492275,-0.0164567461774906,-0.00642274501179345,7.93115380132681e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPS,Colipase,42590,0.0317203120238448,0.00710517632326979,0.017794166430236,0.0456464576174536,8.09513594566181e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN1,Nectin-1,40199,0.0142870193095435,0.00320401527593725,0.00800714936870654,0.0205668892503805,8.3120431665446e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.0201820070717116,0.00453610796470884,-0.029072778682541,-0.0112912354608823,8.68834220833672e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOSB,Protein fosB,42311,0.0165922343650169,0.00374154932995455,0.00925879767830603,0.0239256710517279,9.29981687885471e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PZP,Pregnancy zone protein,40539,0.0220979097278951,0.00498409562220689,0.0123290823083696,0.0318667371474206,9.35066851734048e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42594,-0.0223843777862833,0.00505250824586302,-0.0322872939481748,-0.0124814616243918,9.48265682737644e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,40302,0.0193144130261884,0.00437462336007351,0.0107401512404443,0.0278886748119325,1.01915679204577e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0409795790957434,0.00929306146429101,0.022765178625733,0.0591939795657537,1.04329228029574e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFASC,Neurofascin,42754,-0.0124555611561749,0.0028248837279335,-0.0179923332629245,-0.00691878904942519,1.04537186593442e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB1A1,Uteroglobin,42646,0.0239081125018536,0.0054263541016797,0.0132724584625614,0.0345437665411458,1.06147784901283e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH3,Neurexophilin-3,40199,0.0132617984240524,0.00301088883927726,0.007360456299069,0.0191631405490359,1.06974541117533e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOB,Elongin-B,40116,0.0172219410978958,0.0039240112928855,0.00953087896384021,0.0249130032319514,1.15015859989702e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0224941318026925,0.00512626243684905,0.0124466574264683,0.0325416061789166,1.15424208794936e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3BP,Galectin-3-binding protein,40539,0.0131271490175005,0.00299247349830289,0.00726190096082684,0.0189923970741742,1.16110092088791e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLO1,Lactoylglutathione lyase,42357,0.0246905427962316,0.00564134152775221,0.0136335134018373,0.0357475721906259,1.21409866141694e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH1,Neurexophilin-1,42311,0.0165544025403742,0.00379611265444912,0.00911402173765391,0.0239947833430945,1.30526614373296e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSNL1,Visinin-like protein 1,40483,0.0163034470257425,0.0037416011225391,0.00896990882556586,0.0236369852259191,1.32813142213047e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTN,Pleiotrophin,42357,0.0209353098724094,0.0048202918183999,0.0114875379083456,0.0303830818364732,1.41497099616023e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST3,Cystatin-C,42659,0.0127650403668466,0.00294000823232027,0.0070026242314989,0.0185274565021943,1.42327702970951e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0322540520076908,0.00743521215405314,0.0176810361857466,0.046827067829635,1.45059756653202e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX5,Sorting nexin-5,40223,0.0123137076419242,0.00283940886010571,0.00674846627611697,0.0178789490077313,1.45912664299286e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0181800092786313,0.00421153336742771,0.00992540387847295,0.0264346146787896,1.59715312155639e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGF,Placenta growth factor,42754,0.0111190045983257,0.00258824149154238,0.00604605127490258,0.0161919579217487,1.75143554302191e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS2,Growth arrest-specific protein 2,40302,0.0221014242770042,0.00514614662290169,0.0120149768961169,0.0321878716578915,1.76374882081577e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0205669719201389,0.00479622770247338,0.0111663656232911,0.0299675782169867,1.81664844408133e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP2,Neuropilin-2,42611,-0.0119897642147454,0.00279845352341709,-0.0174747331206429,-0.00650479530884794,1.84488966283839e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0257938226180736,0.00602275632520458,0.0139892202206726,0.0375984250154745,1.86195157393862e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.016507937542259,0.00386097855234121,0.0089404195796702,0.0240754555048478,1.9198510509416e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,42292,0.02345505164802,0.00548974874016942,0.0126951441172879,0.034214959178752,1.94642722990054e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD72,B-cell differentiation antigen CD72,40283,0.018477129518531,0.00432970296282638,0.00999091171139128,0.0269633473256707,1.99292979846691e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP1,Guanylate-binding protein 1,40466,0.0272740737545202,0.00639331979073284,0.0147431669646838,0.0398049805443566,2.00609031883361e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCP1,Plastin-2,40527,0.0199846315603953,0.00468501503857579,0.0108020020847867,0.0291672610360038,2.00939173057433e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMP,Cartilage oligomeric matrix protein,42511,0.0139959551129679,0.00328283048887525,0.0075616073547724,0.0204303028711634,2.02744523220177e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,42311,0.0355639862843575,0.00834756480374638,0.0192027592690145,0.0519252132997004,2.05482563642051e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMCN2,Hemicentin-2,40269,-0.0243666639974293,0.00572128379478717,-0.0355803802352122,-0.0131529477596465,2.07084583312757e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0141695371799076,0.00333159034010916,0.00763962011329359,0.0206994542465215,2.12278070713973e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NHLRC3,NHL repeat-containing protein 3,40013,0.0133802185137243,0.0031460101977354,0.00721403852616291,0.0195463985012857,2.12627186925984e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.0092361209264144,0.00217230938416528,0.00497839453345045,0.0134938473193783,2.13540314581932e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0273671664000739,0.00645195972874129,0.0147213253317409,0.0400130074684068,2.23327345488821e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0147123801994854,0.0034782282683672,0.00789505279348573,0.0215297076054852,2.35383410369419e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS1,"Nitric oxide synthase, brain",42311,-0.0221844133954364,0.00529427674879903,-0.0325611958230825,-0.0118076309677903,2.80455409043598e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGRN,Neugrin,40483,0.00944287113761227,0.00225926133014064,0.00501471893053662,0.0138710233446879,2.94187672672738e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TF,Serotransferrin,40539,0.00868963050489622,0.00208364471433593,0.0046056868647978,0.0127735741449946,3.06327828957502e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0291631781639069,0.00699432280386308,0.0154543054683352,0.0428720508594785,3.07135578710742e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA2,Annexin A2,40054,0.0295197025182882,0.00708815156676386,0.0156269254474311,0.0434124795891454,3.14234699476127e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSAP,Gamma-secretase-activating protein,42346,0.0346857343181544,0.00834290351904183,0.0183336434208324,0.0510378252154764,3.23769342135963e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0201237425858724,0.00484441457681658,0.0106286900153119,0.0296187951564329,3.28764054677499e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO4,Roundabout homolog 4,40223,-0.00734982468592208,0.00178111981594781,-0.0108408195251798,-0.00385882984666437,3.71002209373255e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASN,Vasorin,42449,0.0110784116140734,0.0026854954504196,0.00581484053125102,0.0163419826968958,3.72550028941231e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,40483,0.0962564560864104,0.0234083828432291,0.0503760257136813,0.14213688645914,3.94938205454556e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.0145143082098796,0.00353315439742709,0.00758932559092245,0.0214392908288367,4.01957493496621e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA2,Ephrin type-A receptor 2,42125,-0.0134970136518348,0.00328642477193573,-0.0199384062048288,-0.00705562109884074,4.0347431634921e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGN,Biglycan,42328,-0.0479737912427481,0.0116973615041465,-0.0709006197908753,-0.025046962694621,4.13402431480899e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0277351644550553,0.0067635669271262,0.014478573277888,0.0409917556322227,4.14909276543703e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN1,Tetraspanin-1,42357,0.0271372707207798,0.00662068823972181,0.014160721770925,0.0401138196706345,4.17681865358953e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MET,Hepatocyte growth factor receptor,42654,0.00791839506216467,0.00193571806468051,0.00412438765539088,0.0117124024689385,4.32622259532564e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL15,C-C motif chemokine 15,42794,-0.01781416372913,0.00435763181537879,-0.0263551220872724,-0.00927320537098759,4.37537830929911e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH1,Cadherin-1,42188,-0.0158339527589617,0.00387858199230241,-0.0234359734638745,-0.00823193205404902,4.483829956035e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A13,Protein S100-A13,40199,0.014163713296279,0.00348489871664319,0.0073333118116583,0.0209941147808996,4.85093672506627e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0163416463672395,0.0040221835805634,-0.0242251261851438,-0.00845816654933527,4.88101487983348e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0111988556594138,0.00276451672735776,0.00578040287379257,0.016617308445035,5.13645461083057e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLASP1,CLIP-associating protein 1,40080,0.0287965214859673,0.00711092499237286,0.0148591085009165,0.0427339344710181,5.16571549329789e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC16,Mucin-16,42587,0.0757318758070649,0.0187087029223252,0.0390628180793074,0.112400933534822,5.19589010577269e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.0320907275044645,0.0079323326654211,-0.0476380995286899,-0.0165433554802392,5.2556782661139e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0176245079491447,0.00435952469822369,-0.0261691763576631,-0.00907983954062625,5.31199941015243e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0161308230437338,0.00400167468259634,-0.0239741054216226,-0.00828754066584493,5.58430885565091e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK3,NT-3 growth factor receptor,42711,0.00854636805301816,0.00212097545488306,0.00438925616144736,0.012703479944589,5.62131919093256e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0131660991811634,0.00327812336648318,0.00674097738285636,0.0195912209794704,5.94977014312875e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0165089288978941,0.0041167104718157,0.00844017637313533,0.0245776814226529,6.09882926926005e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0154990620490289,0.00386585141032709,0.00792199328478782,0.02307613081327,6.12457213252722e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.024452378439776,0.00610843986602645,0.0124798363023641,0.0364249205771878,6.29425336779475e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAT,Catalase,40361,0.0211929105538132,0.0052966488788039,0.0108114787513576,0.0315743423562688,6.3430929965852e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD1,Leiomodin-1,40482,-0.0139613525541565,0.00349178007463383,-0.0208052415004388,-0.00711746360787414,6.41922778859723e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.0216413614714219,0.00541961176727102,0.0110189224075707,0.0322638005352731,6.55531752788116e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD86,T-lymphocyte activation antigen CD86,40449,0.011832956110277,0.00296598641651174,0.00601962273391395,0.01764628948664,6.6617582975475e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0170631534024584,0.00428435810983752,0.00866581150717689,0.02546049529774,6.85860078117485e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO1,R-spondin-1,42495,0.0131819538904736,0.00331153919458019,0.00669133706909642,0.0196725707118508,6.91031188332186e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA10,Annexin A10,42311,-0.0335052854949871,0.00842033965504713,-0.0500091512188795,-0.0170014197710947,6.95518127695009e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSA,Arylsulfatase A,42611,0.0172016215122128,0.00433228879931268,0.00871033546555991,0.0256929075588656,7.20772872114254e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.0092751486785993,0.00233817865312758,-0.0138579788387294,-0.00469231851846925,7.32126747797186e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0143632997101811,0.00362451651918692,0.00725924733257473,0.0214673520877875,7.45379632335446e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.0112194688177966,0.00283290865565165,-0.0167719697828738,-0.00566696785271935,7.52122871863282e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE3,Eosinophil cationic protein,42578,0.0423886319926906,0.0107049418716581,0.0214069459242407,0.0633703180611406,7.54242599407733e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAA4,Serum amyloid A-4 protein,40539,0.0125399595036815,0.00316873473000161,0.0063292394328783,0.0187506795744846,7.62308304654648e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL3,Fc receptor-like protein 3,42370,0.0217498496086418,0.00550567837296363,0.010958719997633,0.0325409792196505,7.84142484268287e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCC,Netrin receptor DCC,40182,0.00894394063752149,0.00226618767572081,0.00450221279310871,0.0133856684819343,7.97324653847612e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP10,Bone morphogenetic protein 10,40283,0.0110899874201619,0.00281282929590968,0.00557684200017894,0.0166031328401449,8.10832603040158e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX1,Heme oxygenase 1,42500,-0.0185821673002841,0.00471395467170368,-0.0278215184568233,-0.0093428161437449,8.123588757787e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0147863173960857,0.00375502966302026,0.007426459256566,0.0221461755356054,8.27634292025343e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN4,Nectin-4,42679,-0.0132444537245425,0.00336472207801372,-0.0198393089974494,-0.00664959845163564,8.31735544633136e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC1,Sialoadhesin,42676,-0.0165021369042886,0.00420557880051011,-0.0247450713532884,-0.00825920245528883,8.75709266632132e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0129607248942901,0.00330499636204334,-0.019438517763895,-0.00648293202468514,8.84179795884656e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,40116,0.0175271402107555,0.00447235074631464,0.00876133274797881,0.0262929476735322,8.94597537473331e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA7,Thyroxine-binding globulin,40539,0.00707587084469422,0.00180664122537566,0.00353485404295793,0.0106168876464305,9.03369292190903e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.0118335028096299,0.00302387603624532,-0.0177602998406708,-0.0059067057785891,9.1556539900516e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MBL2,Mannose-binding protein C,40379,0.041689968873505,0.0106569546748642,0.0208023377107712,0.0625776000362389,9.20778407444822e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA1,GDNF family receptor alpha-1,42689,0.0113038684072167,0.00289275917221742,0.00563406042967057,0.0169736763847629,9.36560704899891e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD209,CD209 antigen,42668,0.0147483163036732,0.00378355924764167,0.00733254017829554,0.0221640924290509,9.74599514542485e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A12,Protein S100-A12,42434,0.0285371129916879,0.00732097292822419,0.0141880060523685,0.0428862199310073,9.7470686511821e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.0152957092816512,0.00393466073303002,-0.02300764431839,-0.00758377424491234,0.000101795036884628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0237472756543416,0.00612103944056539,0.0117500383508335,0.0357445129578498,0.000105133324634493
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL4,Myosin light chain 4,40223,-0.0198010223687588,0.00510546592200763,-0.0298077355758937,-0.0097943091616238,0.000105757812635627
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.034767634739013,0.00898176410554551,0.0171633770921438,0.0523718923858822,0.000108951751437162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMB,RGM domain family member B,42711,0.0107395519652624,0.00277544071650536,0.00529968816091186,0.0161794157696129,0.000109573498949613
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCOR1,REST corepressor 1,42357,0.0166983227620145,0.004319529033146,0.00823204585704836,0.0251645996669807,0.000111269574359128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLC,Galectin-10,42611,-0.0247944817560276,0.00642271192231297,-0.0373829971237611,-0.0122059663882942,0.000113714679809771
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.018555906180174,0.00481072722767625,0.00912688081392855,0.0279849315464195,0.000115355196874997
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0148089801474751,0.00384352288606907,0.00727567529077967,0.0223422850041704,0.000117229385265985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0321199123876706,0.00833889567793743,0.0157756768589133,0.048464147916428,0.000117892068849533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB1,Carboxypeptidase B,42794,0.0227234617717979,0.00590540919244896,0.011148859754598,0.0342980637889979,0.00011967595204003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0100492861251927,0.0026142147577473,-0.0151731470503774,-0.00492542520000802,0.00012167468108978
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42794,-0.0117698226070721,0.00306544094132354,-0.0177780868520663,-0.00576155836207802,0.000123833665865721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.0158137236279672,0.00415005139314656,-0.0239478243585345,-0.00767962289739997,0.000139305802560862
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0286782524708928,0.00752900984558036,0.0139213931735553,0.0434351117682303,0.000140145412610998
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171B,Protein FAM171B,40451,0.00980555875989263,0.00258086570231924,0.00474706198334692,0.0148640555364383,0.000145851932619425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPR,Nucleoprotein TPR,40116,0.0180095805934924,0.00474768854896732,0.0087041110375164,0.0273150501494683,0.000149438149632452
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPE,Carboxypeptidase E,42588,0.014276690003871,0.00376510318403129,0.00689708776316971,0.0216562922445724,0.000150188325785413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,-0.0143726275275665,0.0037917464174538,-0.021804450505776,-0.00694080454935709,0.000151006054410039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0159041864204033,0.00419751310151694,0.00767706074143014,0.0241313120993765,0.000151959805857682
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0148396733349854,0.00391838795852188,-0.0225197137336883,-0.00715963293628251,0.000153178345468449
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0397567998911868,0.0105065565191607,0.0191639491136318,0.0603496506687418,0.000155148125239628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.015143402054064,0.00400837076712463,0.00728699535049969,0.0229998087576282,0.000158825415037502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK14,Kallikrein-14,42721,0.0173569963742479,0.00459640884392535,0.00834803504015417,0.0263659577083415,0.000159915432719678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15,Interleukin-15,42594,-0.0122144786536947,0.00323586544514498,-0.0185567749261789,-0.00587218238121056,0.000160879984595284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG4,Regenerating islet-derived protein 4,42638,-0.0193353572971652,0.00512346317410636,-0.0293773451184137,-0.00929336947591677,0.000161415818816124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0220214380903533,0.00584398562744576,0.0105672262605596,0.033475649920147,0.000165127063818088
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LUZP2,Leucine zipper protein 2,40451,0.0169044202918964,0.0044886146680886,0.00810673554244275,0.0257021050413501,0.000166684301660583
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0149984289246306,0.00399145548185914,0.00717517618018667,0.0228216816690745,0.000172393781560019
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRSF1,G-rich sequence factor 1,40014,0.029590400632149,0.00787937869027845,0.0141468183992032,0.0450339828650948,0.000173956049006652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEO1,Neogenin,40482,0.00814757803936528,0.00217105995902931,0.00389230051966784,0.0124028555590627,0.000175738868334419
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.00774740514325019,0.00206838249663061,0.00369337544985419,0.0118014348366462,0.000180692643501029
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0205450932074812,0.00549293994376792,0.00977893091769605,0.0313112554972663,0.000184756610346675
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JCHAIN,Immunoglobulin J chain,42370,-0.022847222358232,0.00611165526817994,-0.0348260666838647,-0.0108683780325993,0.000186049886311863
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_DRA,,42549,-0.0134408605202847,0.00360172192798838,-0.0205002354991419,-0.00638148554142749,0.000190914181605502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.0237505672031288,0.0063876909593888,0.0112306929227267,0.0362704414835308,0.000201672472726303
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,-0.0150309495346347,0.004044359748027,-0.0229578946407676,-0.00710400442850181,0.000202796660670831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0165837099166535,0.00446252977732634,0.00783715155309388,0.0253302682802132,0.000203210762795343
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0185118283238126,0.00498793907413827,0.00873546773850162,0.0282881889091236,0.000207005056604838
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0224509000396216,0.00605815719630522,0.0105769119348634,0.0343248881443799,0.000211651571332528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42587,0.0151126736220005,0.00408841227103394,0.00709938557077393,0.023125961673227,0.000219494284404095
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA2,GDNF family receptor alpha-2,42587,0.00767064762791046,0.00207611886704568,0.00360145464850092,0.01173984060732,0.000221018412239401
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX2,Sorting nexin-2,40451,0.0295435775527585,0.00800975364945164,0.0138444603998333,0.0452426947056837,0.000226686490281389
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGMN,Legumain,42676,0.0127913965167157,0.00346850534729914,0.0059931260360094,0.019589666997422,0.000227027478958446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN3,Neuronal-specific septin-3,40482,-0.0269793210493739,0.00731984964905909,-0.0413262263615298,-0.0126324157372181,0.000229075137056711
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNF,Tumor necrosis factor,42339,0.0138027680085231,0.00374974450148416,0.00645326878561418,0.0211522672314321,0.000233260569886512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.010572370020377,0.00287417432996935,0.00493898833363711,0.016205751707117,0.000235610392288919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0202167987625286,0.00549944855272053,0.00943787959919634,0.0309957179258608,0.000237903297164476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0132796727292839,0.00361799284092246,0.00618840676107583,0.0203709386974919,0.000243076987638127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,40532,0.00979918186417455,0.00267221524835927,0.00456163997739037,0.0150367237509587,0.000246474445961729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0186868511995818,0.00509766572825523,0.00869542637220157,0.0286782760269621,0.000247757021570214
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.0113881183787129,0.00310951418503959,-0.0174827661813905,-0.00529347057603528,0.000251009723165071
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTN,Titin,40116,-0.0235468503746202,0.00643282327375899,-0.0361551839911878,-0.0109385167580526,0.000252987275184693
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42676,0.014335101953901,0.00392396879545668,0.00664412311480593,0.0220260807929961,0.0002599589541252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAP,Prosaposin,40440,0.0103379115810529,0.00282969051979881,0.00479171816224726,0.0158841049998586,0.000259995824489433
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0184800116977725,0.00506732335335142,0.00854805792520372,0.0284119654703413,0.000266422323549101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0172956580020366,0.00475086372975045,0.00798396509172573,0.0266073509123475,0.000273323170058846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGF,Beta-nerve growth factor,42495,0.00426342669893969,0.00117206538244422,0.00196617854934903,0.00656067484853036,0.000276302595324643
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42587,0.0283877104598345,0.00783965317894422,0.0130219902291039,0.0437534306905652,0.00029450254402714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK3,Dickkopf-related protein 3,42794,-0.0106488054413657,0.00294216707067898,-0.0164154528998965,-0.00488215798283486,0.000296387393164619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42636,0.0161661647234294,0.00447321784866135,0.00739865774005314,0.0249336717068056,0.00030262166925602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPP1,Osteopontin,42771,-0.0166352240175992,0.00460552864856674,-0.02566206016879,-0.00760838786640842,0.00030492683898122
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRC,Chymotrypsin-C,42626,0.0232423086753022,0.00644483628914732,0.0106104295485735,0.035874187802031,0.000311664997629572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.0205040299599734,0.00569207879344753,0.00934755552481623,0.0316605043951306,0.000316669978095882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYZL2,Lysozyme-like protein 2,40080,0.0126834677135575,0.00352197310076813,0.00578040043605191,0.019586534991063,0.000318113562389422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MST1,Hepatocyte growth factor-like protein,40370,0.0230057353285838,0.00639427020860895,0.0104729657197102,0.0355385049374573,0.0003222232989074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0155968230774171,0.00433665560736506,0.00709697808698156,0.0240966680678526,0.000323897069605071
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0191284188998544,0.00534036126904168,0.00866131081253269,0.0295955269871761,0.000342367618884981
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00691806377315388,0.00193487243045089,-0.0107104137368376,-0.00312571380947014,0.000351062669337998
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPA2,Replication protein A 32 kDa subunit,40199,0.0110685516093024,0.00310443041592251,0.00498386799409426,0.0171532352245105,0.000364835424216503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XG,Glycoprotein Xg,42734,0.0119736974795235,0.00336142688920951,0.00538530077667286,0.0185620941823741,0.000369180774912301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL3,Follistatin-related protein 3,42574,-0.0117196426940957,0.0032950327101868,-0.0181779068060618,-0.00526137858212959,0.000376753362915337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL19,Interleukin-19,42261,-0.0250744629663402,0.00705610106976822,-0.0389044210630859,-0.0112445048695945,0.000381356911156199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR4,Proline-rich protein 4,40198,-0.0241677687521808,0.00680534793819739,-0.0375062507110477,-0.010829286793314,0.000384948627094547
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0113973433663329,0.00321081559585739,0.00510414479845243,0.0176905419342134,0.000387056788265991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELENOP,Selenoprotein P,40539,0.00797842854006195,0.00225252746521162,0.00356347470824718,0.0123933823718767,0.00039871509846586
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0144500718501865,0.00408670516973299,0.00644012971750982,0.0224600139828632,0.000407830942201422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0232344192816761,0.00657678227997135,0.0103439260129322,0.0361249125504199,0.00041283924967344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS4,Thrombospondin-4,42652,0.0157471952410737,0.00446147048538773,0.00700271308971375,0.0244916773924336,0.000417581694089272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.010904032049842,0.00309460910361899,0.00483859820674878,0.0169694658929352,0.000427209147775602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0135724342044435,0.00385501018363066,0.00601661424452741,0.0211282541643596,0.000431823692932808
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,40136,0.0153058256917279,0.00434771031934334,0.00678431346581498,0.0238273379176409,0.000432594171665454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGR,Tyrosine-protein kinase Fgr,42311,0.0196135215357793,0.00557515600469667,0.00868621576657384,0.0305408273049848,0.000436247381078469
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,42439,0.00996477466525362,0.00283311155439689,0.00441187601863571,0.0155176733118715,0.000437495196290969
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY2,Protein canopy homolog 2,42357,0.021144405219841,0.0060199109269406,0.00934537980303748,0.0329434306366446,0.000445547967360585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F3,Tissue factor,42636,-0.00932765621382383,0.00266045850509708,-0.0145421548838141,-0.00411315754383356,0.000456320932983868
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.0625676985932934,0.0178692016403188,0.0275440633782684,0.0975913338083183,0.000464282946801661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTG,Protogenin,42721,0.00849380256973339,0.00242602880484239,0.00373878611224232,0.0132488190272245,0.000464811191950317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL19,C-C motif chemokine 19,42711,0.0446418749039236,0.0127646073984736,0.0196232444029153,0.0696605054049318,0.000471472901962078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,-0.0118221897242216,0.00339172799808648,-0.0184699766004711,-0.00517440284797213,0.000492609978731509
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC1,Glypican-1,42721,0.0101499543366726,0.00291368024332519,0.00443914105975519,0.0158607676135899,0.000496373252312254
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIC5,Chloride intracellular channel protein 5,40182,-0.0107790734421691,0.00309414161793013,-0.0168435910133122,-0.0047145558710261,0.000496452181310996
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPO,Lactoperoxidase,42134,-0.0205575878103164,0.00594037206136877,-0.0322007170505992,-0.00891445857003357,0.000540597920727104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCB,Calcitonin gene-related peptide 2,40483,0.0138594766158692,0.00400679821163119,0.00600615212107205,0.0217128011106663,0.000544205688482116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXTL1,Exostosin-like 1,40116,0.0160075069393045,0.00463939129758844,0.00691429999603116,0.0251007138825778,0.00056198410405855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,-0.0144645145061334,0.00419728103740753,-0.0226911853394521,-0.00623784367281459,0.000570348773702375
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL4,Early placenta insulin-like peptide,40451,-0.0163712222226427,0.00475863014939423,-0.0256981373154554,-0.00704430712983001,0.000583129407722737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK4,Kallikrein-4,42721,-0.0213134534670338,0.00619857104178658,-0.0334626527089355,-0.00916425422513215,0.000586825109794035
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD2,Sushi domain-containing protein 2,42611,-0.00964830697366499,0.002814053930775,-0.015163852677984,-0.00413276126934599,0.000608492905352256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN2,Calsyntenin-2,42754,-0.0132395350432768,0.00386555456483773,-0.0208160219903587,-0.00566304809619484,0.000616613949806168
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.0163675971352632,0.00477928279902213,-0.0257349914213466,-0.00700020284917986,0.000617361868098084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.0152148026564452,0.00444938857971553,-0.0239356042726877,-0.00649400104020276,0.000629556860114955
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1B,Interleukin-1 beta,42293,0.0189590449693792,0.0055447249314019,0.00809138410383149,0.0298267058349269,0.000629751380337661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,42346,0.0180710031659588,0.00529290429518064,0.00769691074740479,0.0284450955845129,0.000641640139332197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPJ,Centromere protein J,40302,0.0236603488846113,0.00693266740407438,0.0100723207726256,0.0372483769965971,0.000645100790669844
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.010791513470886,0.00317107188613804,-0.0170068143677165,-0.00457621257405542,0.000668175955912022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFHD1,EF-hand domain-containing protein D1,40482,0.0120008184861081,0.00352658078815636,0.00508872014132163,0.0189129168308946,0.000668912502864641
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0272345206927211,0.00800351406304624,0.0115476331291505,0.0429214082562917,0.000669257424154274
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA2,Carbonic anhydrase 2,42573,0.0230036114881566,0.00676507885153442,0.00974405693914914,0.0362631660371641,0.00067497193119422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH17,Protocadherin-17,42636,-0.0123509116578396,0.00363272506281001,-0.0194710527809472,-0.005230770534732,0.000676057993110859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300A,CMRF35-like molecule 8,40283,0.010331367567716,0.00304768241177506,0.00435791004063685,0.0163048250947951,0.000701594312438773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5L,CD5 antigen-like,40479,0.0157930543421763,0.0046715696283403,0.00663677787062927,0.0249493308137232,0.000725534458681721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0190577346447658,0.00564346037030492,0.00799655231896811,0.0301189169705634,0.000735041242578489
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAP,Cartilage-associated protein,40182,0.0158004021026493,0.00468496324679883,0.00661787413892356,0.024982930066375,0.000747251435296036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0209362441612534,0.00622246496172441,-0.0331322754862333,-0.00874021283627356,0.00076908736081722
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.00987397647243144,0.00293633910849799,0.00411875181977538,0.0156292011250875,0.000774097845000585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.00991510902367772,0.0029516285610117,0.00412991704409479,0.0157003010032607,0.000784340812256219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THY1,Thy-1 membrane glycoprotein,42711,-0.00985427327205498,0.00293646371571284,-0.0156097421548521,-0.00409880438925781,0.000793450829285517
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB2,Calretinin,42311,0.0104865987882172,0.00312516674971428,0.00436127195877718,0.0166119256176572,0.000794370643915922
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0126900093645767,0.00378241231686234,0.00527648122352648,0.0201035375056269,0.000796324455725379
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE6,Ribonuclease K6,40468,-0.0111478944557159,0.0033262064426777,-0.0176672590833642,-0.00462852982806763,0.000806292707668234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN2,Prefoldin subunit 2,42311,0.018104264952046,0.00540297617622837,0.00751443164663838,0.0286940982574536,0.000808073808213936
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCOF1,Treacle protein,40511,0.0104794588275934,0.00314518628508188,0.00431489370883289,0.0166440239463539,0.000865303267432424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00850137647548226,0.00255316902859103,-0.0135055877715207,-0.00349716517944383,0.000872071572608976
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASET2,Ribonuclease T2,42749,-0.00897236717858968,0.00269487254589266,-0.0142543173685393,-0.00369041698864007,0.000872586164098136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2,Brorin,42456,0.0133766176442174,0.0040207004703251,0.00549604472238019,0.0212571905660546,0.000880448717543362
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPA33,Cell surface A33 antigen,42587,-0.0450448873009506,0.0135402611960579,-0.0715837992452241,-0.0185059753566771,0.000881057446444929
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XCL1,Lymphotactin,42721,0.0181736655782864,0.00546516027594649,0.00746195143743129,0.0288853797191415,0.000885370228867766
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMPER,BMP-binding endothelial regulator protein,40283,0.00751978101195594,0.0022670478176635,0.00307636728933549,0.0119631947345764,0.000912845996532819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WIF1,Wnt inhibitory factor 1,42721,0.0111405732492246,0.00336129942728936,0.00455242637173749,0.0177287201267118,0.000920928906671154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0111911952403188,0.00337934163931099,0.00456768562726926,0.0178147048533683,0.000929921798284446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA1,Carbonic anhydrase 1,42362,0.0194236007073485,0.00586731451987385,0.00792366424839579,0.0309235371663013,0.000933879624860446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL1,Chordin-like protein 1,42654,0.0103926673862591,0.00314681219906699,0.00422491547608784,0.0165604192964304,0.00096042012475051
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,40283,0.00900474626832478,0.00272971459260262,0.00365450566682365,0.0143549868698259,0.000974096017337271
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0137242578325733,0.00416125636956641,0.00556819534822309,0.0218803203169234,0.000975917206094573
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPL14,60S ribosomal protein L14,40223,0.0128572951404218,0.00391333935676475,0.00518715000116291,0.0205274402796807,0.00102117523239056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGB,Secretogranin-1,42664,-0.0137735979247954,0.00419317195970273,-0.0219922149658128,-0.00555498088377806,0.00102326856586281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.00929408087337542,0.00283293191758603,0.00374153431490681,0.014846627431844,0.00103864932636791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0167575003613623,0.00511295841397837,0.00673610186996471,0.0267788988527599,0.00105010348198238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSL,Cathepsin L1,42636,0.00792215226115813,0.0024177540305795,0.0031833543612223,0.012660950161094,0.00105309913516669
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK8,Kallikrein-8,42154,0.0118998006380334,0.00364626169032724,0.00475312772499197,0.0190464735510747,0.00110306165110558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.0081773397802134,0.00250930622704712,-0.0130955799852258,-0.00325909957520104,0.0011222131204597
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,-0.00931644360335235,0.00287373637903968,-0.0149489669062701,-0.00368392030043457,0.00119067623491255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,42346,-0.0150124378376053,0.00463499236095957,-0.024097022865086,-0.00592785281012451,0.0012027481749798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.0191133188627325,0.00591165602568142,-0.0307001646730681,-0.00752647305239695,0.00122731106814386
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUK1,Guanylate kinase,40116,-0.012170731336011,0.00376625329227713,-0.0195525877888742,-0.00478887488314783,0.0012349772335955
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNU13,NHP2-like protein 1,40116,0.020044956620193,0.00620779455787263,0.00787767928676266,0.0322122339536234,0.00124591899401465
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0165480168337919,0.00513806657205976,0.00647740635255473,0.026618627315029,0.00128265733759043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD101,Immunoglobulin superfamily member 2,40449,0.0136991714811795,0.00425557224455975,0.00535824988184239,0.0220400930805166,0.00128952081005818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD46,Membrane cofactor protein,42580,0.00906917863725839,0.00281785171665644,0.00354618927261178,0.014592168001905,0.00129182289592491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA5,Protein disulfide-isomerase A5,40080,0.01925636829384,0.00600037217306385,0.00749563883463486,0.0310170977530452,0.00133492737279521
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.0303260614592139,0.00946019117016217,0.011784086765696,0.0488680361527317,0.0013507341807984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR4,Toll-like receptor 4,40199,0.00920316147669401,0.00287230855892288,0.00357343670120516,0.0148328862521829,0.00135872028042894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBA,Lysosomal acid glucosylceramidase,40182,0.0173593483953443,0.00542059523149677,0.00673498174161064,0.027983715049078,0.00136637994088801
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A11,Protein S100-A11,42531,0.0142053552858411,0.00444183088475161,0.00549936675172793,0.0229113438199543,0.00138666343953383
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.00834658689853949,0.00261291783596898,0.00322526794004029,0.0134679058570387,0.00140527858744145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0139036436555589,0.00437248242641393,0.00533357809978762,0.0224737092113302,0.00147782427442046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.015271324902197,0.00480927394209804,-0.0246975018287091,-0.00584514797568482,0.0014997188683921
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0216695030489445,0.00685245538596596,0.00823869049245119,0.0351003156054377,0.00156873484210391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.0110968313810854,0.00351890549903534,0.00419977660297614,0.0179938861591947,0.0016169391222332
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI2,Serpin I2,40449,0.0172274190508069,0.0054682865354053,0.00650957744141254,0.0279452606602013,0.00163460883881311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,-0.0115614438548444,0.00367854092288178,-0.0187713840636927,-0.0043515036459961,0.00167622732861697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTXR,Neuronal pentraxin receptor,42636,0.0104154961690408,0.00331490771344807,0.00391827705068262,0.016912715287399,0.00168152644857225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH6,Cadherin-6,42636,-0.0118598578954543,0.00377590681592491,-0.0192606352546672,-0.0044590805362415,0.00168777650495924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0308814355499134,0.00984036307079816,0.011594323931149,0.0501685471686778,0.00170417036783665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.00649825199390622,0.00207513698477749,0.00243098350374233,0.0105655204840701,0.00174369523403745
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA9,Serpin A9,42538,0.0218433293701125,0.00698570679546675,0.0081513440509977,0.0355353146892273,0.00177063487767306
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0172239622742594,0.0055203287862017,0.00640411785330403,0.0280438066952147,0.00181182398251679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPL,Periplakin,40199,0.0101795016960665,0.00326261955700952,0.0037847673643278,0.0165742360278051,0.00181294239450142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0114252666574046,0.00366671307090803,0.00423850903842486,0.0186120242763843,0.00183744204923684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.00991234553727851,0.00318358408071124,-0.0161521703354725,-0.00367252073908448,0.00185309784397556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99,CD99 antigen,42611,-0.0061344978438699,0.00197040150620272,-0.00999648479602724,-0.00227251089171257,0.00185382028817434
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN4B,Sodium channel subunit beta-4,40223,0.0133967397301889,0.00430578923517772,0.0049573928292406,0.0218360866311372,0.00186720894258261
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPS10,40S ribosomal protein S10,40116,-0.012418303049751,0.00399133543447747,-0.0202413205013268,-0.00459528559817511,0.001867360852511
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEK,Angiopoietin-1 receptor,42679,0.00664852069590763,0.0021380205342956,0.00245800044868825,0.010839040943127,0.00187691947109088
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBB,Inhibin beta B chain,40283,0.0165985066016771,0.00533771666467254,0.00613658193891893,0.0270604312644353,0.00187774757009351
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCF2,Neutrophil cytosol factor 2,42578,0.0250432857993099,0.00807067926916013,0.00922475443175602,0.0408618171668637,0.00191971212945363
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,42357,-0.010627941777992,0.00342626607248026,-0.0173434232800534,-0.00391246027593074,0.0019268825155766
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP9,Fatty acid-binding protein 9,42594,0.0171286607258414,0.00553845070726828,0.00627329733959558,0.0279840241120872,0.00198764930674233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0113382008290182,0.00366691143257085,0.00415105442117936,0.0185253472368571,0.0019919960271359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.012998181318409,0.00421011554699456,0.00474635484629966,0.0212500077905183,0.00202355974791732
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0171137910276849,0.00554602262464767,0.00624358668337548,0.0279839953719943,0.00203441630406113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42595,0.00874259764653894,0.00284162990196295,0.00317300303869155,0.0143121922543863,0.00209788483350839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDI2,Protein DDI1 homolog 2,40283,0.0235752106956378,0.00766416142732259,0.00855345429808548,0.03859696709319,0.00210285669406366
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0113505559241401,0.00369815797381831,0.00410216629545617,0.018598945552824,0.00215036902392635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC1,Hamartin,40199,0.0220612080169936,0.00719479839138728,0.00795940316987455,0.0361630128641127,0.0021727176059084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT1A1,Sulfotransferase 1A1,42711,-0.0378456946557088,0.0124220140299,-0.0621928421543129,-0.0134985471571047,0.00231842936025058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42794,-0.00961298362594048,0.00316234614217995,-0.0158111820646132,-0.00341478518726777,0.002371644293285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42794,-0.00797381765665268,0.00262346148815159,-0.0131158021734298,-0.00283183313987556,0.00237479590634466
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL21,C-C motif chemokine 21,42676,-0.012479302975847,0.00410887047175351,-0.0205326891004838,-0.00442591685121009,0.00239273979125768
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERC2,ERC protein 2,40182,0.0225059118808778,0.00742192316111649,0.00795894248508945,0.0370528812766661,0.00243218837647296
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0121611461974334,0.0040156632590246,0.00429044620974519,0.0200318461851216,0.00246385195667355
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0112753554710426,0.00373108394368942,0.0039624309414113,0.0185882800006738,0.00251580288265367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42587,0.0113523215725776,0.00375995842393425,0.00398280306166648,0.0187218400834888,0.00253863519034289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0232148898779485,0.00772989999394805,0.00806428588981029,0.0383654938660866,0.00267692243254951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP8,GTPase IMAP family member 8,40080,0.0154708524384459,0.00515216430741374,0.00537261039591502,0.0255690944809769,0.00268127049959021
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.022405756125427,0.00746570753398282,0.00777296935882069,0.0370385428920334,0.00269558035693239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.015585315135247,0.00520682347964381,0.00537994111514514,0.0257906891553489,0.00276523724712367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME1,Nucleoside diphosphate kinase A,40199,-0.00644060814529922,0.00215770949001321,-0.0106697187457251,-0.00221149754487332,0.0028426824205377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEG1,Protein LEG1 homolog,39926,-0.0204257678347135,0.00685110564456088,-0.0338539348980528,-0.00699760077137418,0.00287593924189264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42676,0.00872060580114769,0.00292830378963546,0.00298113037346219,0.0144600812288332,0.00290614189700241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0103247119291139,0.00346733804673312,0.00352872935751702,0.0171206945007108,0.00290933704189592
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN3,Perilipin-3,42636,-0.0121841703169402,0.00410069013022412,-0.0202215229721795,-0.00414681766170094,0.00297116266430953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,-0.00860687000293208,0.00290329658423641,-0.0142973313080355,-0.00291640869782871,0.00303794628708678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42721,0.0104849547573164,0.00354078029669388,0.0035450253757964,0.0174248841388364,0.00306976163857945
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,-0.0130565370818918,0.00442423235267869,-0.021728032493142,-0.00438504167064153,0.00317153826797277
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00868473665322229,0.00294276153844968,0.00291692403786091,0.0144525492685837,0.00317189927834916
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX2,Neuronal pentraxin-2,40527,-0.00946601660408331,0.00321098107225222,-0.0157595395056977,-0.00317249370246897,0.00320475096666675
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN15,Lipocalin-15,40482,-0.0180292171807057,0.0061181983177843,-0.0300208858835629,-0.00603754847784847,0.00321718574848919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0109058137550244,0.00370760901987485,-0.0181727274339791,-0.00363890007606971,0.00327342136018864
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTA2,"Actin, aortic smooth muscle",42357,-0.0125939488919791,0.00429058572507888,-0.0210034969131337,-0.0041844008708245,0.00333853324619066
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB39B,Ras-related protein Rab-39B,40116,0.0264942307424529,0.00904922049392444,0.00875775857436096,0.0442307029105448,0.00342083545272534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMR1,Synaptic functional regulator FMR1,42346,0.0101102308772695,0.00345401759997847,0.00334035638131172,0.0168801053732273,0.00342732432675675
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0111910946288411,0.00382413902140854,0.00369578214688034,0.0186864071108018,0.00343447167673486
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0176415466371798,0.00602994546952524,-0.0294602397574493,-0.00582285351691031,0.00344432980323372
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0169553570534101,0.00580637185769215,0.00557486821233352,0.0283358458944868,0.00350584370297095
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.00763983988688055,0.00261822881658967,0.00250811140636479,0.0127715683673963,0.0035304498411617
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0116602908752314,0.0039990523154254,-0.0194984334134652,-0.00382214833699765,0.00355540826046069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,-0.00990211104925711,0.00340423420631819,-0.0165744100936408,-0.00322981200487346,0.00363455897938359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD6,Programmed cell death protein 6,42636,-0.0199863743463204,0.00687187776649599,-0.0334552547686526,-0.0065174939239883,0.00363843320881531
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",40483,0.0170594031070587,0.00587277703615447,0.0055487601161959,0.0285700460979214,0.00368168873677696
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG1,Arginase-1,42488,0.0146454038226904,0.00505175502416877,0.00474396397531965,0.0245468436700612,0.00374880698648516
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0119830098035316,0.0041438135170496,0.00386113531011441,0.0201048842969488,0.00383678401327272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRK1,Protein BRICK1,42311,0.0126756267986425,0.00438446840960464,0.00408206871581742,0.0212691848814676,0.00384612556630397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAM,Integrin alpha-M,42611,-0.00890917630840754,0.00308447737663389,-0.01495475196661,-0.00286360065020511,0.00387837682328181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.00553602007071405,0.00191717425819907,-0.00929368161678423,-0.00177835852464388,0.00388822499483877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.0136300119657441,0.00472300284512186,-0.022887097542183,-0.00437292638930528,0.00390959471425696
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,40302,0.0199768945296804,0.00692825750628902,0.00639750981735391,0.0335562792420069,0.00394170648002819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42794,0.00909976495489841,0.00316262369659581,0.00290102250957062,0.0152985074002262,0.00401739185914193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBP1,Z-DNA-binding protein 1,40199,0.0112612149326113,0.00391777550218757,0.0035823749483237,0.018940054916899,0.00405584320955244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.0138724480340642,0.00484206284276263,-0.023362891205879,-0.0043820048622495,0.00417813996733318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0123792834213092,0.00432492626757344,-0.0208561389057531,-0.00390242793686523,0.00421211321010628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAU,Urokinase-type plasminogen activator,42611,0.00818086613578225,0.00287418017351342,0.00254747299569595,0.0138142592758686,0.00442933671713281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACHE,Acetylcholinesterase,40283,-0.00923888431339511,0.0032548679468116,-0.0156184254891458,-0.00285934313764438,0.00454110224438696
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.00869420582702507,0.00306479290353832,0.00268721173608995,0.0147011999179602,0.00456492351464691
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMOD4,Tropomodulin-4,40080,-0.0114461189084541,0.00404116200837389,-0.019366796444867,-0.00352544137204132,0.00462873066307263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.00916138427095793,0.00323852045797395,-0.0155088843685869,-0.002813884173329,0.00467933058531525
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB8,Serpin B8,42754,0.0158829852335555,0.00561683259413959,0.00487399334904189,0.0268919771180691,0.00469454361018745
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.0181835489784487,0.00644117875284601,0.00555883862287053,0.0308082593340269,0.00476577165119242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB1,Lamin-B1,40434,0.0164623927626942,0.00583762362187642,0.00502065046381637,0.0279041350615719,0.00481001719219136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.0108228927030563,0.00384078630872821,-0.0183508338681636,-0.00329495153794905,0.00484280320818423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.00973593311474583,0.0034597598794531,0.00295480375101776,0.0165170624784739,0.00490086094220721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42754,-0.0166672923970837,0.00592904665752059,-0.0282882238458241,-0.00504636094834338,0.00494393953832648
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.00982936634958972,0.00351008075111335,-0.0167091246217719,-0.00294960807740756,0.00511237765173707
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAST,Gastrin,40483,-0.039761915797107,0.0142031730733259,-0.0676001350208258,-0.0119236965733882,0.0051267223042214
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42587,-0.00869180383716753,0.00310706422609007,-0.0147816497203041,-0.00260195795403099,0.0051583966867088
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6,Interleukin-6,42587,-0.020966430485186,0.00749589753295647,-0.0356583896497807,-0.00627447132059135,0.00516444660830291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42594,-0.0132873615782312,0.00475803761990745,-0.0226131153132498,-0.00396160784321258,0.00523581827470496
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA5,Annexin A5,42261,-0.00836277751028621,0.00299521833199911,-0.0142334054410045,-0.00249214957956796,0.00524525211916084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0102200099187361,0.00366168793010495,0.00304310157573041,0.0173969182617418,0.00526260679509456
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0093334745324465,0.0033461220132035,0.00277507538656765,0.0158918736783254,0.00528900492182783
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0146830375808622,0.00526650097514853,0.00436069566957106,0.0250053794921533,0.00531081550985035
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP7,GTPase IMAP family member 7,40283,-0.00867830247881544,0.00311469538149756,-0.0147831054265507,-0.00257349953108022,0.00534132492581126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NADK,NAD kinase,42636,0.0148312958189043,0.00532814141940862,0.00438813863686343,0.0252744530009452,0.00538380646201763
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRLB,Fc receptor-like B,42346,-0.0176233198958913,0.00633337124031154,-0.0300367275269019,-0.00520991226488069,0.0053999992161386
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,40283,0.0144406512510012,0.0051992532811375,0.00425011481997167,0.0246311876820307,0.00548797744354452
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0193055328625045,0.00695608092778589,0.00567161424404413,0.0329394514809648,0.00552187450991309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,-0.0157657792568949,0.0056809570971866,-0.0269004551673806,-0.00463110334640916,0.00552443713786003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YY1,Transcriptional repressor protein YY1,40199,0.0076571464032518,0.0027636518271548,0.0022403888220284,0.0130739039844752,0.0056036235812507
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKCQ,Protein kinase C theta type,42370,0.0118454185551253,0.00427597718468344,0.00346450327314576,0.0202263338371048,0.00560960393491285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS22,Brain-specific serine protease 4,40199,0.00991932886406633,0.00358140782955272,0.002899769518143,0.0169388882099897,0.00562065990653419
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0119271899574357,0.00430748185814107,0.00348452551547919,0.0203698543993922,0.0056331007776246
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0146298871233476,0.00528967554696098,-0.0249976511953911,-0.0042621230513041,0.00568883592733143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR2,Complement receptor type 2,42689,0.0128816722754355,0.00467318008186463,0.00372223931498081,0.0220411052358901,0.00585001100922069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,40483,0.0131432712746323,0.00476971304371612,0.0037946337089487,0.0224919088403159,0.00586841794774378
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB2,Plexin-B2,42743,-0.00647969645241839,0.0023516573009624,-0.0110889447623047,-0.00187044814253208,0.0058703302856183
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP73,Tumor protein p73,40182,0.00929269623800151,0.00338277066711968,0.00266246573044694,0.0159229267455561,0.00602288988287125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUOX2,Dual oxidase 2,42357,0.0191734788353417,0.00698085964690673,0.00549099392740452,0.0328559637432789,0.00603023253160335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF20B,Kinesin-like protein KIF20B,40136,0.0209574382951353,0.00766153851514756,0.00594082280544612,0.0359740537848245,0.00624032776050791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPS,Calcyphosin,40483,0.027673314960929,0.010118196184763,0.00784165043879346,0.0475049794830645,0.00624767409750424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD55,Complement decay-accelerating factor,42201,0.00726597142128656,0.00265861247275311,0.00205509097469047,0.0124768518678827,0.0062846312009109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSS,Cathepsin S,39872,0.00653862221181434,0.00239275777461816,0.00184881697356274,0.0112284274500659,0.00629262165060046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNPO1,Transportin-1,40302,0.00940901916642328,0.00346850667538155,0.00261074608267545,0.0162072922501711,0.00668402341533819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN7,Septin-7,40302,0.0144427366749839,0.005325696656732,0.00400437122778922,0.0248811021221787,0.00670024762932231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBR1,T-box brain protein 1,40182,0.0128700042481558,0.00474759897173718,0.00356471026355095,0.0221752982327607,0.0067216273275557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNXB,Tenascin-X,42611,0.00678970008692364,0.00251765512665695,0.00185509603867603,0.0117243041351713,0.00700893888825398
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0221775276260811,0.00822354101430124,0.00605938723805066,0.0382956680141115,0.00701088303717365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHB,Lutropin subunit beta,42346,0.0221367876010803,0.00821316354667887,0.00603898704958975,0.0382345881525709,0.00704185957308523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0135005999894089,0.00501157106681966,0.00367792069844233,0.0233232792803754,0.00707316319575717
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42566,-0.0101466784656847,0.00377430598678974,-0.0175443181997925,-0.00274903873157677,0.00718937342952841
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.00977058473719071,0.00363837858320958,-0.0169018067602815,-0.00263936271409994,0.00725468998981423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE1,Ribonuclease pancreatic,40532,-0.00692562791744414,0.00258499410457254,-0.0119922163624063,-0.00185903947248195,0.00739123545821269
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12A_IL12B,Interleukin-12,42587,0.0212871855961468,0.00797879998480552,0.00564873762592796,0.0369256335663656,0.00764033040260896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0209079055537389,0.0078476571151312,-0.0362893134993961,-0.00552649760808176,0.00772605860687143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIT,Citron Rho-interacting kinase,40182,0.0117803797465558,0.00442826976386632,0.00310097100937782,0.0204597884837338,0.00781921135065529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RETN,Resistin,42598,-0.0112159038941127,0.00422672811741196,-0.0195002910042402,-0.00293151678398528,0.00797400383026223
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LXN,Latexin,42461,-0.0174850926142683,0.00661107762061407,-0.0304428047506719,-0.00452738047786472,0.00818312964687466
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB37,Ras-related protein Rab-37,42370,0.0208114220759626,0.00788505956272114,0.00535670533302915,0.036266138818896,0.00831632649755254
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMA,Repulsive guidance molecule A,42711,-0.0082406248847482,0.00312337797140105,-0.0143624457086943,-0.00211880406080215,0.00834012458262624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSE,Cathepsin E,40283,0.0132005916290474,0.00500883886006732,0.00338326746331546,0.0230179157947794,0.00841403845854081
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0112148913448518,0.00426091042064761,0.00286350692038247,0.0195662757693211,0.00849727046415656
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMD,Osteomodulin,42676,0.0108179548179431,0.00411287144068834,0.00275672679419399,0.0188791828416923,0.00854144942403992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,40223,0.0143226437636935,0.00544922413529432,0.00364216445851664,0.0250031230688704,0.00859109423296902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP1,Interstitial collagenase,42136,0.0233576529334437,0.0088923870487706,0.00592857431785334,0.0407867315490341,0.00863183163742959
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0100385707843943,0.00382914844242639,0.00253343983723857,0.01754370173155,0.00876343716857036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0166920240971019,0.00637695654675613,0.00419318926545988,0.0291908589287439,0.00886802671662877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0137306931012082,0.00526744337746324,0.00340650408138027,0.0240548821210362,0.00915200082882811
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WNT9A,Protein Wnt-9a,42370,-0.00750603223789885,0.00289751709858119,-0.013185165751118,-0.00182689872467972,0.00959408082551163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITM2A,Integral membrane protein 2A,42594,-0.0155918020018752,0.00602159753323983,-0.0273941331670253,-0.00378947083672511,0.00962715573018232
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX5,Syntaxin-5,40199,0.0104102891052932,0.00402332507655608,0.00252457195524324,0.0182960062553431,0.0096806660692397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOH,Beta-2-glycoprotein 1,42611,-0.00918550513050004,0.00355226595126245,-0.0161479463949744,-0.00222306386602564,0.00972532557811572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAG,Myelin-associated glycoprotein,40182,0.012402490605038,0.00480044022362831,0.0029936277667265,0.0218113534433495,0.00978987064192827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTP1,Glutathione S-transferase P,42237,-0.0176545644997642,0.00684975789120006,-0.0310800899665163,-0.0042290390330121,0.00996555202698901
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0357713710260597,0.0138854062546321,-0.0629867672851386,-0.00855597476698072,0.0100022695589013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOPH1,Enolase-phosphatase E1,40451,0.0138323287206232,0.0053744911635247,0.00329832604011484,0.0243663314011316,0.010074417782519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.0145082530729651,0.00564120192694059,-0.0255650088497686,-0.00345149729616155,0.0101267800558416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.0077054814459707,0.00299790579938213,0.00182958607918172,0.0135813768127597,0.010172293414932
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31,Interleukin-31,40199,0.0141830679355205,0.00552510590391393,0.00335386036384921,0.0250122755071918,0.0102707089019458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF1C,Kinesin-like protein KIF1C,40116,0.00903075793719135,0.0035203007253359,0.00213096851553299,0.0159305473588497,0.010320790757489
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA2,Carboxypeptidase A2,42670,-0.0164952738792041,0.00643341928223489,-0.0291047756723845,-0.00388577208602368,0.0103581581437312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00726378940874517,0.00283533666628995,-0.0128210492746735,-0.00170652954281687,0.010423833558347
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX9,Transcription factor SOX-9,40182,0.00693929694401629,0.00270962914736566,0.00162842381517961,0.012250170072853,0.0104510728923324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF4,Neurotrophin-4,42346,0.00973979818389486,0.00380534232711607,0.00228132722274736,0.0171982691450424,0.010493172928671
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM26,Tripartite motif-containing protein 26,40080,0.0140924210984848,0.00550606770009667,0.00330052840629536,0.0248843137906743,0.010497643251873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX2,Transcription factor SOX-2,40461,0.00597693300082385,0.00233987404535338,0.00139077987193122,0.0105630861297165,0.0106506715792951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBH,Dopamine beta-hydroxylase,40515,0.0273624347052209,0.0107235458495329,0.00634428484013646,0.0483805845703053,0.010735305873834
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP8,Neutrophil collagenase,42681,-0.0181362629115039,0.00711517305566428,-0.0320820021006059,-0.00419052372240192,0.0108155703493809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.00945990085530035,0.00371500868166703,-0.0167413178713677,-0.00217848383923297,0.0108975974178876
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00732748887504408,0.00287983257377931,-0.0129719607196515,-0.00168301703043664,0.0109593019346096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFB,Vascular endothelial growth factor B,40199,0.00737054660997093,0.00289817411758946,0.00169012533949559,0.0130509678804463,0.0109987757909899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP152,Centrosomal protein of 152 kDa,40080,0.0103708819173134,0.0040826925134917,0.00236880459086965,0.0183729592437571,0.0110924806694373
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHISA5,Protein shisa-5,40527,-0.00688856775338228,0.0027201360085725,-0.0122200343301844,-0.00155710117658017,0.0113407188889751
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP4,Guanylate-binding protein 4,42311,0.0121867501364945,0.00481884365989835,0.00274181656309376,0.0216316837098953,0.0114511371124009
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0111405067562991,0.00440563394689774,0.00250546422037955,0.0197755492922187,0.0114625878268248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B4,Protein ATP1B4,40080,-0.0104346094041469,0.00414187922893182,-0.0185526926928533,-0.00231652611544051,0.0117732595745977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP7,Dipeptidyl peptidase 2,42551,0.0147880245005177,0.00587453315015583,0.00327393952621224,0.0263021094748231,0.0118370590547403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN8,Tetraspanin-8,40449,-0.025186088199179,0.0100101532239703,-0.0448059885181608,-0.00556618788019712,0.0118814910776429
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.012261002903715,0.00488192718668516,-0.0218295801896179,-0.00269242561781208,0.0120358560682172
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0100594698054197,0.00401292231591187,0.00219414206623244,0.017924797544607,0.0121955971276542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB2A2,Mammaglobin-A,40116,-0.00781022441488435,0.00311678958840117,-0.0139191320081506,-0.00170131682161805,0.012229979519866
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0133022523258651,0.00531334795096344,0.00288809034197676,0.0237164143097534,0.0123093032180481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.00684385070229537,0.00273944853344476,0.00147453157674364,0.0122131698278471,0.0124926555244627
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0114120033095135,0.00457904759388504,0.00243707002549885,0.0203869365935282,0.0127069285134849
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL25,Interleukin-25,40036,0.00853304809890484,0.00342465080452963,0.00182073252202677,0.0152453636757829,0.0127297770131258
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC5D,Netrin receptor UNC5D,40199,0.00638793256576694,0.00256497092832593,0.00136058954624812,0.0114152755852858,0.0127727668838722
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00883887415728309,0.00354982483162607,0.001881217487296,0.0157965308272702,0.0127908954278795
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROCR,Endothelial protein C receptor,40116,-0.00852017831364539,0.00342528160110715,-0.0152337302518154,-0.00180662637547538,0.0128814649982423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMB,Granzyme B,42594,0.016085568421075,0.00647342259881497,0.00339766012739767,0.0287734767147523,0.0129722398716933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL14,C-X-C motif chemokine 14,42370,0.0136812790638014,0.00550956346021894,0.0028825346817723,0.0244800234458305,0.0130335983291569
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSBP1,Heat shock factor-binding protein 1,40223,0.0229604229014594,0.0092473802626761,0.00483555758661422,0.0410852882163045,0.0130461157836984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCND2,G1/S-specific cyclin-D2,40302,0.00896790923531059,0.00361263735681128,0.00188714001596049,0.0160486784546607,0.0130657611731672
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD160,CD160 antigen,42754,-0.0118499651908457,0.00478194597303344,-0.0212225792979912,-0.00247735108370012,0.0132218486606067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL11,Interleukin-11,42370,0.0151395438646624,0.00611745915402116,0.00314932392278095,0.0271297638065439,0.0133432280794615
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.00786653196132506,0.0031791332701317,-0.0140976331707832,-0.00163543075186694,0.013360070681782
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,40080,0.019253381497361,0.00781328497857018,0.00393934293936344,0.0345674200553586,0.0137478499437415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.0127472345674631,0.00517805427899282,-0.022896220954289,-0.00259824818063719,0.0138397942345036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSM,Oncostatin-M,42534,-0.0167873317941417,0.00682065480383945,-0.030155815209667,-0.0034188483786164,0.0138579785627397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN3,Matrilin-3,42475,0.00785880379194392,0.00319806820224796,0.00159059011553791,0.0141270174683499,0.0140089368579875
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,-0.0158702169406531,0.00646090684874848,-0.0285335943642002,-0.00320683951710611,0.0140508201849685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A14,Zinc transporter ZIP14,42311,-0.00826844452378174,0.00337028337885273,-0.0148741999463331,-0.0016626891012304,0.0141666417964939
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPG,Macrophage-capping protein,42461,0.0139944781328069,0.00570443604833595,0.00281378347806847,0.0251751727875454,0.0141694773985889
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCC1,Regulator of chromosome condensation,40451,0.0125747325688348,0.00512893881815676,0.00252201248524758,0.0226274526524221,0.0142325266948108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST6,Cystatin-M,42332,0.0121076716392664,0.00494255151417387,0.00242027067148557,0.0217950726070471,0.0143112658106559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5,Interleukin-5,42370,0.0333329584437858,0.0136087329266648,0.00665984190752291,0.0600060749800487,0.0143231656478213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAO1,Hydroxyacid oxidase 1,42721,0.0297214698617665,0.0121559861746918,0.00589573695937057,0.0535472027641625,0.0144976038707789
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSTB,Cystatin-B,42437,0.0101378704664819,0.0041514302328352,0.00200106721012492,0.0182746737228389,0.0146183774551458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD7,FERM domain-containing protein 7,40182,0.00799580550628882,0.00327520730711979,0.00157639918433404,0.0144152118282436,0.0146496437356722
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42754,-0.00607679625757055,0.00248989299112309,-0.0109569865201718,-0.0011966059949693,0.0146761920136649
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0101283329789216,0.00415916274340867,-0.0182802919560026,-0.00197637400184057,0.0149001016047215
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP13,Collagenase 3,42311,-0.00790695455232037,0.00325632882727067,-0.0142893590537709,-0.00152455005086985,0.0151881400211948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42721,0.0199140067461213,0.0082049158768239,0.00383237162754647,0.0359956418646962,0.0152337692404816
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN8,Septin-8,40470,-0.0076922155619783,0.00316998737041427,-0.0139053908079903,-0.00147904031596634,0.0152576235975621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APLP1,Amyloid-like protein 1,42636,-0.0122021855684903,0.00503063470042596,-0.0220622295813251,-0.00234214155565537,0.0152972031983099
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH3,Cadherin-3,42711,0.00885889891480756,0.00365580843646328,0.00169351437933953,0.0160242834502756,0.015395832056411
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MELTF,Melanotransferrin,40511,0.00714850286922854,0.00295244739196277,0.00136170598098152,0.0129352997574756,0.0154844493685753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRND,Prion-like protein doppel,40483,-0.0123823708456648,0.00511619762429919,-0.0224101181892912,-0.00235462350203835,0.0155264088678449
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0092188570934044,0.00380980200464004,-0.0166860690224989,-0.00175164516430992,0.0155464044399485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSC,Dipeptidyl peptidase 1,42616,0.0103441141295126,0.00428591865602977,0.00194371356369424,0.0187445146953309,0.0158129318586781
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00819718508685311,0.00340050570468792,-0.0148621762680414,-0.00153219390566479,0.0159405515495195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN4,Contactin-4,42611,-0.00564799221948237,0.00234570237843742,-0.0102455688812197,-0.00105041555774502,0.0160621896839354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC12A2,Solute carrier family 12 member 2,40116,-0.00642706662527839,0.0026706556468883,-0.0116615516931795,-0.00119258155737732,0.0161204920076817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.0071548787638274,0.00297328219458398,0.0013272456624428,0.012982511865212,0.016124396985441
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TERF1,Telomeric repeat-binding factor 1,40199,-0.00694739387009198,0.00289913780946908,-0.0126297039766514,-0.00126508376353259,0.0165751553973557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP6,Guanylate-binding protein 6,40116,-0.0108317803656731,0.00452361527148065,-0.0196980662977752,-0.00196549443357105,0.0166599603895815
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB6,Ephrin type-B receptor 6,42476,0.00783862764523934,0.0032821232390284,0.00140566609674369,0.014271589193735,0.0169413464824014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.0101051688291981,0.00423644302208777,-0.0184085971524902,-0.00180174050590609,0.0170820958322576
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MVK,Mevalonate kinase,42370,0.0185346788920138,0.00777282400676419,0.00329994383875604,0.0337694139452717,0.0171141365685619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00972327448408601,0.00408243460298772,-0.0177248463059419,-0.00172170266223008,0.0172452003394443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRNN,Cornulin,42209,0.0160741352446763,0.00674970368218288,0.00284471602759788,0.0293035544617548,0.0172585512796141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,40116,0.010281290978427,0.00431844327074919,0.0018171421677586,0.0187454397890954,0.0172927696040861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST1,Cystatin-SN,39042,0.025684548530088,0.0108039991007951,0.00450871029252959,0.0468603867676464,0.0174579999854305
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0122289455258809,0.00514569866568525,0.00214337614113784,0.022314514910624,0.0174928344662771
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EP300,Histone acetyltransferase p300,40199,0.00720751737134306,0.00303499743433149,0.00125892240005335,0.0131561123426328,0.0175754165060666
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42676,-0.00642900330344808,0.00271024306994657,-0.0117410797205434,-0.00111692688635279,0.017700628006376
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.0283811893834354,0.0119719471116651,0.00491617304457185,0.0518462057222989,0.0177715987514394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL1,Interferon lambda-1,42311,-0.0105926279006569,0.00447093514994459,-0.0193556607945483,-0.00182959500676546,0.0178400538433683
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.00859086330426993,0.00362948336478373,0.00147707590929383,0.015704650699246,0.0179517547619537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP112,Centrosomal protein of 112 kDa,40116,0.0104018324511142,0.00439862504494015,0.00178052736303152,0.0190231375391969,0.0180575926396872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0155953355760203,0.00662497431834068,0.00261038591207254,0.028580285239968,0.0185858200968678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD1,Polycystin-1,40511,0.00617678709193615,0.00262421967559012,0.00103331652777952,0.0113202576560928,0.0186015368305054
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKIV2L,Helicase SKI2W,40116,-0.00916394297191055,0.00390375107463711,-0.0168152950781993,-0.00151259086562182,0.0189190896742079
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.00792296413440794,0.00337610481755684,0.00130579869199653,0.0145401295768194,0.0189509097340489
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEF,Thyrotroph embryonic factor,40116,0.00998103648116655,0.00425918033548911,0.00163304302360789,0.0183290299387252,0.0191258411681581
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRN,Progranulin,42552,0.00560440151530237,0.00239204030436902,0.000916002518739087,0.0102928005118656,0.0191471686450917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00543598963838401,0.00232032414136417,-0.00998382495545779,-0.000888154321310235,0.0191583669755487
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX3,Syntaxin-3,40483,0.00886650499834636,0.00379202026061475,0.00143414528754146,0.0162988647091513,0.0193941974264225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM19,Probable RNA-binding protein 19,40116,-0.011051120072458,0.00473416653771472,-0.0203300864863788,-0.00177215365853713,0.0195963363058818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00990143853306367,0.00425123835946371,-0.0182338657176125,-0.00156901134851481,0.0198731131305412
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00602128980110277,0.00259482659836189,0.00093542966831347,0.0111071499338921,0.0203323786570004
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD3,Bromodomain-containing protein 3,40116,0.0113035664862728,0.00487594148812046,0.00174672116955673,0.0208604118029889,0.0204550585358104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB118,Beta-defensin 118,40136,0.0129379622872333,0.00558374531603437,0.00199382146780596,0.0238821031066607,0.0205179579117192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.00738378785036788,0.00319358712485986,0.00112435708564256,0.0136432186150932,0.0207924899851238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMS1,PMS1 protein homolog 1,40182,0.0117415765694903,0.00508560501904799,0.00177379073215622,0.0217093624068244,0.020973892195818
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,-0.0144443808782852,0.00626500817031653,-0.0267237968921056,-0.00216496486446478,0.021153013346916
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.00859827664646441,0.00372972265006843,-0.0159085330405985,-0.00128802025233029,0.0211630998661745
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC4,MANSC domain-containing protein 4,40116,0.016175418346115,0.007019687576303,0.00241683069656115,0.0299340059956689,0.021224862231195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.033487706330288,0.0145737050351058,0.00492324446148052,0.0620521681990954,0.0215878717329927
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0145118752530033,0.00633716013497199,0.00209104138845817,0.0269327091175484,0.0220421347993205
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIM,Vimentin,42357,0.0258803948741259,0.0113087528385937,0.00371523931048231,0.0480455504377695,0.022122575702983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS5,Transmembrane protease serine 5,42438,0.00851244935248937,0.00372068602988845,0.00121990473390801,0.0158049939710707,0.0221607252353679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.0133674705369128,0.00584652762502603,0.00190827639186182,0.0248266646819638,0.0222469787606967
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3,Granulocyte colony-stimulating factor,42370,0.0108961938563199,0.00476664334421745,0.00155357290165367,0.0202388148109861,0.022274390193512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0157906867444264,0.00690876561233462,-0.0293318673446022,-0.0022495061442505,0.0222960170307146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.0263724232214417,0.0115752218750039,-0.0490598580964493,-0.0036849883464341,0.0227212960876796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,42443,0.025523646956356,0.0112048290522365,0.0035621820139725,0.0474851118987395,0.0227475028128918
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0163768746485002,0.00720167362443591,0.00226159434460586,0.0304921549523946,0.0229823823818921
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF9,Fibroblast growth factor 9,40065,0.00915725446291094,0.00403684895779046,0.00124503050564165,0.0170694784201802,0.0233233624250265
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIF,Leukemia inhibitory factor,42311,0.0113811605014739,0.00501999042198578,0.00154197927438179,0.021220341728566,0.0233961818169519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG3,Secretogranin-3,42638,-0.00753976520802795,0.00332793048390657,-0.0140625089564848,-0.00101702145957108,0.023491612202871
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDRG1,Protein NDRG1,42311,0.014402974030334,0.0063578260103684,0.00194163505001198,0.0268643130106561,0.023504812745396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,40136,0.01719023658822,0.00763107178770364,0.00223333588432089,0.0321471372921192,0.0243001064513671
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL2,Fc receptor-like protein 2,42681,0.0115250884441466,0.00513051773711881,0.00146927367939374,0.0215809032088995,0.0246958418732536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPESP1,Sperm equatorial segment protein 1,40511,0.00697208021679886,0.0031073068538658,0.000881758783221888,0.0130624016503758,0.024866495375016
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.00716082221129685,0.00319554621337675,-0.0134240927895153,-0.00089755163307841,0.025050710681728
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,40527,-0.00747122671716599,0.0033343042346527,-0.0140064630170853,-0.000935990417246685,0.0250638100700099
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0147275554150752,0.00658210166845721,0.00182663614489907,0.0276284746852513,0.0252690679288564
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42594,-0.0114970813119616,0.00514497246973526,-0.0215812273526428,-0.00141293527128052,0.0254584336082094
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTO1,Protein LTO1 homolog,42370,0.00918246241166021,0.0041096926126628,0.00112746489084113,0.0172374599324793,0.0254772250726553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOD,Apolipoprotein D,40033,0.0094980142280764,0.00426850498617085,0.00113174445518153,0.0178642840009713,0.0260924505718331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMBS,Porphobilinogen deaminase,42721,0.0093610374709037,0.00420753418350882,0.00111427047122642,0.017607804470581,0.0261092563745141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN2,Neuroligin-2,40136,-0.0104417224100255,0.0047069760667044,-0.0196673955007661,-0.00121604931928487,0.0265513962149633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0185772642260775,0.00838146393248393,-0.035004933533746,-0.00214959491840904,0.0266765950807016
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.0066355848766752,0.00299433975585282,0.00076667895520368,0.0125044907981467,0.0267056272240845
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.0124069295195294,0.00560858717571659,0.00141409865512486,0.0233997603839339,0.0269778853888557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0127777072549838,0.00578724193969358,0.00143471305318435,0.0241207014567832,0.0272713445147124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.00963200372980455,0.00437108267119459,0.00106468169426316,0.0181993257653459,0.0275711646498185
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0088757188330916,0.00402826154487066,0.000980326205145116,0.0167711114610381,0.0275898775961377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.00735996530344617,0.00335344311047149,0.000787216806922048,0.0139327137999703,0.0282019721501657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD83,CD83 antigen,42594,0.007556552328416,0.00344346666122277,0.000807357672419367,0.0143057469844126,0.028219406134639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD6,MICOS complex subunit MIC25,40451,0.00617060411369197,0.00281936054995366,0.0006446574357828,0.0116965507916011,0.0286424873569613
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAX,Apoptosis regulator BAX,42292,0.0189094583690468,0.00865496410949505,0.00194572871443654,0.0358731880236571,0.0289203890498118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0129116025136707,0.00592356891795159,-0.0245217975928558,-0.00130140743448558,0.0293007934821996
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLON5,IgLON family member 5,40080,-0.0202251140354661,0.00928467024614431,-0.0384230677179089,-0.00202716035302324,0.0294025540198034
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFLAM,Pikachurin,40449,0.00657984319414132,0.00302828679244619,0.000644401080946795,0.0125152853073359,0.0298166219913489
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,-0.00734104524324206,0.00338250610435574,-0.0139707572077793,-0.000711333278704812,0.0300016207149616
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA4,Carboxypeptidase A4,40060,0.0093657784066622,0.00432651020777469,0.000885818399423807,0.0178457384139006,0.0304291496182847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP4,Bone morphogenetic protein 4,42475,-0.00984767048347755,0.00454990154052491,-0.0187654775029064,-0.000929863464048731,0.0304537243100935
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,-0.00743934718033468,0.00344159458699625,-0.0141848725708473,-0.000693821789822039,0.0306667534667344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.00833458556574268,0.00385853965592068,0.000771847840138145,0.0158973232913472,0.0307875472814067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42689,0.00636383335718714,0.00294861308052471,0.00058455171935871,0.0121431149950156,0.0309262653649421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGT,Angiotensinogen,40532,0.00503148554920605,0.00233653203525957,0.00045188276009728,0.00961108833831481,0.0313083602574472
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK3,Prostate-specific antigen,40527,0.0206722543416903,0.00960206256968306,0.0018522117051115,0.0394922969782691,0.0313477911735987
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP2,Dipeptidase 2,42587,0.00619589036740909,0.00287802618772921,0.000554959039459845,0.0118368216953583,0.0313501386137462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42737,-0.00652944546669859,0.00303795750634894,-0.0124838421791425,-0.000575048754254661,0.0316292447297851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL28,C-C motif chemokine 28,42538,0.0123035661082633,0.00572481833867298,0.00108292216446425,0.0235242100520623,0.0316394332006895
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100P,Protein S100-P,42357,0.0114072845006661,0.00531083312176038,0.000998051582015769,0.0218165174193165,0.0317377119333077
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.0112573345897044,0.00524825470783541,0.000970755362346965,0.0215439138170618,0.0319774132937358
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00569778892930468,0.00265678039374919,0.00049049935755627,0.0109050785010531,0.0320043879445261
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZU1,Azurocidin,42216,0.0159383201924358,0.0074419201318757,0.00135215673395944,0.0305244836509122,0.0322365635572256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18BP,Interleukin-18-binding protein,42689,-0.0066996466639285,0.00315218784029656,-0.0128779348309098,-0.000521358496947236,0.0335717165109479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.00994217895800377,0.00468024494410054,0.000768898867566705,0.0191154590484408,0.0336679084237067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42636,-0.00602293161758217,0.00283564966815879,-0.0115808049671734,-0.000465058267990941,0.0336880042320462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0124867532795214,0.00587960584481163,-0.0240107807353521,-0.000962725823690563,0.0337143151078703
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00604193023877983,0.00285207239087252,0.000451868352669697,0.01163199212489,0.0341605838715459
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.00567537108261227,0.00268443100678226,0.000413886309319043,0.0109368558559055,0.0345181779318103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0207104847569021,0.00980007634830063,-0.0399186343995713,-0.00150233511423287,0.0345978616121989
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0187028205330104,0.00889684339996978,0.00126500746906959,0.0361406335969511,0.0355597700436585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNG,Uracil-DNA glycosylase,40451,0.00699186971556618,0.00333510873366684,0.000455056597579166,0.0135286828335532,0.0360650587323393
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDN1,Endothelin-1,40223,-0.00624280382288944,0.00297814074526502,-0.0120799596836089,-0.000405647962169998,0.0360864308553232
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS2,"Nitric oxide synthase, inducible",40116,-0.00818314313137059,0.00390595407867589,-0.0158388131255753,-0.000527473137165835,0.0361901119152324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNR,Tenascin-R,42495,0.0086714757200034,0.0041398616275321,0.000557346930040481,0.0167856045099663,0.0362228235181943
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ULBP2,UL16-binding protein 2,42495,-0.00817283853911922,0.00390337431983449,-0.0158234522059948,-0.000522224872243621,0.0362977482440465
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG3,Proteoglycan 3,40527,0.0101769199083932,0.00487080434965305,0.000630143383073177,0.0197236964337131,0.0366965376455411
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0106744741979847,0.00512353452289996,0.000632346533100797,0.0207166018628686,0.0372357663524455
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP2,Guanylate-binding protein 2,42370,0.012343974603901,0.00592518200997733,0.000730617864345477,0.0239573313434566,0.0372424565317563
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH4,Cadherin-4,40136,0.0101451691249346,0.00487190743430277,0.000596230553701194,0.019694107696168,0.0373308252420208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POSTN,Periostin,40527,-0.0078320901244819,0.00376656614498191,-0.0152145597686465,-0.000449620480317349,0.0376056513909376
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.0104900076665402,0.00504594916724395,0.00059994729874201,0.0203800680343383,0.0376501946807844
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CILP,Cartilage intermediate layer protein 1,40527,0.011173494284309,0.00539388955642099,0.000601470753723845,0.0217455178148941,0.03833376610858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0105507548673797,0.00509731047859421,0.000560026329335016,0.0205414834054243,0.0384842752265198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0114517245193824,0.00553945318700406,0.000594396272854431,0.0223090527659104,0.038728476260905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.00686358692919996,0.00332765360712491,0.000341385859235137,0.0133857879991648,0.0391707093606095
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,-0.0101709842920243,0.00494015842981536,-0.0198536948144624,-0.000488273769586217,0.0395294392403896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP164,Centrosomal protein of 164 kDa,42370,0.0132650467920285,0.006443199804738,0.000636375174742021,0.025893718409315,0.0395361826869875
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42587,0.0202194810623513,0.00982455951362715,0.000963344415642036,0.0394756177090605,0.0396041873550029
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B2M,Beta-2-microglobulin,40539,-0.00632183091626487,0.0030723561781491,-0.0123436490254371,-0.000300012807092629,0.0396466288921965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO1,Roundabout homolog 1,42638,0.00490580741146045,0.00238677614953985,0.000227726158362339,0.00958388866455856,0.0398585378424131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL9,C-X-C motif chemokine 9,42676,-0.0135363578297461,0.00659685492429785,-0.0264661934813699,-0.000606522178122295,0.0401946563957145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L,Seizure 6-like protein,42679,0.00561263462851615,0.00273659955736435,0.000248899496082015,0.0109763697609503,0.0402908921278511
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.0149327043899485,0.00728370362797241,-0.0292087635007744,-0.000656645279122521,0.0403733128544434
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR158,Probable G-protein coupled receptor 158,40482,0.00721668607042879,0.00352079684259662,0.000315924258939405,0.0141174478819182,0.0404137540671335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42545,0.00898454760181863,0.00438348436875723,0.000392918239054465,0.0175761769645828,0.0404194539689734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0123504552574704,0.00605471664483945,0.00048321063358508,0.0242176998813557,0.0413934881821699
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD302,CD302 antigen,42587,0.00636284813815544,0.0031239046448888,0.000239995034173402,0.0124857012421375,0.0416871725828566
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0100813526848138,0.00495962153249521,0.000360494481123167,0.0198022108885044,0.0421043680974246
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0097437278099592,0.00480804949084733,0.000319950807898437,0.01916750481202,0.0427335332274846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.00704097584518861,0.00347517417890331,0.000229634454538111,0.0138523172358391,0.0427808117567008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QSOX1,Sulfhydryl oxidase 1,40342,0.00859625316632691,0.00424526536944403,0.000275533042216614,0.0169169732904372,0.0429010502231671
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC4A1,Band 3 anion transport protein,40527,-0.00926398291358459,0.00458564390172347,-0.0182518449609626,-0.000276120866206585,0.0433846537858935
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00680960875659059,0.00337214523416908,0.000200204097619189,0.013419013415562,0.0434683598982047
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22,Interleukin-22,40451,-0.0137146807575581,0.00684292622995955,-0.0271268161682788,-0.000302545346837343,0.045071174624736
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD9,Enhancer of filamentation 1,40199,0.00652875701890775,0.00326349135991472,0.000132313953474904,0.0129252000843406,0.0454661099731126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3,Galectin-3,42669,0.00582611155366008,0.00291384348149727,0.000114978329925442,0.0115372447773947,0.0455787194162637
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0139652244664951,0.00699042468252675,-0.0276664568442476,-0.000263992088742691,0.0457622219806826
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42613,0.0157541239492596,0.00789704785290058,0.000275910157574479,0.0312323377409448,0.046069788621563
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,40116,0.00785937635372036,0.00394787452682648,0.000121542281140463,0.0155972104263002,0.0465292111199664
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,40470,0.00794365040109973,0.0040041355559702,9.55447113981343e-05,0.0157917560908013,0.0472954899117311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTTG1,Securin,40302,0.00793778181483536,0.00400998391583786,7.82133397931612e-05,0.0157973502898776,0.0477838635677034
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHPK,Sedoheptulokinase,40302,-0.00794550584529552,0.00402084631159098,-0.0158263646160139,-6.46470745771944e-05,0.0481706498021427
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRXN3,Neurexin-3,40182,0.00686234158417736,0.003478808466975,4.38769889063726e-05,0.0136808061794484,0.0485647414282629
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH12,Protocadherin-12,40482,0.00496398726770704,0.0025212852046117,2.22682666681014e-05,0.00990570626874597,0.0489967995997826
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMCH,Pro-MCH,40116,-0.016355368767838,0.00830925968100654,-0.0326415177426108,-6.92197930651783e-05,0.0490552823364006
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.0101542922309451,0.00516691313976693,2.71424770019076e-05,0.0202814419848883,0.0494060160512642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR2,Interferon gamma receptor 2,42495,0.00994309363894553,0.00508172842956886,-1.70940830094418e-05,0.0199032813609005,0.0504111521665362
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A16,Protein S100-A16,42292,-0.0115730984489815,0.00592940945525907,-0.0231947409812892,4.85440833263052e-05,0.0509816915217543
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGCR6,Protein DGCR6,40136,0.0084627985589646,0.00433766679045292,-3.90283503231142e-05,0.0169646254682523,0.0510822410607525
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3B,Protein FAM3B,42587,-0.00669465783383527,0.0034375468924895,-0.0134322497431147,4.2934075444148e-05,0.0514944595161582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC2,Stanniocalcin-2,42591,0.0047022566663343,0.00242579594073862,-5.23033775133974e-05,0.00945681671018199,0.0525907046334198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3B,Sodium channel subunit beta-3,40136,0.00912651439417288,0.00471564818206941,-0.00011615604268316,0.0183691848310289,0.0529708918136392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,42315,0.00547889186404336,0.00284310722606102,-9.35982990362336e-05,0.011051382027123,0.0539913676489834
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRUNE2,Protein prune homolog 2,40302,0.00566606720575654,0.00294227316380692,-0.000100788195305014,0.0114329226068181,0.054161743266098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42611,0.00841487387185298,0.00437401542088424,-0.000158196353080129,0.0169879440967861,0.0543966886003002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTN3,Myeloblastin,42276,-0.00913447363890107,0.00476050370113092,-0.0184650608931177,0.000196113615315531,0.0550308762129531
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.00595292677317819,0.00310268662941611,-0.0120341925668338,0.000128339020477381,0.0550562755089963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA6C,Semaphorin-6C,40199,0.00492142544446941,0.00257337957625045,-0.000122398524981467,0.00996524941392029,0.0558461414491746
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBQLN3,Ubiquilin-3,40116,-0.0101673840401759,0.00531962831231156,-0.0205938555323066,0.000259087451954724,0.0559927054204167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.014373277459835,0.00754426755885795,-0.000413486955526529,0.0291600418751966,0.0567769758620263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,40199,0.0119202057792871,0.00625791831354532,-0.000345314115261687,0.024185725673836,0.0568295618291241
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL9,Interleukin-9,40302,0.0104839630252134,0.00550658368215165,-0.000308940991803877,0.0212768670422306,0.0569495362603418
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMMT,MICOS complex subunit MIC60,40451,0.00838859138290799,0.00440649675073195,-0.000248142248526635,0.0170253250143426,0.056976413074676
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00738293896991435,0.00390271059512083,-0.00026637379652248,0.0150322517363512,0.0585503394899583
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNC,Tenascin,42689,-0.0088894056421621,0.00471065612743593,-0.0181222916519365,0.000343480367612317,0.0591704194269923
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL8,Interleukin-8,42494,0.0127978907085456,0.00678850346807711,-0.000507576088885528,0.0261033575059767,0.0594205650446717
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL34,Interleukin-34,42292,0.00670184829336258,0.00356955078844376,-0.000294471251987191,0.0136981678387123,0.0604711613804888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,42443,0.00558565376028408,0.00298402591296642,-0.000263037029130111,0.0114343445496983,0.0612491480390439
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPF,Centromere protein F,40302,0.00997628663657025,0.00533059476856028,-0.000471679109807903,0.0204242523829484,0.0613000322412912
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIL1,Nucleotide exchange factor SIL1,40223,0.00565003200638068,0.00303057463453161,-0.000289894277301268,0.0115899582900626,0.0623000325462546
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.00635575534460608,0.00341032085857744,-0.000328473538205706,0.0130399842274179,0.0623929147362735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR2,TGF-beta receptor type-2,42679,-0.00649849875351681,0.00349634541972969,-0.013351335776187,0.000354338269153373,0.0630978735205999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.00586666075379378,0.00315724167091738,-0.000321532921204284,0.0120548544287919,0.0631681838957694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,40483,0.00701577708808453,0.00378209549644981,-0.000397130084957101,0.0144286842611262,0.0636226588745051
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBLN2,Fibulin-2,40527,-0.00591015102007996,0.00319335295182869,-0.0121691228056642,0.000348820765504273,0.0642291403082626
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42600,0.00319374177897204,0.00172799903052051,-0.000193136320848158,0.00658061987879223,0.0645909080042065
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNG,Interferon gamma,42370,0.0203161066633915,0.0110199349323001,-0.00128296580391668,0.0419151791306997,0.0652671454681804
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D17,TBC1 domain family member 17,42311,0.00815399424306091,0.00442404406269499,-0.000517132119821266,0.0168251206059431,0.0653356844185512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0116771626283946,0.00633789771464228,-0.000745116892304226,0.0240994421490935,0.0654335645271946
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,0.00519812587151964,0.00282412118164463,-0.000337151644503846,0.0107334033875431,0.0656994551027058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00938221273486944,0.00509887737158968,-0.0193760123831852,0.000611586913446319,0.0657874670029568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42501,0.00524560677172453,0.00285099907023218,-0.000342351405930534,0.0108335649493796,0.0658024187329622
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G1B,Phospholipase A2,42782,-0.00818352182978439,0.00444884000501405,-0.0169032482396119,0.000536204580043156,0.0658674230827583
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SATB1,DNA-binding protein SATB1,40482,0.00525909427130603,0.00286258518997941,-0.000351572701053612,0.0108697612436657,0.0662090833605282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1,Methionine aminopeptidase 1,42311,0.00522692976296365,0.00285120274698064,-0.000361427621118402,0.0108152871470457,0.0667900145153213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDK,Midkine,42638,0.00910101046773677,0.00497064926699311,-0.000641462095569723,0.0188434830310433,0.0671301213309115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK2,Protein AHNAK2,40223,0.00535305809554641,0.00295852331137922,-0.000445647594756861,0.0111517637858497,0.0704210289133907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.00884944221804118,0.00489106010704663,-0.000737035591770217,0.0184359200278526,0.0704303426248829
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA1,Annexin A1,40235,0.00734907823650901,0.00406503091524621,-0.000618382357373566,0.0153165388303916,0.0706527574402292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0112000271708221,0.00620062847372725,-0.000953204637683306,0.0233532589793275,0.070902240163896
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0155640269356101,0.00862760582481452,-0.0013460804810264,0.0324741343522465,0.0712620088002837
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2B,Sodium channel subunit beta-2,40182,-0.0051276131309705,0.00285118387249651,-0.0107159335210637,0.000460707259122665,0.0721386317936003
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39633,0.00962958578347976,0.00536137390832008,-0.000878707076827598,0.0201378786437871,0.072506863595572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.00964847695222603,0.0053761242643202,-0.0201856805102936,0.000888726605841571,0.072730681152811
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOBR,Apolipoprotein B receptor,40223,-0.00747842277150851,0.00417158382107796,-0.0156547270608213,0.000697881517804297,0.0730473631188902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP350,Centrosome-associated protein 350,40080,0.00667189047868262,0.00372471292148733,-0.000628546847432545,0.0139723278047978,0.0732810220304631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.00944903990891255,0.00528495230981845,-0.000909466618331614,0.0198075464361567,0.0738167057868001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00477047007040809,0.00267325587489121,-0.0100100515851949,0.000469111444378668,0.0743666757484734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41948,-0.00760802330489253,0.00427323705791993,-0.0159835679384156,0.000767521328630541,0.075036155744655
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00595837227023606,0.00335179677105745,-0.0125278939415087,0.000611149401036547,0.075481745569942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC2,Mucin-2,40527,0.0161321243878231,0.00909032679343022,-0.0016849161273001,0.0339491649029463,0.075982971400467
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D2,DCN1-like protein 2,40080,0.0139060774282335,0.00785199944644587,-0.00148384148680042,0.0292959963432674,0.0765847300234628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00324669745339513,0.00183398841740623,-0.000347919844721076,0.00684131475151134,0.0767051404767149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR1,Folate receptor alpha,42600,-0.00522634995493887,0.00296171042975498,-0.0110313023972586,0.000578602487380891,0.0776472111246068
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,0.00425734948977862,0.00242086358903765,-0.000487543144735174,0.00900224212429241,0.0786666422388974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR5,Proline-rich protein 5,40199,0.00818281987843846,0.00468660869162243,-0.0010029331571415,0.0173685729140184,0.0808388141439616
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX1,Neuronal pentraxin-1,42611,0.00680727791426081,0.00390910984911156,-0.000854577389997838,0.0144691332185195,0.0816384678421502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0157510870210328,0.00905284870155375,-0.00199249643401256,0.0334946704760782,0.081904149601346
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL14,C-C motif chemokine 14,42618,0.00680936119873705,0.0039304720771466,-0.000894364072470288,0.0145130864699444,0.0832157682226752
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,-0.00664067048812525,0.00383852437638536,-0.0141641782658405,0.000882837289590046,0.0836572979480205
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.00983233617217927,0.0056840854690837,-0.00130847134722477,0.0209731436915833,0.0836940527939792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00411307069607007,0.00238547951219048,-0.000562469147823265,0.00878861053996341,0.0846977896964233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0084076585522939,0.0048856077062986,-0.00116813255205135,0.0179834496566392,0.0852958462661723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMI,N-myc-interactor,40421,0.0120708636649498,0.00702788486641385,-0.00170379067322132,0.025845518003121,0.0859031862946565
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO6,Unconventional myosin-VI,40482,0.00609359925985922,0.00355360873858738,-0.000871473867772039,0.0130586723874905,0.0864160074865682
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGN,Mimecan,42611,-0.00738672010680686,0.00432325601706333,-0.015860301900251,0.00108686168663726,0.0875479884083797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.00990503464712117,0.00579959188558695,-0.00146216544862925,0.0212722347428716,0.0876860913229342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASS1,Argininosuccinate synthase,40116,0.0129705408352096,0.00760570759567585,-0.00193664605231503,0.0278777277227343,0.0881539907732539
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,42370,-0.00601800370760739,0.00353044111100341,-0.0129376682851741,0.000901660869959287,0.088291897617887
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALY,RNA-binding protein Raly,40451,0.00788481137581078,0.00462732317471798,-0.00118474204663645,0.016954364798258,0.0884146334068904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.00715867340332135,0.00420217635930509,-0.00107759226091663,0.0153949390675593,0.0884862849501942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLGAP5,Disks large-associated protein 5,40482,0.00845797563905093,0.00496760201187349,-0.00127852430422111,0.018194475582323,0.088665337771487
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.00645114391362909,0.00379070907973766,-0.000978645882656727,0.0138809337099149,0.0888103350810605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM1,Myomesin-1,40136,0.0080125714587142,0.00471403455532369,-0.00122693626972024,0.0172520791871486,0.0892107242527237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLGN,Calmegin,40182,0.00771866934595902,0.00454317694033227,-0.00118595745709222,0.0166232961490103,0.0893553002565286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00469447376936833,0.00277017596635471,-0.000735071124686892,0.0101240186634236,0.0901653372226512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR1B,Cornifin-B,40302,-0.0137587870984931,0.00813173506080938,-0.0296969878176795,0.00217941362069325,0.0906765678687783
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLMP,CXADR-like membrane protein,42721,-0.00361340137162796,0.00214163039163697,-0.00781099693923642,0.000584194195980496,0.0915841361425062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROS,Uroporphyrinogen-III synthase,40182,0.0111962754475666,0.00663699321894469,-0.00181223126156495,0.0242047821566982,0.0916413593579831
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRTN,Neurturin,42370,0.00810122896720227,0.00480337258794247,-0.00131338130516497,0.0175158392395695,0.0917095432669822
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI4,Protein-arginine deiminase type-4,42292,0.0118238617795421,0.0070125118688164,-0.00192066148333802,0.0255683850424223,0.0917985575931507
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3A,Uroplakin-3a,40136,0.00843914091332257,0.00500633208222249,-0.00137326996783351,0.0182515517944787,0.0918833823162731
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN2,Nectin-2,42613,-0.00518052483753851,0.00307561054216932,-0.0112087215001904,0.000847671825113352,0.0921297538156101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZPR1,Zinc finger protein ZPR1,40136,0.0160500603890972,0.0095492482621673,-0.00266646620475076,0.0347665869829451,0.0928367422776774
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42636,-0.012313983518453,0.00733942305541612,-0.0266992527070685,0.00207128567016265,0.0934120706949381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42594,-0.010155647864783,0.00606809562026031,-0.0220491152804932,0.00173781955092724,0.0942298873253131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.0100920189578829,0.00603448248268667,-0.0219196046239487,0.001735566708183,0.0944756797637479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALCAM,CD166 antigen,42794,0.00320405418522978,0.00191676328978932,-0.000552801862757292,0.00696091023321685,0.0946269850160687
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.00593638238603031,0.00356934971225152,-0.00105954304998267,0.0129323078220433,0.0963098559565777
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0121275975775818,0.00730449248816271,-0.0264444028543808,0.00218920769921707,0.0968842336729163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA11,Carbonic anhydrase-related protein 11,42346,0.0052579368120902,0.00316712218394311,-0.000949622668438294,0.0114654962926187,0.0969056480595473
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.00938402618846151,0.00566234221271806,-0.00171416454846589,0.0204822169253889,0.0974888389306529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",40116,-0.010056605743624,0.00607341230696334,-0.0219604938652722,0.00184728237802413,0.0977827287026801
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.00490645649414892,0.00296611590890892,-0.000907130687312551,0.0107200436756104,0.0981168092952323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1,Programmed cell death protein 1,42689,0.00724729461963617,0.00439253871805013,-0.00136208126774209,0.0158566705070144,0.0989845682452729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.013411859368584,0.00816331195447468,-0.00258823206218637,0.0294119507993544,0.100423216105229
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.0104730641436372,0.00637911875103924,-0.00203000860839971,0.0229761368956741,0.100665390413247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42676,-0.00453017087272834,0.00276041672148409,-0.00994058764683715,0.000880245901380476,0.100796150803147
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.00939022287634768,0.00575242846587572,-0.00188453691676873,0.0206649826694641,0.102625685134128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI3,Elafin,42446,0.00904842106455995,0.00554547532572107,-0.00182071057385334,0.0199175527029732,0.102771440989883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TK1,"Thymidine kinase, cytosolic",40302,0.00723985126254195,0.00444258227140885,-0.0014676099894194,0.0159473125145033,0.103203984669642
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.0102735572656436,0.00631446738409565,-0.00210279880718393,0.022649913338471,0.103768457021169
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA,Adenosine deaminase,42754,0.00548112785099274,0.00337513898890342,-0.00113414456725796,0.0120964002692434,0.104405240271173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCARE,Photoreceptor cilium actin regulator,40136,0.0133598326903586,0.00823295020298363,-0.00277674970748935,0.0294964150882065,0.104676530497409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100G,Protein S100-G,40482,0.00765015451201276,0.00471606792710197,-0.0015933386251071,0.0168936476491326,0.10479984589948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.00706449192224868,0.00435742007399583,-0.00147605142278314,0.0156050352672805,0.104990833610503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB44,Ras-related protein Rab-44,40451,0.00663680732502078,0.00409815130286986,-0.00139556922860415,0.0146691838786457,0.105375540196189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMH,Granzyme H,42357,0.0122643273555143,0.00757332844323992,-0.00257939639323597,0.0271080511042645,0.105382932374727
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD4,Sushi domain-containing protein 4,40451,-0.00662893372254554,0.00410341686782009,-0.0146716307834729,0.00141376333838184,0.106237668048515
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1B,Protein phosphatase 1B,40199,0.00966144833051554,0.00598187581680223,-0.00206302827041684,0.0213859249314479,0.106313338871043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH7B,Myosin-7B,40080,-0.00708740472733968,0.00439493320779033,-0.0157014738146087,0.00152666435992937,0.106853726408932
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYT1,Synaptotagmin-1,40483,0.00665985194096983,0.00414179836066654,-0.00145807284593659,0.0147777767278763,0.107871594784263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,40451,0.00923274832260113,0.00574846531269593,-0.00203424369028288,0.0204997403354851,0.108274707680447
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00835333238121211,0.00523443041070709,-0.0019061512237738,0.018612815986198,0.110552643391681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSG,Basigin,42746,0.00336389296006544,0.00211827437301764,-0.000787924811049137,0.00751571073118002,0.112301847947133
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYMP,Thymidine phosphorylase,42563,-0.0100410977930143,0.00633374538490008,-0.0224552387474185,0.00237304316138981,0.112914266896875
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00692240632851707,0.00437780251828827,-0.00165808660732793,0.0155028992643621,0.113848585987139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.0131178042686202,0.00830347141378481,-0.0293926082396385,0.003156999702398,0.114181900845018
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA3,Carbonic anhydrase 3,42770,-0.0091770900574452,0.00581237349311361,-0.0205693421039479,0.00221516198905746,0.114384916630883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00660773260933741,0.00419004089185341,-0.00160474753869527,0.0148202127573701,0.114822218829931
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00579694711306853,0.00369098828525116,-0.00143738992602375,0.0130312841521608,0.116310993818403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLN,Mesothelin,42553,0.0090886911839897,0.00581231246907908,-0.0023034412554053,0.0204808236233847,0.117912606638918
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN10,Ataxin-10,42311,0.0110089329783192,0.00704715870674791,-0.00280349808690673,0.0248213640435451,0.118269628469753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0090657852729176,0.0058053765143039,-0.00231275269511804,0.0204443232409532,0.118406783773556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD2,Leiomodin-2,40136,0.00953334369949305,0.00610974761233452,-0.0024417616206826,0.0215084490196687,0.118706151950633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.0100487713161174,0.00644260420430178,-0.00257873292431412,0.0226762755565488,0.118850416754558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.006245902064186,0.00400635019429707,-0.00160654431663626,0.0140983484450083,0.119024366673214
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC1,Plexin domain-containing protein 1,42346,-0.00478939986050711,0.00307487173452371,-0.0108161484601736,0.00123734873915936,0.119353729930934
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD248,Endosialin,40527,0.00618676585095829,0.00398475829534128,-0.00162336040791062,0.0139968921098272,0.120544841952097
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF1,Formylglycine-generating enzyme,40199,0.00973153084585346,0.00629205947868574,-0.00260090573237058,0.0220639674240775,0.121979600905778
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO1,Alpha-enolase,42588,0.0118240397375094,0.00766780691488994,-0.00320486181567491,0.0268529412906936,0.123088297454085
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.00956959940749724,0.00622956379377305,-0.00264034562829795,0.0217795444432924,0.124527536008694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GM2A,Ganglioside GM2 activator,40269,0.00612298629248307,0.0039985226668813,-0.00171411813460428,0.0139600907195704,0.12572082901927
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARTN,Artemin,42370,0.0066784261478391,0.00436494865688796,-0.00187687321966131,0.0152337255153395,0.126037633217964
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0069753361781405,0.0045656655135647,-0.00197336822844632,0.0159240405847273,0.126595063250022
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGA,Glycoprotein hormones alpha chain,42611,-0.00936348921123611,0.00614651967281861,-0.0214106677699606,0.00268368934748837,0.127687065172871
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.00765916211069612,0.00503105001962577,-0.0175200201491626,0.00220169592777039,0.127943179754599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.00970920665085409,0.00638592802056045,-0.0222256255711526,0.0028072122694444,0.128432247313938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00722548346269448,0.00476840720126074,-0.0165715615771655,0.00212059465177656,0.129729844238686
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSMB,Beta-microseminoprotein,42559,-0.0106853243264631,0.00705980011359519,-0.0245225325491097,0.00315188389618342,0.130164955827406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVR,Poliovirus receptor,42711,0.00539683246593179,0.00357851013292102,-0.0016170473945934,0.012410712326457,0.131546490228629
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4,Interleukin-4,42370,0.0137813429618128,0.0091451207097362,-0.00414309362927017,0.0317057795528957,0.131844551895476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP7,Retinoid-binding protein 7,40449,-0.00882694379318824,0.00586539729742276,-0.0203231224961368,0.00266923490976036,0.132373141029614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD70,CD70 antigen,42594,0.00635216398409541,0.00422421083831902,-0.00192728925900987,0.0146316172272007,0.13266889374406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA11,Integrin alpha-11,42594,0.00496535328063339,0.00331002152287098,-0.00152228890419374,0.0114529954654605,0.133612843372527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN1,Cerebellin-1,40136,0.013937962202515,0.00929495392123898,-0.00428014748311345,0.0321560718881433,0.133767832520714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOC,Brother of CDO,42357,-0.00341456782613277,0.00228700374639298,-0.00789709516906302,0.00106795951679747,0.135453001506757
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF23,Fibroblast growth factor 23,42711,0.00791306761123818,0.00530406689327438,-0.0024829034995796,0.018309038722056,0.13575214952572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL21R,Interleukin-21 receptor,40199,0.00818553833802968,0.00548712717162479,-0.00256923091835491,0.0189403075944143,0.135787797426462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00495828575283281,0.00332825252740016,-0.0114816607065371,0.00156508920087151,0.136317154507971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0125388066098447,0.00848221542119204,-0.00408633561569171,0.0291639488353811,0.13937070097751
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NINJ1,Ninjurin-1,42346,0.00777732452975786,0.00526298993316606,-0.00253813573924761,0.0180927847987633,0.13950164527597
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFRC,Transferrin receptor protein 1,42673,-0.00544839572087454,0.0036914843895939,-0.0126837051244786,0.00178691368272951,0.139984359348177
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0104137598672413,0.00708198036798077,-0.003466921654001,0.0242944413884836,0.141465427444136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP290,Centrosomal protein of 290 kDa,40302,0.00784502648973808,0.00533884553086856,-0.0026191107507643,0.0183091637302405,0.141746206029949
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO6,Coronin-6,40136,-0.00535388617050448,0.00364453894734757,-0.0124971825073057,0.00178941016629676,0.141857186888996
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PREB,Prolactin regulatory element-binding protein,42370,0.0042221658647532,0.0028767738850707,-0.00141631094998536,0.00986064267949176,0.1422167007639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.0073159713623551,0.00498570146678581,-0.00245600351254509,0.0170879462372553,0.142298456886204
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.00560054813869435,0.00382532675868572,-0.0130981885857184,0.00189709230832967,0.143203460895855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.00648437047281236,0.00443100509962306,-0.00220039952244882,0.0151691404680736,0.143383481493809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH23,Cadherin-23,40483,-0.00372767830871761,0.00255293305752096,-0.00873142710145869,0.00127607048402346,0.144275270562124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6,Seizure protein 6 homolog,40182,-0.00447446075486691,0.00307055095024941,-0.0104927406173558,0.00154381910762193,0.1450849120583
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBX2,Chromobox protein homolog 2,40116,0.00573288724897281,0.00393622721113351,-0.00198211808484887,0.0134478925827945,0.145299174339015
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CX3CL1,Fractalkine,42495,-0.00489001298411928,0.00336243176970232,-0.0114803792527358,0.00170035328449728,0.145884400603001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,40182,0.00597608000438077,0.00411305695507189,-0.00208551162756013,0.0140376716363217,0.146265254731205
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0102166241711991,0.00704938363840726,-0.00360016776007915,0.0240334161024773,0.147283483212275
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST2,Bone marrow stromal antigen 2,42711,-0.00718421547938496,0.00498463535616721,-0.0169541007774727,0.00258566981870278,0.149531013078486
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM2,Paralemmin-2,40483,0.00530387791567858,0.00368228222510166,-0.00191339524552067,0.0125211510768778,0.149788246435182
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42794,-0.00352093748978407,0.00244598851261172,-0.00831507497450304,0.00127319999493491,0.150039215027531
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD9,COMM domain-containing protein 9,40451,0.00558378484736262,0.00387999280968957,-0.00202100105962894,0.0131885707543542,0.150143629944589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,-0.00807018682225977,0.00560803402218897,-0.0190619335057501,0.00292155986123061,0.150162327186184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB7,Integrin beta-7,42721,0.00646139814944234,0.00449410072163323,-0.00234703926495879,0.0152698355638435,0.150527827378365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UMOD,Uromodulin,42764,0.0077330631825228,0.0053805175627079,-0.00281275124038469,0.0182788776054303,0.150674550328809
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,40199,0.014281110346568,0.00996181757398026,-0.00524405209843327,0.0338062727915694,0.151719190663445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.00501889036461294,0.00350325263965596,-0.00184748480911275,0.0118852655383386,0.151984770683601
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.00933396369568243,0.00652944520727473,-0.00346374891057605,0.0221316763019409,0.152879034012917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.0126349337249388,0.0088566630225968,-0.0299939932492285,0.00472412579935094,0.15372236297973
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0073074352453561,0.00516828868303949,-0.00282241057340129,0.0174372810641135,0.157419305572997
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKKL1,Dickkopf-like protein 1,42587,-0.0121192712347714,0.00857460997536394,-0.0289255067864847,0.00468696431694193,0.157564214005979
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTR,Methionine synthase,40116,0.00917939294304136,0.00650762391483357,-0.00357554993003245,0.0219343358161152,0.15840291991734
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNN,Tenascin-N,40527,-0.0060518460857784,0.00430914468405422,-0.0144977696665247,0.00239407749496787,0.160221423375027
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA4,Apolipoprotein A-IV,40539,-0.00495863865113139,0.00353216748547147,-0.0118816869226555,0.00196440962039269,0.160390444201284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.00372327946398827,0.00265433832194849,-0.00147922364703078,0.00892578257500732,0.160729316004162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUP50,Nuclear pore complex protein Nup50,40116,-0.00477376652319669,0.00340425332544075,-0.0114461030410606,0.00189856999466718,0.160855672094858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00469028635849632,0.00334896755260235,-0.00187369004460428,0.0112542627615969,0.161386010097071
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR1,Interferon gamma receptor 1,42676,0.00297777658700683,0.0021335772404691,-0.00120403480431261,0.00715958797832627,0.162835910897542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAGE2A,G antigen 2A,40080,0.00911547683390605,0.00653185897681023,-0.00368696676064199,0.0219179204284541,0.162881232457135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEBP1,Heme-binding protein 1,42357,0.00716132972522857,0.00514965217317436,-0.00293198853419317,0.0172546479846503,0.164357102851479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.0038346010967094,0.0027654874544772,-0.00925495650748472,0.00158575431406592,0.165593775512849
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN1,Contactin-1,42794,0.00375953107424876,0.00271492794688184,-0.00156172770163964,0.00908078985013716,0.166147742458833
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12B,Interleukin-12 subunit beta,42754,0.00760908964830863,0.0055262694615039,-0.00322239849623902,0.0184405777928563,0.168567619726149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00752257460463759,0.00547595029063597,-0.0182554371742841,0.00321028796500891,0.169548019524079
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00676336014169121,0.00492676906276662,-0.00289310722133137,0.0164198275047138,0.169849508347103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.00863752225125858,0.00630338269796681,-0.00371710783675636,0.0209921523392735,0.170621536793823
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,-0.00823911204684461,0.00603276568679796,-0.0200633327929686,0.0035851086992794,0.172047704245823
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUCL3,Mucin-like protein 3,40080,-0.0056936652095735,0.00417121771111812,-0.013869251923365,0.00248192150421802,0.172284798359306
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.0050573291945075,0.00370724957103818,-0.00220887996472734,0.0123235383537423,0.172541281584776
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0075210481282397,0.00552020935268821,-0.00329856220302919,0.0183406584595086,0.173081314157861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.011508339400287,0.00845295661960438,-0.00505945557413758,0.0280761343747116,0.173396836381433
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.00414147319246017,0.00304495145654824,-0.00182663166237437,0.0101095780472947,0.173822533811006
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANPEP,Aminopeptidase N,42666,0.00367872622084915,0.00270620046506602,-0.00162542669068024,0.00898287913237854,0.174052301623195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,42351,-0.0072921592911535,0.00536769053575169,-0.0178128327412268,0.00322851415891981,0.174319412329877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42592,0.00648947593617918,0.00478747521730738,-0.00289397548974327,0.0158729273621016,0.175277614386019
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42741,0.00691839762942444,0.00510718051344201,-0.0030916761769219,0.0169284714357708,0.175554460742714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR1,TGF-beta receptor type-1,40199,-0.00286741855235274,0.00211926822836198,-0.00702118427994222,0.00128634717523674,0.176076092253587
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.0198727228650281,0.014717926377349,-0.0487198585646322,0.00897441283457604,0.176962034709336
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",40116,0.00747080296752612,0.00553510692202117,-0.00337800659963537,0.0183196125346876,0.177136196297716
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.00946920363949183,0.00702830256331753,-0.00430626938461053,0.0232446766635942,0.177912882687835
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0149552439478705,0.0111257089977555,-0.00685114568773017,0.0367616335834712,0.178904949347414
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00739834687305474,0.00550389314536324,-0.0033892836918572,0.0181859774379667,0.178910784368184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA7A,Semaphorin-7A,42760,0.00372498237079604,0.002774760991419,-0.00171354917238519,0.00916351391397727,0.179472072530225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,-0.0036805292217676,0.0027597482381368,-0.00908963576851573,0.00172857732498053,0.182342410794552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9orf40,Uncharacterized protein C9orf40,40449,0.010586022660142,0.00794300558519322,-0.00498226828683669,0.0261543136071207,0.182641583237801
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.00583891232027703,0.00438473342296428,-0.00275516518873295,0.014432989829287,0.183004361757865
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00479342852370699,0.00360165939676072,-0.011852680941358,0.00226582389394402,0.183251615543446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD3,Extracellular superoxide dismutase,40532,-0.00759652274909519,0.00571579296203089,-0.0187994769546757,0.00360643145648535,0.183861212980718
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,40451,0.00683727993029363,0.00515150205449009,-0.00325966409650695,0.0169342239570942,0.184456199812971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,40451,0.00690975228801981,0.00524853069264382,-0.00337736786956208,0.0171968724456017,0.188029142804117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD177,CD177 antigen,42595,-0.0169035009288442,0.0128564133154772,-0.0421020710271795,0.00829506916949109,0.188602536849325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK15,Kallikrein-15,40429,0.0068359918366739,0.00521868746180232,-0.00339263558845864,0.0170646192618064,0.190254301720008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAEP,Glycodelin,42495,-0.01148516134262,0.00880025444015183,-0.0287336600453176,0.00576333736007759,0.191883337913341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLFM4,Olfactomedin-4,39870,-0.0156743708612588,0.0120840670942883,-0.0393591423660639,0.00801040064354629,0.194621183855697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN4,Alpha-actinin-4,42370,0.00414156997235333,0.00319662216090767,-0.00212380946302571,0.0104069494077324,0.19513318994991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42495,-0.00460133950641777,0.00355741134361817,-0.0115738657399094,0.00237118672707384,0.195877364567973
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-0.00254188843171216,0.00197114453085017,-0.0064053317121785,0.00132155484875418,0.19722919536217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300C,CMRF35-like molecule 6,42711,0.00450675440687494,0.0035035385572871,-0.00236018116540778,0.0113736899791577,0.198345203721165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH2,Growth hormone variant,42346,0.0208838129355824,0.0162696180696842,-0.0110046384809987,0.0527722643521634,0.19930174177715
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00462884986250534,0.00360773487492649,-0.00244231049235058,0.0117000102173613,0.199506899907344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHD,SH2 domain-containing adapter protein D,40083,-0.0110586790528695,0.00862079289946207,-0.0279554331358152,0.00583807503007616,0.199592469476319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRP15,RRP15-like protein,40136,-0.0115382826721432,0.00899539068869517,-0.0291692484219858,0.00609268307769929,0.199628460052424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00507018754389366,0.00396732319022864,-0.00270576590895447,0.0128461409967418,0.201280708009239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFL4,Insulin growth factor-like family member 4,40199,0.00919736524079565,0.00721863277971666,-0.004951155007449,0.0233458854890403,0.202649718812097
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0104779868944674,0.00822765729573657,-0.00564822140517631,0.026604195194111,0.202864795823417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,40482,0.00939279768172688,0.00737802791085924,-0.00506813702355723,0.023853732387011,0.203016935163895
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC13,Mucin-13,42311,0.00646951298829264,0.00508748155056452,-0.00350195085081382,0.0164409768273991,0.203518856516439
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL25,C-C motif chemokine 25,42754,-0.00590816864007296,0.00466937599679629,-0.0150601455937937,0.00324380831364778,0.20578499643596
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00361848717675187,0.0028606003302612,-0.00198828947056007,0.00922526382406381,0.205916024368318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENND2B,DENN domain-containing protein 2B,40116,-0.00619003545366541,0.00489849351130883,-0.0157910827358307,0.0034110118284999,0.206378681755796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRC1,Macrophage mannose receptor 1,40532,-0.00361070099421817,0.0028574143050022,-0.00921123303202249,0.00198983104358614,0.206390530884286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2,Apoptosis regulator Bcl-2,40449,0.00706362603232676,0.00559095581966617,-0.00389464737421892,0.0180218994388724,0.206470833741882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAPPA,Pappalysin-1,42370,0.00573096952479206,0.00456183547018922,-0.00321022799677882,0.0146721670463629,0.209034610000717
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.00415669525275487,0.00331051090125974,-0.00233190611371422,0.010645296619224,0.20928507219827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CADPS,Calcium-dependent secretion activator 1,40182,0.00526311641254557,0.00419208316905264,-0.00295336659879762,0.0134795994238887,0.209327814158882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00718258788078805,0.00572737228738533,-0.0184082375640633,0.0040430618024872,0.209839412122858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCP11,T-complex protein 11 homolog,40302,0.00724439224864742,0.0057960259678343,-0.0041158186483078,0.0186046031456026,0.211366232191579
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD5,Sushi domain-containing protein 5,40235,0.00425558482807131,0.0034051250604272,-0.00241846029036601,0.0109296299465086,0.211414180320513
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,42311,0.00686075550546128,0.00549177567069116,-0.00390312480909339,0.017624635820016,0.21158563865846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0147605715733436,0.011822140664776,-0.00841082412961728,0.0379319672763045,0.211855251278661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0107095344195856,0.00859111679729037,-0.00612905450310356,0.0275481233422747,0.212577542416459
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,40449,0.00621372750935222,0.00499353617875457,-0.00357360340100673,0.0160010584197112,0.213395158805304
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB2,Lamin-B2,40483,-0.00348341589188145,0.00280061208437287,-0.00897261557725228,0.00200578379348938,0.213597090281545
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK4,Dickkopf-related protein 4,42477,0.00562378289755346,0.0045257195246141,-0.00324662737069019,0.0144941931657971,0.214027119269103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.00457742349428287,0.00370622616583524,-0.00268677979075421,0.0118416267793199,0.21683275249979
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00445347603904042,0.00360706547952863,-0.00261637230083569,0.0115233243789165,0.216985603409302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42587,-0.00545834524937805,0.00443900190303474,-0.0141587889793261,0.00324209848057004,0.218855996410485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.00381762153994358,0.00310695572007629,-0.00990725475129312,0.00227201167140595,0.219193610385
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHP1,Calcineurin B homologous protein 1,40136,0.00891916553480012,0.00725991023251661,-0.00531025852093243,0.0231485895905327,0.219266848867574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLI2,Zinc finger protein GLI2,40199,-0.00386576755447282,0.00314712453274676,-0.0100341316386565,0.00230259652971082,0.219342218902048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.00768494959920837,0.00627221919289141,-0.00460860001885879,0.0199784992172755,0.220512772126646
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00456083931150097,0.00373244666457971,-0.00275475615107526,0.0118764347740772,0.22175488615916
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5A,Cytochrome b5,40080,0.00872152495615955,0.00716199145786779,-0.00531597830126131,0.0227590282135804,0.22334486120448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT1,Diamine acetyltransferase 1,40116,-0.00613581480779658,0.00503920890794416,-0.0160126642673671,0.00374103465177397,0.223396733447284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGBL1,Integrin beta-like protein 1,40527,-0.00462958213144803,0.00380251327962608,-0.0120825081595151,0.00282334389661909,0.22343716478991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTOA,Otoancorin,40136,-0.00650829583290539,0.0053522471827308,-0.0169987003110577,0.00398210864524697,0.224013769223562
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,40482,0.00385070575860458,0.00317904328569732,-0.00238021908136217,0.0100816305985713,0.225814166560381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D1,DCN1-like protein 1,40136,-0.0088797733499206,0.00734024992953928,-0.0232666632118176,0.00550711651197638,0.226405888099616
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.00749028638160139,0.0062055720088252,-0.004672634755696,0.0196532075188988,0.227448137814873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42495,-0.00277745551272195,0.00230410725317339,-0.0072935057289418,0.0017385947034979,0.22805619351905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSTN,Osteocrin,40182,-0.00489981336982255,0.00409447998528912,-0.0129249941409892,0.00312536740134412,0.231454166323523
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNW1,Interferon omega-1,40116,-0.00431887856301467,0.00361496588229456,-0.011404211692312,0.00276645456628266,0.232221683349712
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.00832180841032635,0.00697587947008406,-0.00535091535103841,0.0219945321716911,0.23291847587697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.00563013758149932,0.00473076329320776,-0.00364215847318788,0.0149024336361865,0.23402813513341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL20,C-C motif chemokine 20,42754,0.0106017419316596,0.00893043192254393,-0.00690190463652654,0.0281053884998456,0.235190152679308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAFB2,Scaffold attachment factor B2,40482,0.00317850297207152,0.00268505144687036,-0.00208419786379439,0.00844120380793742,0.236526154901947
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB2,Lysosome membrane protein 2,42302,0.00403932237205193,0.00341461904087238,-0.00265333094805793,0.0107319756921618,0.236850560849872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.00673812964939088,0.00571788055610962,-0.00446891624058397,0.0179451755393657,0.238645770868938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR2,Toll-like receptor 2,40302,0.00269163522507136,0.00229272467264205,-0.00180210513330705,0.00718537558344977,0.240424307620645
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00371535902187205,0.00317567728464768,-0.00250896845603741,0.0099396864997815,0.242049692647217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.00594628751792096,0.00509624309234769,-0.00404234894308052,0.0159349239789224,0.243316570741042
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.00563675409066132,0.00483256313374748,-0.00383506965148374,0.0151085778328064,0.243473014487982
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42565,-0.00296183268382727,0.00255070505937487,-0.00796121460020202,0.00203754923254747,0.245588641193244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPO,Myeloperoxidase,42611,0.00524499778853217,0.00453181189309391,-0.00363735352193191,0.0141273490989962,0.247140508125802
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMPD3,AMP deaminase 3,40483,0.0079928315508032,0.00691484429112236,-0.00556026325979663,0.021545926361403,0.247748711621136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.0045884275489136,0.00397941276633089,-0.00321122147309495,0.0123880765709221,0.248918591771364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAX,Integrin alpha-X,40302,0.00614042183670622,0.005328960160403,-0.00430434007768366,0.0165851837510961,0.249233326153686
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAVL4,ELAV-like protein 4,40136,0.00958101662689114,0.00831893211529949,-0.00672409031909585,0.0258861235728781,0.249464470728226
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53BP1,TP53-binding protein 1,40199,-0.00979204251136757,0.00851263016267306,-0.0264767976302068,0.00689271260747164,0.250047064982332
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB1,Calbindin,42587,0.00510793288889927,0.00444833081988854,-0.00361079551808226,0.0138266612958808,0.250873169834328
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0108414860410887,0.0094467452497464,-0.00767413464841428,0.0293571067305916,0.251140579188226
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSHB,Follitropin subunit beta,40223,0.006077586999981,0.00530164351130978,-0.00431363428218617,0.0164688082821482,0.251671490985353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00791066975071973,0.00690317794257111,-0.00561955901671965,0.0214408985181591,0.251842146422508
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00352960621964935,0.00308899599994596,-0.00252482594024472,0.00958403837954342,0.253209434030859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,-0.00335523332397226,0.00294303071042466,-0.0091235735164046,0.00241310686846008,0.254281479425512
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,-0.00412661147368379,0.00362147107111909,-0.0112246947730772,0.00297147182570963,0.254525724533131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHH,Sonic hedgehog protein,40199,-0.00470439015260158,0.0041424751319419,-0.0128236414112077,0.00341486110600454,0.256128991097881
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00541261688653094,0.00476951332844621,-0.0147608630102855,0.00393562923722363,0.256468815577289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00726335532741076,0.00641054538901027,-0.00530131363504936,0.0198280242898709,0.257221376312681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS8,Regulator of G-protein signaling 8,42370,0.00713185783831326,0.00629574169390614,-0.00520779588174277,0.0194715115583693,0.257316085920601
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00701494443723562,0.0062052393559807,-0.0191772135749578,0.00514732470048656,0.258295344949238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OBP2B,Odorant-binding protein 2b,42462,0.0067513315474613,0.00599899129058519,-0.00500669138208567,0.0185093544770083,0.260435215301802
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBN,Ameloblastin,42370,-0.0031301392750869,0.00279721288925286,-0.00861267653802251,0.00235239798784871,0.263151684925033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GL3,Endophilin-A3,40250,0.00932042375548374,0.00835474759520928,-0.00705488153112644,0.0256957290420939,0.264624438756337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,40136,0.00665903149770493,0.00597501843070202,-0.00505200462647103,0.0183700676218809,0.265098303598857
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,-0.00364261747591639,0.00327045598979285,-0.0100527112159104,0.0027674762640776,0.265387486831951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCLN,Nicalin,42370,-0.0056368944402275,0.00506213101567404,-0.0155586712309486,0.00428488235049361,0.265496123312661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD80,T-lymphocyte activation antigen CD80,40511,-0.00379600701179372,0.00340931184931215,-0.0104782582364455,0.00288624421285809,0.265550350463807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42676,0.00313733603383101,0.00282161873458426,-0.00239303668595415,0.00866770875361617,0.266204303375265
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42721,0.00652873396858168,0.00587705858402277,-0.00499030085610295,0.0180477687932663,0.266637763310147
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCL2,Phosducin-like protein 2,40080,0.00575565449509719,0.00519845001413875,-0.00443330753261475,0.0159446165228091,0.268237699010237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,40302,0.00585022507406354,0.00531620996409623,-0.00456954645556506,0.0162699966036921,0.27115980112731
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM2,Junctional adhesion molecule B,42711,-0.0030328070309887,0.00277236589522155,-0.00846664418562294,0.00240103012364555,0.273999983489001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,-0.00731243761427865,0.00669946961608296,-0.0204433980618012,0.00581852283324395,0.275079024524799
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2,Interleukin-2,42370,-0.00341628516223273,0.00313257536009384,-0.00955613286801666,0.0027235625435512,0.275483140016514
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,-0.00396135461513175,0.00363925981117077,-0.0110943038450265,0.00317159461476296,0.276395589751985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6B,Ras-related protein Rab-6B,42311,0.00523805108573468,0.00481254689247917,-0.00419454082352448,0.0146706429949938,0.276431677195209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.00302314153241756,0.00277776359145581,-0.00242127510683583,0.00846755817167095,0.276469754668968
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB5,Serpin B5,42357,0.00513526768311133,0.00475294606948903,-0.00418050661308716,0.0144510419793098,0.279966589524049
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP12,Macrophage metalloelastase,42592,0.00588906446419141,0.00546863182372547,-0.00482945391031052,0.0166075828386933,0.281552923441648
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STEAP4,Metalloreductase STEAP4,40136,0.00768038279310204,0.00713310165388743,-0.00630049644851732,0.0216612620347214,0.281627259781033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_A,,40482,-0.00348753348531547,0.00324362807619007,-0.00984504451464801,0.00286997754401708,0.282310304548557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN7,Tetraspanin-7,40136,-0.00991760994630598,0.00923235168935762,-0.0280130192574469,0.00817779936483496,0.282746171224288
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST7,Cystatin-F,42642,-0.00979799960462158,0.00912602655109146,-0.0276850116447608,0.00808901243551768,0.283006644976098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MKI67,Proliferation marker protein Ki-67,40199,0.00407180994262758,0.00379688823204984,-0.00337009099219011,0.0115137108774453,0.283560730733248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSF,Cathepsin F,42679,-0.00413415141648537,0.00385802648745906,-0.0116958833319051,0.00342758049893439,0.283931695600758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP3,"Fatty acid-binding protein, heart",40511,-0.00549262676960714,0.00513089719166494,-0.0155491852652704,0.00456393172605614,0.284417022670253
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBS,Cystathionine beta-synthase,40223,-0.00536200944396495,0.00502260292850687,-0.0152063111838384,0.00448229229590851,0.285735262238214
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G15,Phospholipase A2 group XV,42679,0.0027602781203041,0.0025888240521174,-0.00231381702184601,0.0078343732624542,0.286339427218882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP1,Caspase-1,42311,0.00718698363209749,0.00674676143785332,-0.00603666878609502,0.02041063605029,0.286782687867426
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,-0.00291502234723672,0.00275258194140332,-0.00831008295238722,0.00248003825791379,0.289612453571458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42587,0.0024480894300244,0.00231551448732465,-0.00209031896513191,0.00698649782518071,0.290414262116438
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.00623265001075371,0.00590505096803175,-0.00534124988658852,0.0178065499080959,0.291225912940957
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0177587179979392,0.0168291897019978,-0.0152264938179766,0.0507439298138549,0.291337997866788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00693423885338545,0.00660565134388378,-0.00601283778062677,0.0198813154873977,0.293859194669676
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00620353845243941,0.00593116718844009,-0.00542154923690317,0.017828626141782,0.295620134388581
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.004911570882721,0.00470000447492495,-0.0141235796535739,0.0043004378881319,0.29603958647748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNIP4,Kv channel-interacting protein 4,42311,0.00502710604997892,0.00481702947711481,-0.0044142717251661,0.0144684838251239,0.296684528494477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPEP,Aspartyl aminopeptidase,40483,-0.00579140251429041,0.00557961405126449,-0.0167274460547688,0.00514464102618799,0.299312050994226
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,-0.00384639506380519,0.00371390148352991,-0.0111256419715238,0.00343285184391343,0.300375955202067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00497320143155967,0.00480196263980896,-0.00443864534246589,0.0143850482055852,0.300383467743924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOC,Myocilin,42611,-0.00450058384329828,0.00436013727004221,-0.013046452892581,0.00404528520598445,0.301991653111975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,40302,0.00804582244122613,0.00782306671796854,-0.00728738832599222,0.0233790332084445,0.303749205560359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.00679298833481659,0.00660809186549751,-0.00615887172155853,0.0197448483911917,0.303981472728559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESPL1,Separin,40080,0.00578677420586528,0.00563638017938706,-0.00526053094573337,0.0168340793574639,0.304592694675848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN2,Contactin-2,42721,0.00442130931439995,0.0043491611943042,-0.00410304662643627,0.0129456652552362,0.309367183683943
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEB,Nebulin,40116,-0.00382702096711377,0.00376584805062909,-0.0112080831463468,0.00355404121211925,0.309535658414381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM2,Isthmin-2,40527,0.00430686702658419,0.00423838482079803,-0.00400036722217994,0.0126141012753483,0.309576027327433
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00393268957060739,0.00387917831564299,-0.0115358790692676,0.00367049992805287,0.310703068427106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA1,Laminin subunit alpha-1,40116,-0.00535705769288437,0.00528762837921275,-0.0157208093161414,0.00500669393037261,0.311020264655631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.00554705563770622,0.00548907689915794,-0.00521153508464335,0.0163056463600558,0.312247564210967
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00387580538199168,0.00384085775416938,-0.0114038865801637,0.00365227581618031,0.312949554166667
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00310627498037562,0.00310036325925875,-0.00297043700777153,0.00918298696852276,0.316410771674621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.00702088208375992,0.00701839649847765,-0.00673517505325627,0.0207769392207761,0.317161177615584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00309013011744403,0.00309083823922392,-0.00914817306632291,0.00296791283143485,0.317443615326097
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42794,-0.003695085079294,0.00370154527225267,-0.0109501138129092,0.00355994365432123,0.318173613562872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLINT1,Clathrin interactor 1,40080,0.00451425784860848,0.0045263156156492,-0.00435732075806396,0.0133858364552809,0.318623576812319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.00648129543726786,0.00650271253591302,-0.00626402113312166,0.0192266120076574,0.318925607511085
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA3,GDNF family receptor alpha-3,42474,0.00280182387228668,0.00281169999359313,-0.00270910811515585,0.00831275585972922,0.3190314981137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD48,CD48 antigen,42654,-0.00300938441389822,0.00302106850132938,-0.00893067867650379,0.00291190984870736,0.319203694614371
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLLT1,Protein ENL,40080,0.00647825450695864,0.00650494551561626,-0.00627143870364924,0.0192279477175665,0.319322419827122
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10,Interleukin-10,42370,-0.00824280391850021,0.00829299692900778,-0.0244970778993555,0.00801147006235504,0.32026665941221
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC2,MAM domain-containing protein 2,40511,-0.00354087206482637,0.00357236461285738,-0.0105427067060268,0.00346096257637409,0.321616739403871
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00821341928964229,0.00828764773732015,-0.0244572088547898,0.0080303702755052,0.321686374748088
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,-0.00326890818175315,0.00330061368294555,-0.00973811100032642,0.00320029463682013,0.322003488400501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,-0.00264735296322246,0.00268520883174336,-0.00791036227343945,0.00261565634699454,0.324198706874032
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42594,0.004600352454872,0.00467970402769914,-0.00457186743941831,0.0137725723491623,0.325603796314327
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSG1,Tryptase gamma,40199,0.00256115287355694,0.00260733991665091,-0.00254923336307886,0.00767153911019273,0.325980681519966
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13,Interleukin-13,42370,-0.00454836015666219,0.00463615949925938,-0.0136352327752106,0.0045385124618862,0.326580155104187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOP56,Nucleolar protein 56,40116,0.0107101684471947,0.010974037639389,-0.0107989453260077,0.0322192822203971,0.329108310119632
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.00352609016099643,0.00361521632163881,-0.00355973382941564,0.0106119141514085,0.329409013888704
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00462669786187367,0.00474662897477672,-0.0139300906524361,0.0046766949286887,0.329714101520941
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00767573137018324,0.00788921332616585,-0.0231385894894683,0.00778712674910182,0.330604299231806
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC8,Histone deacetylase 8,40199,0.00563259824469441,0.00579617705651111,-0.00572790878606737,0.0169931052754562,0.331182283771925
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00437996726106082,0.00451078165716319,-0.0132210993091007,0.00446116478697902,0.331569842703312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.0104921948746453,0.0108105297148242,-0.0106964433664101,0.0316808331157007,0.331792282283239
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00450184096461236,0.00464395366256039,-0.0136039901432307,0.004600308214006,0.332363826054942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPN1,Epsin-1,40302,0.00421249597999502,0.00435814947814223,-0.00432947699716375,0.0127544689571538,0.333775555411348
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300E,CMRF35-like molecule 2,42677,-0.0040732055020479,0.00421492811255018,-0.0123344646026463,0.00418805359855045,0.333873386135319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGR1,Prostaglandin reductase 1,40511,-0.00787790841329299,0.0081870935022941,-0.0239246116777894,0.00816879485120345,0.335952099842328
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.00332663312908485,0.00345989104834091,-0.00345475332566334,0.010108019583833,0.336325594150485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTLA,B- and T-lymphocyte attenuator,40080,0.0082753867523078,0.0086295054858886,-0.00863844400003385,0.0251892175046494,0.337598082158377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXOSC10,Exosome component 10,40116,0.00567432908550265,0.00592318457483383,-0.00593511268117166,0.017283770852177,0.338090921805951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,-0.00806670153977889,0.00846552948422912,-0.024659139328868,0.00852573624931019,0.340664003625394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00406307577048833,0.00426723503628379,-0.0124268564416046,0.0043007049006279,0.341038506783697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGM2,Phosphoglucomutase-2,40182,0.00556306318763799,0.00585209598574358,-0.00590704494441942,0.0170331713196954,0.341823105702039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESR1,Estrogen receptor,40199,-0.00515519020098364,0.00542390524721384,-0.0157860444855228,0.00547566408355548,0.341900825770359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00590800334053063,0.00623145417321946,-0.00630564683897952,0.0181216535200408,0.343102306939737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF3,Fibroblast growth factor 3,40199,0.00269956981463472,0.00285334416043656,-0.00289298473982094,0.00829212436909038,0.344114619694266
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00470948600810635,0.00499196135227235,-0.0144937302585602,0.00507475824234746,0.345490074992735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00306353917101023,0.00324756354177911,-0.00330168537087683,0.0094287637128973,0.345527078498379
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.00686086601184583,0.00740643488796698,-0.00765574636856946,0.0213774783922611,0.354290508449023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNL1,Thioredoxin-like protein 1,40124,0.00891070290714382,0.00965343405307478,-0.0100100278368827,0.0278314336511704,0.355996094307305
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN3,CCN family member 3,42779,-0.00318978574156292,0.00346119673429654,-0.00997373134078415,0.00359415985765831,0.356761639804359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABO,Histo-blood group ABO system transferase,40532,0.0130130454829927,0.0142165110326761,-0.0148513161410524,0.0408774071070378,0.360028783682393
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTKN2,Rhotekin-2,40116,-0.0046284285306608,0.00506077760865193,-0.0145475526436186,0.00529069558229698,0.360438314245738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.00556911004533078,0.00609057578158001,-0.0175066385772276,0.00636841848656603,0.360536432851238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG2,"Arginase-2, mitochondrial",40451,-0.00380737368694422,0.00417726983773437,-0.0119948225689036,0.00438007519501515,0.362077698258672
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRV1,Acrosomal protein SP-10,40199,0.00716280859161456,0.00786071088980655,-0.00824418475240627,0.0225698019356354,0.36220132889175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC2,Plexin domain-containing protein 2,40483,-0.00241081074800658,0.00266834091952186,-0.00764075895026942,0.00281913745425626,0.366286879128366
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00244473434496143,0.00270657461962668,-0.00286015190950687,0.00774962059942973,0.366405674128061
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,40136,0.00985151094688859,0.0109714127665015,-0.0116524580754544,0.0313554799692316,0.369245042572373
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,40182,0.00317417715924981,0.00354333513595902,-0.00377075970722987,0.0101191140257295,0.370370538665357
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00256586642022199,0.00287430317884404,-0.00306776781031234,0.00819950065075632,0.372041847422998
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00608306035806842,0.00682134506793515,-0.0194528966912213,0.00728677597508448,0.372536697934084
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00484224390040447,0.00544100808792331,-0.0155066197527342,0.00582213195192522,0.373510550233981
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.00231510886108489,0.00260610006505158,-0.00279284726641621,0.00742306498858599,0.374372754127872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,-0.00236443372492559,0.00266519214345316,-0.00758821032609379,0.00285934287624261,0.375015245427904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PITHD1,PITH domain-containing protein 1,40065,-0.00696380689544908,0.00791097609475004,-0.0224693200411592,0.00854170625026101,0.378731700157266
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.0038411840117184,0.00436877869109926,-0.012403990246273,0.00472162222283616,0.379293069706771
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI2,Protein-arginine deiminase type-2,42370,-0.00476926145774815,0.00543792622022856,-0.0154275968493961,0.00588907393389983,0.380482635712462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDM3A,Lysine-specific demethylase 3A,40199,-0.00751724647050549,0.00859373528094023,-0.0243609676211483,0.00932647468013736,0.381736856374301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCN,Decorin,42357,-0.0020505588047683,0.00234707501789586,-0.00665082583984419,0.0025497082303076,0.382316304707248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYDC1,Pyrin domain-containing protein 1,40223,-0.00365950913706997,0.00419113707006147,-0.0118741377943904,0.0045551195202505,0.382598018409776
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00294194508032368,0.00337211271723953,-0.00366739584546579,0.00955128600611315,0.382990962261827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00387577813323399,0.00445375515823038,-0.00485358197689755,0.0126051382433655,0.384192270607781
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM132A,Transmembrane protein 132A,40223,0.00533207937364876,0.00613684131044899,-0.00669612959483127,0.0173602883421288,0.384940528353425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL24,Interleukin-24,42370,0.00424603627652644,0.00493492831708935,-0.00542642322496868,0.0139184957780216,0.389581566557354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGEA3,Melanoma-associated antigen 3,40302,-0.00722722221285294,0.00850079791829217,-0.0238887861327056,0.00943434170699972,0.395242438746329
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELB,Transcription factor RelB,40199,-0.0041325830592186,0.00487256773342745,-0.0136828158167364,0.00541764969829919,0.396382629064028
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,40449,0.00385217080971826,0.00455400002503816,-0.00507366923935654,0.012778010858793,0.39763359794442
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.010403784415832,0.0123736967977889,-0.0138486613078343,0.0346562301394983,0.400476171639534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC1,Syndecan-1,42636,-0.00332407856262485,0.00396752948750978,-0.011100436358144,0.00445227923289432,0.402146274970748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX2,Peroxiredoxin-2,40333,0.00512107958918691,0.00611285998324384,-0.00686012597797101,0.0171022851563448,0.402186238608487
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00572815128620671,0.00683892409402905,-0.00767613993809022,0.0191324425105036,0.402284219038657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.00446145612107124,0.00533483227717116,-0.0149177273843267,0.00599481514218424,0.403010935631204
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42721,0.00476349247502638,0.00570406795176258,-0.00641648071042827,0.015943465660481,0.403673655609882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00641665533078271,0.00769062252622893,-0.008656964820626,0.0214902754821914,0.40410306308301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD33,Myeloid cell surface antigen CD33,42679,0.00648012948602896,0.00781534906251079,-0.00883795467649218,0.0217982136485501,0.407031834621377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.00404469511100119,0.00489150890961942,-0.0136320525738553,0.00554266235185287,0.408322120482323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDSN,Corneodesmosin,42710,0.003588196586914,0.00434355807019696,-0.00492517723067204,0.0121015704045,0.40876413466128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.0115365093185034,0.0140419233316442,-0.0390586790485261,0.0159856604115192,0.411336159928378
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO1,Amphoterin-induced protein 1,40182,0.00406559621856681,0.00494906165236488,-0.00563456462006836,0.013765757057202,0.411386011925819
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00382692095913514,0.00471016741000449,-0.00540500716447367,0.013058849082744,0.416533462149074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1,DNA topoisomerase 1,40449,0.00889412297656203,0.0109717386765518,-0.0126104848294794,0.0303987307826035,0.417589959473717
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPH,Hephaestin,40511,-0.00207709467885842,0.00258842005182985,-0.00715039798044492,0.00299620862272808,0.42230575128011
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC44A4,Choline transporter-like protein 4,40182,-0.00559677564750616,0.00697996880606181,-0.0192775145073873,0.00808396321237499,0.422666382889582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA1,Apolipoprotein A-I,40539,0.00216505614341937,0.00270120367379814,-0.00312930305722498,0.00745941534406372,0.422850161765308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.00546382525152202,0.00690923880983324,-0.0190059333187952,0.00807828281575113,0.429077390060054
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFD,Vascular endothelial growth factor D,42734,-0.00278122700331151,0.003517810417338,-0.009676135421294,0.00411368141467098,0.429183646431847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00372713984650887,0.00474099887757654,-0.00556521795354114,0.0130194976465589,0.431793324093292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00174488533783336,0.0022195847597378,-0.00260550079125272,0.00609527146691945,0.431804190122888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.00298150991342545,0.00379340741296331,-0.00445356861598264,0.0104165884428336,0.431898349139664
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERVV_1,,40116,0.00335647159868388,0.00427999067626657,-0.0050323101267986,0.0117452533241664,0.432925666220726
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.00226474863640375,0.0028944076172093,-0.00793778756613397,0.00340829029332648,0.433962593456605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.00634407724269082,0.00811176967023002,-0.00955499131096001,0.0222431457963417,0.43417961377824
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42600,-0.00365576222100731,0.00469048556612078,-0.012849113930604,0.00553758948858942,0.435758162069075
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00362491630812995,0.00466634263556428,-0.00552111525757604,0.0127709478738359,0.437280784127482
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGN,Cingulin,40182,-0.00312710594968551,0.00403361609127611,-0.0110329934885867,0.00477878158921566,0.438202029855374
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,-0.00301433343161374,0.00390166847270416,-0.0106616036381139,0.00463293677488642,0.43978711995391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH15,Cadherin-15,42692,-0.00469266843179814,0.00608119785447301,-0.0166118162265652,0.00722647936296895,0.440324339278251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN1,Transcobalamin-1,40337,0.00257145773782055,0.0033403699541448,-0.00397566737230325,0.00911858284794435,0.441427585682498
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS2,Podocin,40199,-0.00791583036964305,0.0103011181371552,-0.0281060219184671,0.012274361179181,0.442240056206297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOS,Proto-oncogene c-Fos,40065,-0.0026870466506883,0.00350140573815613,-0.00954980189747433,0.00417570859609772,0.442848871450108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG2,Secretogranin-2,42636,-0.0025499438577672,0.00333502735710858,-0.00908659747770002,0.00398670976216561,0.444526416660248
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD2,Bromodomain-containing protein 2,40136,0.00267732067976833,0.00350285596841769,-0.00418827701833034,0.00954291837786701,0.44469002302792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.00464118365682454,0.00607536315900267,-0.0072665281348207,0.0165488954484698,0.44491956346342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,-0.00291808338714427,0.00382870689533872,-0.0104223489020082,0.00458618212771963,0.445981575980425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00221980899710292,0.00293925402690207,-0.00354112889562514,0.00798074688983099,0.450127465928163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.00191224361735435,0.00253666420910816,-0.00305961823249764,0.00688410546720633,0.450960447250729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2B,Alpha-amylase 2B,41779,-0.00366269006193594,0.00489266095215499,-0.0132523055281597,0.00592692540428784,0.454106891296396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00262099174992788,0.003506204862735,-0.00425116978103273,0.00949315328088849,0.454757088626451
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.0056741547691474,0.0075916796978838,-0.00920553743870485,0.0205538469769996,0.454824895888105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYY,Peptide YY,40116,0.00745624099900302,0.0100272377248901,-0.0121971449417817,0.0271096269397877,0.457135281547731
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORN4,MORN repeat-containing protein 4,40080,-0.00560152997132808,0.00753430075603404,-0.0203687594531548,0.00916569951049865,0.457212950753314
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.00560968137618697,0.00761510199347149,-0.00931591853101716,0.0205352812833911,0.461349777408943
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00351282259650237,0.00480082087284751,-0.00589678631427876,0.0129224315072835,0.464359397434963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42713,-0.00206121239051432,0.00282120311236098,-0.00759077049074184,0.00346834570971319,0.465027207979043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN4,Prefoldin subunit 4,40080,0.00375596493193735,0.00514556167689935,-0.00632933595478537,0.0138412658186601,0.465440946751421
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YAP1,Transcriptional coactivator YAP1,40483,0.00205088690982421,0.00281022453076719,-0.00345715317047949,0.00755892699012791,0.465530839728939
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00411282037993033,0.00563662100712432,-0.015160597553894,0.00693495679403334,0.465613277066614
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD7,T-cell antigen CD7,40166,-0.00319167721530213,0.00438138572191438,-0.0117791932302543,0.00539583879965006,0.466345780960841
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_E,,42594,0.00218672265656341,0.00300540998270673,-0.00370388090954178,0.00807732622266861,0.4668739732753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,-0.00194322146900833,0.00267418527333937,-0.0071846246047535,0.00329818166673683,0.467447228037323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,40182,-0.00455561617215281,0.00629107758370497,-0.0168861282362145,0.00777489589190892,0.468995670129355
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSD1,Tryptase delta,40482,-0.00271876687146688,0.00375496320093448,-0.0100784947452985,0.0046409610023647,0.469052371525148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHIT1,Chitotriosidase-1,42699,-0.0108854700101916,0.0150468440848981,-0.0403772844165919,0.0186063443962087,0.469422903870721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX33,Testis-expressed protein 33,40302,0.00269668041873747,0.00373565704832098,-0.00462520739597164,0.0100185682334466,0.470386036299989
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,0.00204651214307664,0.00284270916483196,-0.003525197819994,0.00761822210614728,0.471592021041457
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA10,Ephrin type-A receptor 10,42311,-0.00470798151926504,0.00654138043806606,-0.0175290871778745,0.00811312413934443,0.471708426129024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00287803600891027,0.00401176315257952,-0.0107410917879661,0.00498501977014558,0.473143012059985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.00238469602948538,0.00333248449752277,-0.00891636564463002,0.00414697358565925,0.474259180359891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,40199,-0.00383721970197707,0.005376049809405,-0.0143742773284109,0.00669983792445672,0.475389539207588
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF12,Fibroblast growth factor 12,40199,0.00327664254619843,0.00459194924830698,-0.00572357798048325,0.0122768630728801,0.475512916819639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL2,Interferon lambda-2,40136,0.00430099865755696,0.00606417742486075,-0.00758478909517011,0.016186786410284,0.478186424467665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,40449,0.0102967952097897,0.0145314303502149,-0.0181848082766316,0.038778398696211,0.478594944278011
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42611,0.003615554405036,0.0051321167807921,-0.00644339448531652,0.0136745032953885,0.481136330334293
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD59,CD59 glycoprotein,42130,0.00169915612957567,0.00243929736779075,-0.0030818667112942,0.00648017897044555,0.486080663477746
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00500061768553542,0.00725088580110868,-0.0192123538557084,0.0092111184846376,0.490424880397218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.00222092622210081,0.00322727032959925,-0.00410452362391371,0.00854637606811533,0.491354565282747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,42408,-0.00321970204210847,0.00468025536642376,-0.012393002560299,0.0059535984760821,0.491507059375208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.00474415441573526,0.00692230363662564,-0.008823560712051,0.0183118695435215,0.493141615902284
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.00389338279139034,0.00568902702548667,-0.00725711017856354,0.0150438757613442,0.493757969469439
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRING1,SREBP regulating gene protein,40080,0.00396282730478607,0.00579776774938184,-0.00740079748400233,0.0153264520935745,0.494299717942213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD1,Glutamate decarboxylase 1,40080,0.00172066059868,0.00256460111462637,-0.00330595758598768,0.00674727878334768,0.502281153711516
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.007531969775683,0.0112692448845879,-0.0145557501981092,0.0296196897494752,0.503914245502921
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALB,Ras-related protein Ral-B,40199,0.00196378530876461,0.00293937645174494,-0.00379739253665548,0.00772496315418469,0.504086400143067
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00464769428723101,0.00697452400003538,-0.0183177613273004,0.00902237275283834,0.505181285818903
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,-0.00228325466392852,0.00343730660907613,-0.00902037561771774,0.00445386628986071,0.506537330887584
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCLRE1C,Protein artemis,40080,0.00202728023856719,0.00306220098983965,-0.00397463370151852,0.00802919417865289,0.507963640826877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.00242056642507825,0.00365652032585417,-0.00474621341359593,0.00958734626375244,0.507991589040061
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.00185638778768943,0.00281816680606919,-0.00366721915220619,0.00737999472758505,0.510087932208605
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00252297504662859,0.00386613206286613,-0.00505464379658904,0.0101005938898462,0.514038384362257
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN1,Calsyntenin-1,42311,0.00338631014173909,0.00519024055910575,-0.00678656135410818,0.0135591816375864,0.514130093720618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR1,Toll-like receptor 1,40199,-0.00170986234322157,0.00262528269509291,-0.00685541642560367,0.00343569173916054,0.514862582412435
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00242553733350676,0.00372589914549231,-0.00487722499165816,0.00972829965867168,0.515064092647779
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC13A1,Solute carrier family 13 member 1,40451,0.00397794142045909,0.00611750318387636,-0.00801236481993857,0.0159682476608567,0.515540326167257
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,40367,-0.00216913972285968,0.00334334056696926,-0.00872208723411943,0.00438380778840006,0.516484788950357
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42602,-0.00360815289813175,0.00556363678984853,-0.0145128810062349,0.00729657520997136,0.516657093545159
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC1A4,Neutral amino acid transporter A,40182,-0.00330696601148413,0.00510057904321644,-0.0133041009361883,0.00669016891322008,0.516771441366309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI2B,Protein EVI2B,40080,-0.00260115579024766,0.00401201179793068,-0.0104646989141918,0.00526238733369647,0.516777443739342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00444314595680742,0.00685606571869395,-0.0178810347654476,0.00899474285183272,0.516959388958441
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.00323815819453676,0.00503655318059403,-0.00663348603942755,0.0131098024285011,0.520282452885793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF830,Zinc finger protein 830,40451,-0.0048634177958224,0.00758142923454568,-0.0197230190955319,0.00999618350388713,0.521216857826791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.0026131192832024,0.00408893141492107,-0.0106274248564477,0.0054011862900429,0.522789759775379
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP4,Caspase-4,40302,0.0107908328767394,0.0169131634131177,-0.0223589674129714,0.0439406331664501,0.523477801968299
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A14,Protein S100-A14,40482,-0.00340286754888986,0.00535879728795888,-0.0139061102332893,0.00710037513550955,0.525437479837166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNLZ,DNL-type zinc finger protein,40136,0.00562642955852842,0.00891742701815822,-0.0118517273970617,0.0231045865141185,0.528087937181477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GJA8,Gap junction alpha-8 protein,40080,-0.0040318902478797,0.00639442682732562,-0.0165649668294379,0.00850118633367852,0.528359858960923
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL2,Podocalyxin-like protein 2,42679,0.00172679568358908,0.00275839872399119,-0.00367966581543365,0.00713325718261181,0.531316481208671
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASQ2,Calsequestrin-2,40116,0.00300701816748505,0.00481603868715965,-0.00643241765934786,0.012446453994318,0.532393833984234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK12,Kallikrein-12,42346,0.00846582567052183,0.0136165124922348,-0.0182225388142583,0.035154190155302,0.534128683667033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.0018365331380424,0.00295628681644447,-0.00395778902218877,0.00763085529827356,0.534461449174852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTNNA1,Catenin alpha-1,40136,-0.00213655473544804,0.00344524271201764,-0.00888923045100262,0.00461612098010655,0.53517434552293
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.00172654458191657,0.00278848853422399,-0.00373889294516245,0.00719198210899559,0.535818102490684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSP90B1,Endoplasmin,42247,-0.00402256375106422,0.00651412139876664,-0.0167902416926468,0.00874511419051839,0.536906259930684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00474501609029336,0.00771466700651413,-0.0103757312424743,0.0198657634230611,0.538525009163785
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A3,Protein S100-A3,40451,0.00261414490009962,0.0042549134857156,-0.00572548553190296,0.0109537753321022,0.538974933799564
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFD,Complement factor D,40539,0.0012577194312428,0.00205298402227403,-0.00276612925241429,0.0052815681148999,0.540133351192899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00366975259134806,0.00599035418189282,-0.015410846787858,0.00807134160516186,0.540144675054398
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX101,Testis-expressed protein 101,40182,0.00315768960869105,0.00517920594374252,-0.00699355404104429,0.0133089332584264,0.542082404745078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKLR,Pyruvate kinase PKLR,42636,-0.00383965007480807,0.0063516438757426,-0.0162888720712636,0.00860957192164742,0.545512959604249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPN3,Calpain-3,40451,-0.0022551821389682,0.00373807399822089,-0.00958180717548113,0.00507144289754474,0.546320915025387
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX18,Sorting nexin-18,40449,0.002582193409147,0.00428393405163817,-0.00581431733206381,0.0109787041503578,0.54667905713326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00173253075640015,0.00290541339979109,-0.00396207950719039,0.00742714101999069,0.5509775472444
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.00201967957820976,0.00339664469951855,-0.0046377440328466,0.00867710318926613,0.552114006603151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TG,Thyroglobulin,40451,-0.00669152422629725,0.0112602021207231,-0.0287615203829146,0.0153784719303201,0.552348001628673
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSND,Barttin,40080,0.00198013034346929,0.00334539757595008,-0.00457684890539287,0.00853710959233144,0.55393194392987
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1,Huntingtin-interacting protein 1,40116,0.00192674059814374,0.00327683316288859,-0.00449585240111789,0.00834933359740536,0.556552090531325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NENF,Neudesin,40451,-0.00632110528766015,0.0107605893691076,-0.0274118604511111,0.0147696498757908,0.556925966582313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,-0.00163110545983379,0.00278620042582379,-0.00709205829444842,0.00382984737478085,0.558275416037585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,-0.00231801626480715,0.0039760439880247,-0.0101110624813356,0.00547502995172126,0.559907837714599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP1,Dipeptidase 1,42476,0.00284273764423139,0.00488128045482005,-0.0067245720472159,0.0124100473356787,0.560323735119939
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN6,Prefoldin subunit 6,40182,0.00368373507633822,0.00634093120280755,-0.00874449008116458,0.016111960233841,0.56128913999549
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMP,Olfactory marker protein,40136,-0.00285436121566536,0.00492946835906346,-0.0125161191994297,0.00680739676809903,0.562573848647835
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,40080,0.0017352544863413,0.00300104196906363,-0.00414678777302342,0.00761729674570601,0.563129358179756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNNI3,"Troponin I, cardiac muscle",42357,-0.00474245978003879,0.00823509880691867,-0.0208832534415994,0.0113983338815218,0.564703589060598
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MENT,Protein MENT,40283,-0.0013022701628981,0.00226560703813529,-0.00574285995764327,0.00313831963184707,0.565438455380918
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,42311,0.00226358747107281,0.00394623985972076,-0.00547104265397987,0.00999821759612549,0.566244180233213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.00191073806264268,0.00333732595594431,-0.00463042081100816,0.00845189693629353,0.566968661070113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA11,Serpin A11,42794,-0.0022797134687772,0.00398747201926471,-0.010095158626536,0.00553573168898163,0.567521816799758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF8,SLAM family member 8,42346,-0.003058262662503,0.00539471722622073,-0.0136319084258956,0.00751538310088964,0.5707921177233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.00116425267468687,0.00205632549211377,-0.00286614528985612,0.00519465063922985,0.57128218126906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2,T-cell surface antigen CD2,40116,-0.00213242410499111,0.00377799183022886,-0.00953728809223967,0.00527243988225745,0.572470924747257
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTH3,Cytohesin-3,40080,-0.00413003002124545,0.00731921754119934,-0.0184756964019961,0.0102156363595053,0.572580612702813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.00314190387029255,0.00557915228412051,-0.0140770423471687,0.00779323460658365,0.573343765617714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEL1L,Protein sel-1 homolog 1,40223,-0.00179836802765726,0.00319382470474847,-0.00805826444896425,0.00446152839364973,0.573394155655892
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42618,-0.0162431826499113,0.0288847862495919,-0.0728573636991115,0.0403709983992889,0.573891139859392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA6,Carbonic anhydrase 6,42581,-0.00341871526679472,0.00609742056287905,-0.0153696595700377,0.00853222903644822,0.575023576936758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXDNL,Peroxidasin-like protein,40451,-0.00305493471301813,0.00544965236432098,-0.0137362533470872,0.00762638392105098,0.575098975218405
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00365662716607942,0.00656346103545636,-0.0165210107955739,0.00920775646341504,0.577457526970177
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.00205948275326832,0.00371610598529816,-0.00934305048445272,0.00522408497791609,0.579450228419161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC123,Cell division cycle protein 123 homolog,40080,0.00340617943126082,0.00618684611675202,-0.00872003895757314,0.0155323978200948,0.581952236898321
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB6,Heat shock protein beta-6,42721,0.00210799549713542,0.00384478988019656,-0.00542779266804983,0.00964378366232068,0.583513330275142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42794,-0.00169129229934089,0.00309179342171746,-0.0077512074059071,0.00436862280722533,0.58436964277367
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00242027120696632,0.00443152178285088,-0.0111060539013541,0.0062655114874214,0.584974709403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36G,Interleukin-36 gamma,40154,0.00368649288971892,0.00675213138642869,-0.00954768462768132,0.0169206704071192,0.585094442710977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.00223709748967027,0.00410624403967422,-0.0058111408280912,0.0102853358074317,0.585899545632759
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRAS,GTPase Hras,40286,0.00530838823901993,0.00975916455111198,-0.0138195742811595,0.0244363507591994,0.586494521704416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPTC,Opticin,42587,0.00245165499327155,0.00451860806087548,-0.00640481680604438,0.0113081267925875,0.587435869332578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN15,Tetraspanin-15,40116,0.00277004973716022,0.0051108727749881,-0.00724726090181646,0.0127873603761369,0.587835399955949
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRAXIN,Draxin,42495,-0.00231243927553477,0.00428339873228349,-0.0107079007908104,0.00608302223974087,0.589302037478275
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42689,-0.00145566240381385,0.00270168023462616,-0.00675095566368111,0.00383963085605341,0.590034493600992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLHL41,Kelch-like protein 41,40482,-0.0025089804114982,0.00468540287949515,-0.0116923700553087,0.00667440923231229,0.592322502034705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.00268757357808743,0.00507030287932559,-0.0126253672215656,0.00725022006539072,0.596079833841504
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.00158600940045509,0.00300556342049268,-0.00430489490371056,0.00747691370462074,0.597722354061025
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,-0.00172779264468828,0.00328231171166923,-0.00816112359955998,0.00470553831018341,0.598624338001938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42698,0.00212099561067779,0.00403170617238104,-0.00578114848718905,0.0100231397085446,0.598842016764209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4C,Semaphorin-4C,42587,-0.00140576631301683,0.00271282438703055,-0.00672290211159671,0.00391136948556305,0.604332254086338
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFA,Protransforming growth factor alpha,42594,-0.00238753188743317,0.00462267894065942,-0.0114479826111256,0.00667291883625929,0.605526115602012
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCNA,Proliferating cell nuclear antigen,40080,-0.00315324860311579,0.00612878092281366,-0.0151656592118306,0.00885916200559898,0.606913952309041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGA4,Pepsin A-4,40532,0.00405173706690407,0.00789560065397505,-0.011423640214887,0.0195271143486952,0.607846688244391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALLD,Palladin,40199,0.00195817335051328,0.0038221072097774,-0.00553315678065042,0.00944950348167697,0.608431605761342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.00453913415910194,0.00888208596951784,-0.012869754341153,0.0219480226593569,0.609330702662447
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSB,Lupus La protein,42311,-0.00288175539843354,0.00568849207125088,-0.0140311998580853,0.00826768906121818,0.612448302418205
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00182797844516735,0.00362925385730766,-0.00894131600549035,0.00528535911515566,0.614496895310784
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH4,Myosin-4,40116,-0.00223062139845343,0.00444725014366636,-0.0109472316800395,0.00648598888313263,0.615977898541074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3C,Protein FAM3C,42613,-0.00151785391241809,0.00303438293988362,-0.00746524447458998,0.0044295366497538,0.616929568485147
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,42346,-0.00235082435555188,0.00471057107286126,-0.0115835436583599,0.00688189494725619,0.617750434347221
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,42311,-0.00244899563028874,0.00493019359976849,-0.012112175085835,0.00721418382525751,0.619384846817827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPACAM2,HEPACAM family member 2,40483,-0.00204333591623723,0.00411833843786329,-0.0101152792544493,0.00602860742197481,0.619794424174815
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.0019277718175139,0.00390851656663402,-0.00573292065308878,0.00958846428811658,0.621864604706251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.00209186456153003,0.00424735142702331,-0.0104166733584957,0.00623294423543566,0.622368503066571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB2,Integrin beta-2,42569,0.00137257725415627,0.00279053597336214,-0.00409687325363353,0.00684202776194607,0.62282025070832
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA1,Ephrin-A1,42590,-0.00144119391364762,0.00295561422629875,-0.00723419779719317,0.00435180996989793,0.625832446166661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCP2,Non-specific lipid-transfer protein,42346,0.00349521528605701,0.00721137871232536,-0.0106390869901007,0.0176295175622147,0.627911009067002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,-0.00132744379158069,0.00274592632948873,-0.0067094593973786,0.00405457181421722,0.628803308937471
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC25A,M-phase inducer phosphatase 1,40080,-0.00183495418631028,0.00382005934910936,-0.00932227051056462,0.00565236213794407,0.630990300396359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,-0.00157280647161289,0.00328129748325148,-0.00800414953878579,0.00485853659556,0.631717277290242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00241855583195415,0.00505298757428363,-0.0123224114775501,0.00748529981364176,0.632205185247283
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.00236929491254167,0.00495376344108404,-0.00734008143198305,0.0120786712570664,0.632459250536445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00265766152760511,0.0056201450558422,-0.0083578227818456,0.0136731458370558,0.636307313058158
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COLEC12,Collectin-12,42618,0.00128225969143961,0.00272446468139401,-0.00405769108409266,0.00662221046697187,0.637900862025929
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHDC3L,KH domain-containing protein 3,40080,0.00315202376775578,0.00676349933362696,-0.0101044349261531,0.0164084824616646,0.641200158167907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH22,Cadherin-22,40302,-0.00128154994654922,0.00275180098426497,-0.00667507987570856,0.00411197998261012,0.641429958370602
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00122000745009509,0.00263571427559566,-0.00394599253007242,0.00638600743026259,0.643462892880877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00262250741437468,0.00567428232071109,-0.00849908593421907,0.0137441007629684,0.643965573788225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,-0.0018848794135269,0.00408699011243331,-0.00989538003389619,0.00612562120684239,0.644671102833881
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTN,Neuroplastin,42346,0.00353720750093066,0.00767075035977878,-0.0114974632042358,0.0185718782060971,0.644713489708349
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171A2,Protein FAM171A2,40482,0.00719068354631839,0.0156376156327009,-0.0234590430937753,0.0378404101864121,0.645645325348631
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD82,CD82 antigen,40302,-0.0018403753972573,0.00401093089602835,-0.00970179995347287,0.00602104915895826,0.646358069748032
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBZ,Hemoglobin subunit zeta,40511,0.00474610667995488,0.0104069125324177,-0.0156514418835838,0.0251436552434936,0.648360410322206
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GKN1,Gastrokine-1,42017,0.00125092565181152,0.00274566773988804,-0.00413058311836904,0.00663243442199208,0.648685507090466
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2BP,LRP2-binding protein,40182,-0.00384258441013695,0.00844650700042058,-0.0203977381309613,0.0127125693106874,0.649167311177045
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHC1,SHC-transforming protein 1,40080,0.00525732156615156,0.0115763690178766,-0.0174323617088866,0.0279470048411897,0.649735294856145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.00281170182757487,0.00624788894708418,-0.00943416050871011,0.0150575641638599,0.652701836800963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00295870409166823,0.00662903953632389,-0.0159516215828631,0.0100342133995266,0.655371564052848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.00307461918336323,0.00689162977099777,-0.0165822135345189,0.0104329751677924,0.655506015399529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN1,Neuroligin-1,40182,0.00303589773820348,0.0068396670775932,-0.0103698497338792,0.0164416452102862,0.657147988863382
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2A,Pancreatic alpha-amylase,42114,-0.00210423774710094,0.00477540992342685,-0.0114640411970176,0.00725556570281568,0.659480842604411
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.00182957381784644,0.00416382530843531,-0.00633152378668677,0.00999067142237966,0.660382271810667
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF20,Fibroblast growth factor 20,40199,0.00193257888744648,0.00442574441330496,-0.00674188016263123,0.0106070379375242,0.662361046414395
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE2,Angiotensin-converting enzyme 2,42357,0.00227959856879527,0.00522911362238781,-0.00796946413108484,0.0125286612686754,0.662884806276645
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,40199,0.000879055575268368,0.00203034065944577,-0.00310041211724533,0.00485852326778207,0.66505257078843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA2,Protein disulfide-isomerase A2,40080,0.00177401677062955,0.00412958838206797,-0.00631997645822368,0.00986800999948277,0.667504723299326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00158091187397829,0.00369363428739011,-0.00565861132930633,0.00882043507726292,0.668652257920595
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20,Interleukin-20,42370,0.00204553560828824,0.0048012097620776,-0.00736483552538385,0.0114559067419603,0.670081378722775
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,-0.00244769911129527,0.0057705895242539,-0.0137580545788329,0.00886265635624238,0.671450147747955
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00290383241671325,0.0068733889773345,-0.0105680099788624,0.0163756748122889,0.672686921138176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNB2,Ephrin-B2,40182,-0.00225366208069307,0.00534044281456863,-0.0127209299972476,0.00821360583586145,0.673033927786138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KEL,Kell blood group glycoprotein,42311,0.0014932837115948,0.00354016734153632,-0.00544544427781639,0.00843201170100599,0.673169438070164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.00117489521995776,0.00278970105447662,-0.00664270928673193,0.00429291884681641,0.67365023242911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3G,Semaphorin-3G,40283,0.00184522019632536,0.00438231609644629,-0.00674411935270937,0.0104345597453601,0.67371906636995
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HK2,Hexokinase-2,42357,0.00113342624375938,0.00269480812025693,-0.00414839767194421,0.00641525015946297,0.674056784042982
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17F,Interleukin-17F,42370,0.00309981013120736,0.00737963002666636,-0.0113642647210587,0.0175638849834734,0.674456119807282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,42357,0.00227196539205451,0.00541375146311985,-0.00833898747566041,0.0128829182597694,0.674736589230464
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRC1,Protein regulator of cytokinesis 1,40451,0.00181169617430774,0.00435340383327654,-0.00672097533891429,0.0103443676875298,0.677303611570162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,40302,0.00161281593425132,0.00391006302447998,-0.00605090759372944,0.00927653946223209,0.679996883369462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA4,Ephrin-A4,42475,0.00135765166674932,0.00331615520294191,-0.00514201253101682,0.00785731586451546,0.682248819773836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.000833503986097262,0.0020375614083903,-0.00482712434654225,0.00316011637434773,0.682496765945788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,-0.00188147185274892,0.00463571852094157,-0.0109674801537944,0.00720453644829654,0.68485025465525
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00132110972759378,0.00325832741487616,-0.0050652120055635,0.00770743146075106,0.685149982694002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.00191252703968009,0.0047990924514557,-0.0074936941651731,0.0113187482445333,0.690254359086832
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00201297264237261,0.00509715638354272,-0.00797745386937112,0.0120033991541163,0.69290911367909
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42676,-0.0010913495032601,0.00276647074163458,-0.00651363215686387,0.00433093315034368,0.693224358566843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.0029625608725884,0.00754151042182714,-0.0177439212993696,0.0118187995541928,0.694449792873938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00166279288914696,0.00423575776642866,-0.00996487811134713,0.0066392923330532,0.694651468222864
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK1,Cyclin-dependent kinase 1,40080,0.00140942626259464,0.00361104464327178,-0.00566822123821804,0.00848707376340732,0.696315083652445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,40511,-0.00150269428200025,0.00386232817826272,-0.00907285751139517,0.00606746894739467,0.697235849186807
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0102901208947096,0.0265350982692469,-0.0417186717130143,0.0622989135024334,0.698176834631858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00179269019022125,0.00462815457915021,-0.00727849278491316,0.0108638731653557,0.698508681035946
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB116,Beta-defensin 116,40136,0.00290682165725109,0.0075428370977605,-0.0118771390543595,0.0176907823688617,0.699967013575471
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00128324646295821,0.0033611794970787,-0.00530466535131605,0.00787115827723247,0.702627212264048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKZF2,Zinc finger protein Helios,42346,0.00326736605465144,0.00857966919796734,-0.0135487855733646,0.0200835176826674,0.703338087706548
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCIN,Adseverin,40136,-0.00271582811948486,0.00714298323651828,-0.0167160752630607,0.011284419024091,0.703797491954461
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.00151810146772184,0.00399630495836695,-0.00631465625067738,0.00935085918612106,0.704043404644012
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF7,Fibroblast growth factor 7,40080,0.00293606465267282,0.00776933263568194,-0.0122918273132638,0.0181639566186094,0.705509013797014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.00290176154662348,0.00768475463601708,-0.01216035753997,0.017963880633217,0.70573526288331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.00176676817139411,0.0047354356123849,-0.0075146856288803,0.0110482219716685,0.709084760206875
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDAN1,Codanin-1,40483,0.000820611058079651,0.00221145899781731,-0.00351384857764228,0.00515507069380158,0.710590684955213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,40182,-0.00372848328338512,0.0100699182947623,-0.0234655231411193,0.0160085565743491,0.711196256247216
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,40080,0.00123861036727101,0.00334824024413013,-0.00532394051122404,0.00780116124576607,0.711442766860411
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB1,Scavenger receptor class B member 1,42311,0.00208835440248563,0.00567914934002028,-0.00904277830395411,0.0132194871089254,0.713085647114334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TUBB3,Tubulin beta-3 chain,40136,-0.00100773406001274,0.00275539254587824,-0.0064083034499341,0.00439283532990862,0.714572451325145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,0.000755755260594933,0.00208811384395329,-0.00333694787355351,0.00484845839474338,0.717408641421588
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD10,Frizzled-10,40182,0.00211172402100091,0.00593923018985544,-0.00952916715111574,0.0137526151931176,0.722180544026098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL5,Insulin-like peptide INSL5,40449,0.00342135451094665,0.0096294363490195,-0.0154523407331316,0.0222950497550249,0.722370286240295
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MN1,Transcriptional activator MN1,40182,-0.00204266488520482,0.0058034489336405,-0.0134174247951402,0.00933209502473057,0.724864284941814
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00136465055514738,0.00391618076456743,-0.00631106374340478,0.00904036485369955,0.727497909418058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00134314470640118,0.0038579163442425,-0.00621837132831412,0.00890466074111648,0.727731891849972
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,40182,0.00167880828911627,0.0048220453755431,-0.00777240064694821,0.0111300172251808,0.727732150806708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR101,Probable G-protein coupled receptor 101,40136,-0.00205933895677373,0.00591633406109683,-0.0136553537165235,0.00953667580297606,0.727789161260919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OCLN,Occludin,40482,0.00150774611070117,0.00439100074983373,-0.00709861535897294,0.0101141075803753,0.731325118564324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.00180010211793448,0.00527498644501259,-0.0121390755501592,0.0085388713142902,0.732920083556599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL33,Interleukin-33,42370,-0.00128882326548181,0.00378418312769604,-0.00870582219576605,0.00612817566480244,0.733423988968476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.00101778852228802,0.0030044858714354,-0.00487100378572537,0.0069065808303014,0.734798624131224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.00253690001684723,0.00749201351361429,-0.0121474464698368,0.0172212465035312,0.734906915050017
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF6,Fibroblast growth factor 6,40199,-0.00137586999877734,0.00406728332123767,-0.00934774530840318,0.0065960053108485,0.735160611314175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA8,Carbonic anhydrase-related protein,40199,-0.000940102745814438,0.00280856764806613,-0.00644489533602405,0.00456468984439517,0.737837593290008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB5,Integrin beta-5,42679,0.00120886611197966,0.00362605142095981,-0.00589819467310158,0.0083159268970609,0.738849916985238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGR,Progesterone receptor,40199,0.00317543013720021,0.00959220741150442,-0.0156252963893484,0.0219761566637489,0.74061854320056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIP,Gastric inhibitory polypeptide,40223,0.00189596642799391,0.00573126264683146,-0.00933730835979575,0.0131292412157836,0.740793311654154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,-0.000944502546702035,0.00285625804941474,-0.00654276832355493,0.00465376323015086,0.740892658480536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,40080,-0.00134012750113759,0.00409490626439143,-0.0093661437793448,0.00668588877706961,0.743472276878078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP1,Retinol-binding protein 1,40182,-0.0021442869347808,0.00668891547444087,-0.0152545612646849,0.0109659873951233,0.748539957636956
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00135588466692782,0.0042956297883955,-0.00706354971832737,0.00977531905218301,0.752279490613058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.00129767636573729,0.00411328145315744,-0.0067643552824513,0.00935970801392588,0.752398851910487
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42711,-0.000701379120463929,0.00227151007887049,-0.00515353887505008,0.00375078063412222,0.75749959098137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42611,-0.000814709189737757,0.00265073015287234,-0.00601014028936754,0.00438072190989202,0.758579662519251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,-0.00222750418129932,0.00728779558264411,-0.0165115835232818,0.0120565751606831,0.75987786942339
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.00099650975129792,0.00338951565310337,-0.00763996043138053,0.00564694092878469,0.768765278365461
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRAL,GDNF family receptor alpha-like,40109,-0.00180678862921313,0.00615264151823513,-0.013865966004954,0.0102523887465277,0.769022818964069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TET2,Methylcytosine dioxygenase TET2,40286,-0.00292027967819085,0.0100221747638422,-0.0225637422153215,0.0167231828589398,0.770764753878554
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRX,Cone-rod homeobox protein,42357,0.00300767278424636,0.0103796704386468,-0.0173364812755013,0.023351826843994,0.772000030933925
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42636,-0.000894183571858436,0.00309013579743516,-0.00695084973483134,0.00516248259111447,0.772304947147876
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.00120763495687072,0.00419190418840019,-0.00700849725239366,0.0094237671661351,0.77328509392404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42676,-0.000784931124239562,0.00273037188314382,-0.00613646001520145,0.00456659776672233,0.773748162288578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPB41L5,Band 4.1-like protein 5,40182,-0.00170548343440748,0.00599797084006871,-0.0134615062809422,0.0100505394121272,0.776152586152568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,-0.00141563698417364,0.0049913665565883,-0.0111987154350867,0.00836744146673943,0.776709036072733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.0012409324411728,0.00438996190874983,-0.00736339289997687,0.00984525778232248,0.777430429607021
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPT,Microtubule-associated protein tau,42311,-0.00145798390684434,0.00519932300419525,-0.011648656995067,0.00873268918137836,0.779161229149519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FH,"Fumarate hydratase, mitochondrial",40136,0.00234913988825995,0.00838484885376567,-0.0140851638651208,0.0187834436416407,0.779356332044723
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC16A1,Monocarboxylate transporter 1,42311,0.001566999631075,0.00560829899864882,-0.0094252664062767,0.0125592656684267,0.779936681572638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1A,Interleukin-1 alpha,42370,0.00154347826034416,0.00569243805248434,-0.00961370032252515,0.0127006568432135,0.786283470261585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPE,Coatomer subunit epsilon,42311,0.00124556990199322,0.00463347925116475,-0.00783604943028969,0.0103271892342761,0.788072760245026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,40223,0.00105206971493264,0.00391704329562587,-0.00662533514449407,0.00872947457435936,0.788251989292399
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJP3,Tight junction protein ZO-3,40136,-0.00110590002961859,0.0041214768072769,-0.00918399457188132,0.00697219451264414,0.788453332704098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG4,Proteasome assembly chaperone 4,40199,0.00149020367311132,0.00558212776721841,-0.00945076675063677,0.0124311740968594,0.789505120571007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBN2,Fibrillin-2,40182,0.00157383584677506,0.00595999824934635,-0.0101077607219438,0.0132554324154939,0.791733633288574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC9,Histone deacetylase 9,40136,0.00169371764486567,0.00642838826985117,-0.0109059233640426,0.014293358653774,0.792189685687608
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB2,Beta-crystallin B2,40483,-0.00209456941523127,0.00798328103448605,-0.0177418002428239,0.0135526614123614,0.793041375766473
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR3,Small proline-rich protein 3,40483,0.00178453286946701,0.00684683999163636,-0.0116352735141403,0.0152043392530743,0.794377992158945
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK11,Kallikrein-11,42543,0.00082697912104463,0.00319063153552124,-0.00542665868857701,0.00708061693066627,0.795492804221086
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REST,RE1-silencing transcription factor,40080,0.000862001442548786,0.00336149463524839,-0.00572652804253805,0.00745053092763562,0.797620599577542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO3,R-spondin-3,42721,0.00073576502781737,0.00289940749570951,-0.00494707366377327,0.00641860371940801,0.799681801349188
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3,Interleukin-3,40080,0.00153538197317557,0.00605526065914236,-0.0103329289187435,0.0134036928650946,0.799839004357873
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,-0.00107046836300673,0.00422897838344289,-0.00935926599455479,0.00721832926854134,0.800173991378468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.00106487726168012,0.00421767085982718,-0.00720175762358114,0.00933151214694139,0.800673967175949
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00079906410683567,0.00317635908538768,-0.00542659970052419,0.00702472791419553,0.801381082865701
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.00180500109050084,0.00718458372645478,-0.0122767830133505,0.0158867851943522,0.801639059329657
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.000896412692247103,0.00357590610026526,-0.00611236326427281,0.00790518864876701,0.802064449418366
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCG22,Protein PBMUCL2,40116,-0.00137154210800862,0.00559042846481037,-0.0123287818990369,0.00958569768301971,0.806199676981065
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCNE1,G1/S-specific cyclin-E1,40199,0.00207853147846324,0.00869096464287163,-0.0149557592215651,0.0191128221784916,0.810985938257389
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARCL1,SPARC-like protein 1,42644,-0.000645319666154776,0.00270016874763115,-0.00593765041151183,0.00464701107920228,0.811115158378829
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,-0.000497192312524416,0.00210430669252701,-0.00462163342987736,0.00362724880482853,0.813224598847758
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSPN,Claspin,42292,0.00080854985387855,0.00342583849708666,-0.0059060936004113,0.0075231933081684,0.81342458928226
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPGN,Epigen,40451,0.00102830464708759,0.004449417243011,-0.00769255314921398,0.00974916244338915,0.817233576757912
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RUVBL1,RuvB-like 1,42346,-0.00237175699933018,0.0103076299274339,-0.0225747116571006,0.0178311976584402,0.818019802967082
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JUN,Transcription factor AP-1,42370,-0.00106490910686491,0.00467530935538357,-0.0102285154434167,0.0080986972296869,0.819826273877061
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD2,Glutamate decarboxylase 2,40199,-0.00102544965064688,0.00452210992575061,-0.00988878510511809,0.00783788580382432,0.820611828605311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR3,Folate receptor gamma,42629,-0.004089268133417,0.0180814454130333,-0.0395289011429622,0.0313503648761282,0.821081777925395
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,-0.000605917298177302,0.00269279914857505,-0.00588380362938441,0.0046719690330298,0.821971853858957
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.000619599876533767,0.00277665312228837,-0.00482264024315144,0.00606183999621897,0.823425014768334
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF174,Zinc finger protein 174,40199,0.00081837245975203,0.00367143412744884,-0.00637763843004769,0.00801438334955175,0.823615397279732
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAGLN3,Transgelin-3,40080,-0.0013319078506892,0.00600665071482471,-0.0131049432517456,0.0104411275503672,0.824521340458385
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,-0.000644444878062746,0.00291997856372509,-0.00636760286296392,0.00507871310683843,0.825327961512917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,40199,-0.000858753459385301,0.00393520649809014,-0.00857175819564198,0.00685425127687138,0.827259235153747
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.00123085795398997,0.00565122190255063,-0.00984553697500926,0.0123072528829892,0.82758601780487
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00134087389005884,0.00620554484393648,-0.0108219940040567,0.0135037417841743,0.828931979954904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME2,Proteasome activator complex subunit 2,42441,-0.000759435908467071,0.00352905768636095,-0.00767638897373453,0.00615751715680038,0.82961852679827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00112791594603717,0.00526143456945144,-0.00918449581008765,0.011440327702162,0.830259213559354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFC1,Cryptic protein,42346,-0.000984442346001499,0.00461626204990501,-0.0100323159638153,0.00806343127181232,0.831131142772847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEFL,Neurofilament light polypeptide,42262,-0.00093403778774956,0.00451662746998249,-0.00978662762891524,0.00791855205341612,0.836169411762039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDNRB,Endothelin receptor type B,40199,-0.000888829311402201,0.00437241115539707,-0.00945875517598046,0.00768109655317606,0.838918949242358
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPBGL,Trophoblast glycoprotein-like,40182,-0.000832257182627105,0.0041116283546142,-0.00889104875767094,0.00722653439241673,0.839595683519655
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,-0.00119084111510767,0.00591606208362534,-0.0127863227990133,0.010404640568798,0.840475969135548
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.000945813713684081,0.00472924336789574,-0.0102151307147597,0.00832350328739156,0.841490085868482
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPLX2,Complexin-2,40080,0.000617599306886331,0.00311162828132131,-0.00548119212450343,0.00671639073827609,0.842672401439228
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENG,Endoglin,42794,0.000335034402785595,0.00169634552447929,-0.00298980282519381,0.003659871630765,0.843436390849783
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00120118080878792,0.00613212547226449,-0.0132201467344263,0.0108177851168505,0.844705167187129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,-0.00117273582511214,0.0060109840721114,-0.0129542646064505,0.0106087929562262,0.845319225011907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,40080,-0.00109283557583345,0.00562544807580728,-0.0121187138044157,0.00993304265274882,0.845970914107323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.000780972461638166,0.00404148130384281,-0.00870227581717007,0.00714033089389374,0.846774599870155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RB,Interleukin-17 receptor B,42416,-0.000993622321895028,0.0052036284283223,-0.0111927340414067,0.00920548939761667,0.848569283137431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.00135031301217256,0.00712338078261471,-0.0126115133217523,0.0153121393460974,0.84965625163062
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.000600796342408478,0.00318627889308396,-0.00564431028803607,0.00684590297285303,0.850442617249099
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.000901536294470805,0.00479750715804187,-0.0103046503242329,0.00850157773529125,0.850944705181855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY6D,Lymphocyte antigen 6D,42548,-0.000736286887452969,0.00397787739700924,-0.00853292658559107,0.00706035281068514,0.853157004794639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAG,S-arrestin,40136,-0.000935151762793001,0.00513277419955872,-0.0109953891939281,0.00912508566834209,0.855435217243169
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON1,Spondin-1,42638,-0.00060107820247894,0.00330185774161896,-0.00707271937605211,0.00587056297109423,0.855552173514668
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36A,Interleukin-36 alpha,40199,0.00102117723833188,0.00564574548924508,-0.0100444839205885,0.0120868383972522,0.856468602740597
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHODH,Dihydroorotate dehydrogenase,40116,-0.000860833541058474,0.00476980874478517,-0.0102096586808374,0.00848799159872045,0.856782647836679
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,-0.000781692666345337,0.0043897481272762,-0.00938559899580668,0.00782221366311601,0.858669378308539
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVPL,Envoplakin,40302,0.00061088585313584,0.00344640997533984,-0.00614407769853025,0.00736584940480193,0.859313047611559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAND5,DAN domain family member 5,40199,-0.000962677679841399,0.00543586659891902,-0.0116169762137227,0.00969162085403988,0.85943516659885
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.000600290803419116,0.00339323191319969,-0.00605044374645228,0.00725102535329051,0.85958313994926
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANK2,Ankyrin-2,40116,0.00126158203567431,0.00722098608326394,-0.012891550687523,0.0154147147588716,0.861310361017405
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPEP,Glutamyl aminopeptidase,40116,-0.000799285379662322,0.00467823280407,-0.00996862167563952,0.00837005091631488,0.864343313515172
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLNS1A,Methylosome subunit pICln,40182,0.000539977637836139,0.00326425401491993,-0.00585796023140693,0.00693791550707921,0.868615313461013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200,OX-2 membrane glycoprotein,42594,0.000429218592155161,0.00267832010786132,-0.00482028881925302,0.00567872600356335,0.872681326023528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF75D,Zinc finger protein 75D,40302,-0.000958837519594495,0.00600735132662734,-0.0127332461197841,0.0108155710805951,0.873190655686104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SBSN,Suprabasin,40511,-0.000545033017585148,0.00342128918981272,-0.00725075982961807,0.00616069379444778,0.873430378294036
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP15,Matrix metalloproteinase-15,40511,-0.000749190617372368,0.00477974087608569,-0.0101174827345003,0.00861910149975558,0.875450243398665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF3,Neurotrophin-3,42594,-0.000543564767681254,0.00350092761174723,-0.00740538288670582,0.00631825335134332,0.876616267208171
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.000572932358036114,0.00370079084923606,-0.0078264824225388,0.00668061770646657,0.876971214269209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.000449798921352145,0.00292941942806984,-0.00529186315766475,0.00619146100036904,0.877970476215197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00252601973420547,0.0171293072965164,-0.0310474225669667,0.0360994620353776,0.882765505609744
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN1,Prorelaxin H1,40482,-0.000688800590699368,0.00473441471363671,-0.00996825342942732,0.00859065224802858,0.884328176760526
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA4,Ephrin type-A receptor 4,40283,0.000412204698931386,0.00285469971736873,-0.00518300674711132,0.00600741614497409,0.88519109671757
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,H2AP,Huntingtin-interacting protein M,40080,-0.000740595540855742,0.00516129352096325,-0.0108567308419437,0.00937553976023223,0.885905629615526
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BEX3,Protein BEX3,40080,-0.000671453606828974,0.00468480525383232,-0.00985367190434032,0.00851076469068237,0.886035508900021
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,40284,0.000749643565232347,0.00523943385036539,-0.00951964678148383,0.0110189339119485,0.886231804726267
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLNL,Mesothelin-like protein,40182,-0.000545870287116499,0.00385278735821206,-0.00809733350921214,0.00700559293497914,0.887333858783792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.000745065400594434,0.00529241147842012,-0.009628061097109,0.0111181918982979,0.88804633897289
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RYR1,Ryanodine receptor 1,40116,-0.000472797273025418,0.00338270263932522,-0.00710289444610284,0.00615729990005201,0.888845012516549
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.000345531650372945,0.00247221426360175,-0.00519107160703238,0.00450000830628648,0.888847312835561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.000992975692005114,0.00728256177014998,-0.0152667967614991,0.0132808453774888,0.891546817517774
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.000877869092453631,0.0064670547928921,-0.0135532964865222,0.0117975583016149,0.892025536081727
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,40302,-0.000583348701629968,0.00429769829090875,-0.00900683735181112,0.00784013994855119,0.892033122533201
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR1,Cadherin-related family member 1,42311,0.000557736155530027,0.004179268107167,-0.0076336293345173,0.00874910164557735,0.893837124864074
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPE4,NXPE family member 4,40116,0.00044042477694578,0.00330615570004227,-0.00603964039513706,0.00692048994902862,0.894026939791733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.000460787463830542,0.003598042543398,-0.00659137592122953,0.00751295084889062,0.898098979921595
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,40080,-0.00059665819052095,0.00467388697410345,-0.0097574766597637,0.00856416027872181,0.89842213495409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX1B,Syntaxin-1B,40182,0.000505778358517488,0.00397102106234749,-0.00727742292368359,0.00828897964071856,0.898652001484792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00069201827998045,0.00544416558666289,-0.00997854626987882,0.0113625828298397,0.89885417371313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADM,Pro-adrenomedullin,42721,0.00031513898854828,0.0026143995121273,-0.00480908405522122,0.00543936203231778,0.904057406227177
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAP1,Antigen peptide transporter 1,40302,-0.000701257151766347,0.00603280645883028,-0.0125255578110737,0.011123043507541,0.907463947638847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.000587799540802227,0.00508125230721697,-0.00937145498134303,0.0105470540629475,0.907907861081977
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMMR,Hyaluronan mediated motility receptor,40059,0.000553585768419863,0.00487029891472019,-0.00899220010443171,0.0100993716412714,0.909504930979349
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTNL10,Butyrophilin-like protein 10,40080,-0.000444483498352133,0.00417915410327493,-0.008635625540771,0.00774665854406673,0.915300839459624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,40182,-0.00037420211698774,0.00356754884380705,-0.00736659785084956,0.00661819361687408,0.91646458176363
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI16,Peptidase inhibitor 16,40532,0.00024662813938921,0.00245689904191513,-0.00456889398276445,0.00506215026154287,0.920042931356462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK1,Kallikrein-1,42505,-0.00126637919886468,0.0126486893321246,-0.026057810289829,0.0235250518920996,0.92025104076324
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAP1A,Ras-related protein Rap-1A,40199,0.000652135213060199,0.00696295993541117,-0.0129952662603457,0.0142995366864661,0.925382732326707
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTF,Ciliary neurotrophic factor,40136,-0.000298117208953656,0.00336666873541783,-0.00689678793037261,0.0063005535124653,0.929441475320274
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD8,Frizzled-8,40136,0.000395637967525876,0.00448204436153477,-0.00838916898108228,0.00918044491613403,0.929662294833499
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPT1,Translationally-controlled tumor protein,42370,0.000559373053382427,0.00638178069564119,-0.0119489171100743,0.0130676632168392,0.930154950428234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.000376184493047094,0.0043542119777778,-0.00815807098339739,0.00891043996949158,0.931153564370108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.000394654656678527,0.0049138893119945,-0.0100258777081877,0.00923656839483068,0.935988883503229
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,-0.000389338557148446,0.00485905031499411,-0.00991307717453689,0.00913440006024,0.936138137153273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSLP,Thymic stromal lymphopoietin,42357,0.000475122519616007,0.00596019681915825,-0.0112068632459342,0.0121571082851662,0.936464416337252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,0.000269186385528373,0.00355570889410826,-0.00670000304692383,0.00723837581798057,0.93965486151029
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,40223,-0.000231787703918312,0.00317182719827631,-0.00644856901253988,0.00598499360470326,0.941746147214876
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.000393526417256555,0.00580473748186937,-0.0109837590472074,0.0117708118817205,0.945950642663764
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.000178902292757346,0.00266217794671914,-0.00503896648281217,0.00539677106832686,0.946422304630349
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RA,Interleukin-17 receptor A,42611,0.000283997298062116,0.00429158298093102,-0.00812750534456268,0.00869549994068691,0.947239153353206
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL6B,Myosin light chain 6B,40182,-0.000576649534955202,0.00890303271442617,-0.0180265936552305,0.0168732945853201,0.948358296576437
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRN1,Neuritin,40482,-0.000226724099727629,0.00355710275660405,-0.00719864550267158,0.00674519730321632,0.949179642970797
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,42370,-0.000237559464344748,0.0038332883546708,-0.00775080463949951,0.00727568571081001,0.950585463589278
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,40182,0.00021930296738139,0.00363200687812955,-0.00689943051375252,0.0073380364485153,0.951853560842851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,-0.000221825981644005,0.00367836776424568,-0.00743142679956553,0.00698777483627752,0.951913216590817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM25,RNA-binding protein 25,40080,-0.000268821999059914,0.00465153888256405,-0.00938583820888546,0.00884819421076563,0.953915326116056
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,-0.000230945974382089,0.00401306950691087,-0.00809656220792738,0.00763467025916321,0.954109318240937
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,0.000456677317593136,0.00794349298992607,-0.015112568942662,0.0160259235778482,0.954155313646207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSCA,Prostate stem cell antigen,40449,-0.00145064994263279,0.0260282527301217,-0.0524660252936713,0.0495647254084058,0.955554968914245
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXK,Tyrosine-protein kinase TXK,40302,-0.000332524395508827,0.00734683504497534,-0.0147323210836605,0.0140672722926428,0.963900163181739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASA1,Ras GTPase-activating protein 1,42311,0.000136065671972521,0.00316354891070565,-0.00606449019301054,0.00633662153695559,0.965693855878165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42636,-6.71528309563535e-05,0.00170747274297439,-0.00341379940718615,0.00327949374527345,0.968628840121001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM3,Paralemmin-3,40116,0.000273976856443262,0.00701674340977418,-0.0134788402267141,0.0140267939396006,0.968854303282028
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL6,Fc receptor-like protein 6,42594,-0.000264914628503738,0.00683718599505868,-0.0136657991788188,0.0131359699218113,0.969093356491181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAN,Versican core protein,42711,0.000110909686211266,0.00298092286383518,-0.00573169912690569,0.00595351849932823,0.970320910820513
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMA1,Proteasome subunit alpha type-1,42346,-0.000152414412750142,0.00450882627601673,-0.00898971391374292,0.00868488508824264,0.973034304201479
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,0.000191042022403626,0.00587488759898009,-0.0113237376715973,0.0117058217164046,0.974059226388792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,40080,8.0174380349902e-05,0.00247099215892186,-0.00476297025113694,0.00492331901183674,0.974116790368446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKAP12,A-kinase anchor protein 12,40283,6.89469775088705e-05,0.00215798625285883,-0.00416070607809445,0.00429860003311219,0.974512752242209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLVRB,Flavin reductase,42611,0.00019694773536766,0.00640908221795238,-0.012364853411819,0.0127587488825543,0.97548574122938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,-0.000119006991381563,0.00399304784355041,-0.00794538076474038,0.00770736678197725,0.97622425635665
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.000117429875412129,0.00467116708359831,-0.00927291735926481,0.00903805760844055,0.979944313184554
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,40451,-8.71005852206007e-05,0.00357972112032247,-0.00710335398105265,0.00692915281061145,0.98058848460244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALMS1,Alstrom syndrome protein 1,40302,0.000105829294280487,0.00436675692765682,-0.00845301428392687,0.00866467287248785,0.980665423954867
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L15,Bcl-2-like protein 15,40199,0.000109349805151483,0.0055133667017789,-0.0106968489303352,0.0109155485406381,0.984176488930577
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,-4.89061933144316e-05,0.00278997967153645,-0.00551726634952587,0.005419453962897,0.986014672283531
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,40116,-0.00013511750105861,0.00938082668661744,-0.0185215378068288,0.0182513028047116,0.988508265199756
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,-5.91456880884666e-05,0.00616189743579917,-0.0121364646622548,0.0120181732860779,0.992341702361561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,-8.86546543403012e-05,0.0104745664379901,-0.020618804872801,0.0204414955641204,0.993247070772377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,-7.53996547029437e-06,0.0025912026105156,-0.00508629708208087,0.00507121715114028,0.997678336218754
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP29,Dual specificity phosphatase 29,40182,1.91550889667533e-05,0.00659163090123656,-0.0129004414774569,0.0129387516553904,0.99768142653383
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,2.607101978658e-05,0.0094342922731846,-0.0184651418356552,0.0185172838752284,0.997795154169281
